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VOORWOORD 
Doel van het onderzoek 
Gewervelde dieren beschikken over ee~ immuunsysteem waarmee zij lichaams-
vreemde elementen (antigenen) herkennen en onschadelijk maken. Het immuun-
systeem onderscheidt zich van andere afweermechanismen, doordat het in staat 
is lichaamseigen (zelf) en lichaamsvreemd (niet-zelf) van elkaar te onderscheiden. 
Het is niet aileen betrokken bij de bescherming tegen ziekteverwekkers als 
bacteriE!n, virussen en parasieten welke het lichaam van buitenaf binnendringen, 
maar het is oak in staat om te reageren tegen bepaalde tumoren, welke binnen 
het lichaam (zijn) ontstaan. 
De lymfocyten, die behoren tot de witte bloedcellen of leukocyten, staan 
centraal in het immuunsysteem. Lymfocyten Iaten zich op grand van hun 
funktionele eigenschappen in twee groepen onderscheiden, de B en T lymfo-
cyten. 
De B lymfocyten zorgen voor de z.g.n. humorale immuniteit, d.w.z. immuni-
teit die wordt veroorzaakt door oplosbare verbindingen, de z.g.n. antistoffen, 
oak wei antilichamen genoemd. Plasmacellen, de uitgerijpte nakomelingen van B 
lymfocyten, produceren deze antistoffen welke d.m.v. het bloed en de lymfe 
door het hele lichaam getransporteerd worden en daardoor op grate afstand van 
de antistofproducerende plasmacel hun werking kunnen uitoefenen. Chemisch 
gezien zijn antistoffen eiwitten, die immunoglobulinen (lg) worden genoemd. 
Antistoffen spelen een belangrijke rol bij de afweer tegen bacterien en 
virussen. 
De T lymfocyten zorgen voor de cellulaire immuniteit, d.w.z. immuniteit die 
veroorzaakt wordt door een direkte interaktie tussen de T lymfocyt en het anti~ 
geen. Zo kan de interaktie van bepaalde T lymfocyten (cytotoxische T lymfo-
cyten) leiden tot vernietiging van met virus geihfekteerde lichaamscellen. Andere 
T cellen produceren faktoren welke op korte afstand hun werking hebben, zoals 
faktoren die fagocyten aanzetten tot het doden van intracellulair groeiende bac-
teri8n (b.v. Listeria monocytogenesL of faktoren die vertraagd type overgevoelig-
heidsreakties teweegbrengen (b.v. een positieve Mantoux reactie bij mensen die 
een infektie hebben doorgemaakt met tuberkelbacillen). In tegenstelling tot de 
humorale immuniteit, welke met serum naar andere individuen kan worden 
overgedragen, kan de cellulaire immuniteit aileen via cell en worden overgedragen. 
Naast de hierboven beschreven funkties vervullen T lymfocyten oak een be-
langrijke rol bij de regulatie van de immuunreaktie. T helper cellen zijn nood-
zakelijk voor de antilichaamvorming tegen bepaalde antigenen. T amplifier cell en 
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kunnen de immuunreaktie versterken, terwij! T suppressor cellen de immuun-
reaktie juist kunnen remmen. 
Naast het vermogen tot specifieke herkenning van antigenen is een tweede 
kenmerk van het immuunsysteem het bezit van een 'geheugen'. Wanneer een 
individu een bepaa1de infektie voor de eerste maal doormaakt, zal het enige 
dagen duren voordat het immuunsysteem specifiek reageert tegen de binnen-
gedrongen ziektekiemen. We spreken dan van een primaire immuunreaktie. 
Bij een herhaald kontakt met hetzelfde antigeen is de afweerreaktie vaak sterker 
en komt deze sneller op gang. We spreken dan van een sekundaire immuun-
reaktie. Door deze sne!!ere en sterkere immuunreaktie kunnen binnendringende 
ziektekiemen sne! en effektief onschade!ijk worden gemaakt, waardoor een 
infektieziekte wordt voorkomen. Op dit verschijnsel, dat meestal wordt aan-
geduid als immunologisch geheugen, berust de bescherming van vaccinatie tegen 
infektieziekten. Door de specificiteit van lymfocyten voor een bepaald antigeen 
of voor nauwverwante antigen en, is ter bescherming tegen verschi11ende infektie-
ziekten voor elke ziekte een afzonder!ijke vaccinatie met het betreffende 
antigeen nodig. Met andere woorden, het geheugen van het immuunsysteem is 
antigeen specifiek. 
Om lichaamseigen 'antigenen' {z.g.n. 'ze!f') te kunnen onderscheiden van andere 
antigenen {'niet-zelf') worden op de cel!en van elk individu een aantal verschil-
lende weefselkenmerken tot expressie gebracht. De genen die voor deze 
determinanten coderen zijn sterk polymorf. Dat wil zeggen dat van elke deter-
minant die door een van deze genen wordt gecodeerd, verschi!lendetypen bekend 
zijn. Dit brengt met zich mee dat elk individu een uniek patroon van erfe!ijk 
bepaalde weefselkenmerken bezit. Juist om deze reden is het bijzonder moeilijk 
om tussen individuen van dezelfde species weefsels uit te wisse!en. Weefsels van 
een ander individu worden a!s 'niet-ze!f' van de eigen weefsels onderscheiden, 
waarna het immuunsysteem wordt geaktiveerd en het transplantaat wordt 
afgestoten. 
De genen welke coderen voor de belangrijkste weefse!kenmerken zijn het eerst 
bij de muis ontdekt door de sterke transplantaat afstotingsreakties die warden 
waargenomen toen men (tumor-)weefsel transplanteerde van de ene ingeteelde 
muizestam naar de andere. Men heeft deze weefselkenmerken transplantatie-
antigenen of histocompatibiliteitsantigenen genoemd. 
Bij de mens zijn de weefse!kenmerken, die de sterkste afstotingsreakties ver-
oorzaken, gelokaliseerd in een genencomp!ex. Dit genencomplex wordt aangeduid 
met de term 'Major Histocompatibility Complex' (MHC), bij de mens ook wei 
het HLA complex genoemd. Dergelijke MHC complexen zijn ook aangetoond bij 
de muis (H-2), de rat I Rt1), de hand (D LA) en bij tal van andere gewervelde 
dieren. _Dit genencomplex speelt ook een belangrijke rol bij de afweer tegen aller-
lei bacteriele, virale en andere antigenen. T tymfocyten reageren namelijk a!Jeen 
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tegen vreemde antigenen wanneer deze worden herkend in combinatie met 'zelf' 
{MHC) determinanten. Aan deze voorwaarde van antigeenherkenning in combi-
natie met 'zelf' herkenning wordt o.a. voldaan na antigeenpresentatie door fago-
cyterende eel len, die het antigeen presenteren op het celoppervlak in combinatie 
met MHC determinanten, of door herkenning van virusantigenen in combinatie 
met MHC determinanten op de membraan van geinfekteerde lichaamscellen. 
Verschillen in een of meerdere loci van het MHC tussen donor en ontvanger 
vormen bij klinische toepassing van orgaan- en weefseltransplantatie nog steeds 
het belangrijkste probleem door de sterke afstotingsreakties die deze verschillen 
veroorzaken. Om afstotingsreakties te voorkomen wordt gebruik gemaakt van 
verschi!lende immunosuppressiva. Deze midde!en hebben een onderdrukking van 
het immuunsysteem tot gevolg, die niet beperkt is tot de afweer tegen het 
getransplanteerde orgaan of weefseL Hierdoor zijn getransplanteerde pati8nten 
vaak erg vatbaar voor infekties. Bovendien is er, om onduidelijke redenen, een 
verhoogde kans op het ontstaan van tumoren bij pati8nten die met immuno-
suppressiva worden behandeld. Daarnaast hebben immunosuppressiva nog andere 
nadelige bijwerkingen. Om deze prob!emen te vermijden is het wense!ijk om de 
afstotingsreaktie tegen de transp1antatie antigenen van de donor selectief te 
onderdrukken, terwijl de rest van het immuunsysteem ongestoord biijft funktio-
neren. Hlervoor is een grotere kennis nodig van de regulatie van de immuun-
reaktie tegen transplantatie antigenen. In dit proefschrift worden experimenten 
beschreven waarbij gebruik gemaakt is van een muizen-proefdiermodel. Bij vee! 
transplantaatafstotingsreakties speelt de cellulaire immuniteit een centrale rol. 
Een van die vormen van ce!lulaire immuniteit is de vertraagd type overgevoelig~ 
heidsreaktie. In dit proefschrift wordt ons onderzoek beschreven naar de regula-
tie van vertraagd type overgevoeligheidsreakties tegen transplantatie antigenen. 
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CHAPTER I 
GENERAL INTRODUCTION 
The failure of successful exchange of tissues and organs between individuals of 
the same species is mainly due to the expression of histocompatibility (H) anti-
gens on the cell surface of the transplanted tissues. Every individual has a unique 
set of genetically determined H-antigens. 
Gorer and Snell (1) found in their studies with inbred mouse strains that a 
single locus, situated on chromosome 17, controlled a cell surface antigen (which 
they called, antigen II) that elicited remarkable rapid allograft rejection. Snell 
(2) suggested that loci determining the fate of allografts should be referred to as 
histocompatibility antigens. The locus controling antigen II was called therefore 
histocompatibility antigen 2 locus or H-2 locus. Later studies (3, 4) showed that 
H-2 covered a cluster of loci. This complex of loci is called Major Histo-
compatibility Complex or MHC. Similar MHC's have been described in man 
(HLA complex) (5), in rat (Rt1 complex) (6), in dog (DLA complex) (7) and in 
several other vertebrates (8). 
Because of their capacity to induce rapid allograft rejection, the MHC coded 
antigens were called 'strong' or 'major' histocompatibility antigens and the 
antigens coded for by other loci were referred to as 'weak' or 'minor' histo-
compatibility (H) antigens (9). A striking quality of most MHCs is their poly-
morphism. The significance of this polymorphism is still a matter of speculations 
(1 0). 
The experiments described in this thesis deal with the regulation of the 
immune response of mice against H-antigens. Therefore the structure and 
function of the MHC of the mouse will be described in more detail. 
1.1. The H-2 complex 
Since the discovery of the H-2 complex, a large number of different traits 
have been associated with this gene complex (11). However, the main natural 
function, which can be ascribed to the MHC up-till now, is the control or guidance 
of the immune system (12, 13). Obviously, the fact that MHC molecules are able 
to function as antigens in case tissues are transplanted from one individual to 
another is non-physiological. 
Very complicated maps and schemes of the H-2 complex have been presented 
in which all the in vivo and in vitro immunological traits are indicated. Recently, 
Klein (12, 14) published a more convenient map (fig. 1) This map shows primarily 
the well defined loci of the H-2, the molecules coded for by these loci and the 
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Fig. 1. Loci composing the mouse H-2 complex and their products (adapted from J. Klein (14)). 
The various loci of the H-2 complex are divided into four classes. K, D and l, usually 
indicated as H-2K, H-20 and H-2L, represent class I loci. Each of these loci is coding for a 
glycoprotein heavy chain of 43.000 to 45.000 molecular weight {MW) (15). The heavy 
cha·m is non-covalently bound to a light cha"m. The l'lght chain, .62-microglobunn, is a 
glycoprotein with a MW of about 12.000, which is coded for by a locus on chromosome 2 of 
the mouse. Class I products are expressed on cells of a! I somatic tissues. The concentration of 
these molecules on macrophages and lymphocytes is higher than on other cells (15, 16). 
Acx, All, E{3 and Ea are class II loci. These loci are situated together in one region of the 
H-2 complex, which is called the H-21 region. The class II molecules A and E are heterodimers 
composed of an a: chain, a 32.000 to 35.000 MW glycoprotein (Aa and Ea), and all chain, a 
28.000 to 31.000 MW glycoprotein (All and Ell) (17), The A and E molecules are almost 
exclusively expressed on macrophages and B lymphocytes (16, 17). Several H-2 maps indicate a 
J locus in between Eo and Ecx. The products coded for by the J locus have been mainly 
serologically defined, The existence of a J locus inside the H-21 region is still a matter of 
debate (18). The genetic code between E{3 and Ea appeared to be too small for all the traits 
of the J locus (17). The J locus has been claimed to code for one or more soluble T cell 
factors and cell surface antigens on macrophages and T cells, which may be involved in T cell 
suppression (16), 
Class Ill loci cover twoS loci situated in the H-2S region, which are coding for some serum 
proteins (C4) (16), while class IV loci are situated in the H2-Tia region (19). The Tla locus is 
coding for an antigenic determinant on thymocytes and certain leukemias. Other lad of the 
Tla region are Oa-1, Qa-2 and Oa-3 which are coding for antigenic determinants on different 
lymphocyte subpopu!ations. Some molecules like the products of Tla and Oa-2 are strikingly 
similar to the products of the K and D loci. All have a MW of approximately 44.000 dalton 
and are associated wi.th ll2-microglobulin. 
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assoc1at1on between these molecules or the association of H·2 molecules with 
molecules coded for outside the H-2 complex when they are expressed on the 
cell surface. The most important loci are situated in the K, I and D region of the 
H-2 complex. The K and D loci are coding for so-called class I molecules and the 
I loci for class II molecules. 
The products of two different alleles of a single locus, which are inherited 
from both parents, are codominantly expressed on the cell surfaces of the 
offspring. 
1.2. Genetic aspects of immune regulation 
1.2. 7. H-2 restricted recognition 
One of the main functions of the MHC molecules is to serve as markers of self 
in the recognition of non-self by T lymphocytes. Zinkernagel and Doherty (20) 
described this function of H-2 molecules for the first time. T lymphocytes from 
lymphocytic choriomeningitis virus I LCMV) infected mice could lyse LCMV 
infected targets only if they expressed the same H-2 molecules as the donor of 
the effector cells. H-2K and/or H-2D molecules were found to be the restriction 
elements for the cytotoxic T lymphocytes (21). In vitro studies also showed that 
helper activity by helper T cells needed for antibody formation depends on 
presentation of antigen by macrophages which express the appropriate H-21A 
restriction element (22). Delayed type hypersensitivity (DTH) experiments 
showed that the in vivo immune response is also subject to H-2 restriction. 
DTH reactions against virus infected cells were H-2K/H-2D restricted (23) and 
DTH against Listeria monocytogenes was found to be restricted by H-21 coded 
molecules (24). 
The need for self recognition can be explained from a teleological viewpoint (25). 
Cytotoxic T cells lyse virus infected cells to prevent viral replication and do not 
interact with free virus particles, because the virus infected cells are the most 
important threat for survival. Interaction with free virus would be very inefficient. 
Viruses are able to infect different cell types. As class I molecules are expressed 
on all cell types, recognition by cytotoxic T cells of virusantigen in combination 
with K and/or D restriction molecules on a cell's surface is an appropriate signal 
to lyse an ir.fected cell (23, 25). 
For intracellularly growing bacteria and parasites the situation is different. 
When cells, expressing the antigens of intracellularly growing bacteria and class I 
molecules, would be lysed by cytotoxic T cells, the bacteria would not be 
eliminated. lntracellularly growing pathogens are only internalized by phagocytic 
cells like macrophages. These cells bear next to class I molecules, other restriction 
elements, namely class II molecules (25, 26). Recognition of bacterial antigens ·m 
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combination with class II restnct1on molecules, is sufficient for activation of 
helper type T cells, which in turn can activate macrophages to kill the intracellular 
bacteria.The requirement of class II restricted recognition of bacterial antigens 
by helper type T cells prevents inefficient interaction of these T cells with free 
bacteria. 
Restricted recognition has also been described for 'non physiological' immune 
responses like in vivo responses against H-antigens. DTH effector cells specific 
for minor H antigens appeared to be H-2K/D restricted (27). while Korngold and 
Sprent (28) described H-2 restricted recognition of minor H antigens in a Graft· 
versus-Host IGvH) mortality assay. 
1.2.2. Immune response genes 
The magnitude of the T cell responses to a number of antigens, including T 
cell dependent humoral immune responses, has been shown to be regulated by 
the H-2 complex. Benacerraf and McDevitt (29) showed that the phenomenon of 
antigen-specific high and low responsiveness in guinea pigs and mice was genetically 
determined. The immune response (I r) genes responsible for this phenomenon 
have been mapped within the MHC (30, 31 ). 
Two major mechanisms are proposed for the lr gene function (26, 32, 33). 
The lr genes could operate by controlling the T cell receptor repertoires or by 
controlling antigen presentation to T cells. These hypotheses explain the non-
responder status by a gap in the T cell repertoire and an inadequate association 
between MHC molecules and foreign antigens onthesurfaceofantigen-presenting 
cells, respectively. No conclusive evidence for either hypothesis has been published 
as yet (34- 36). 
Other studies showed that the non-responder status of certain mouse strains 
depends on suppressor T cells (37, 38). The suppressor T cells, which suppress 
the antibody formation against the antigen lactate dehydrogenase B ILDH-B). 
are only induced by LDH-B inthecontextof H-2E moleculesofthe k orb haplotype. 
1.3. Cellular aspects of immune regulation 
1.3.1. Memory lymphocytes 
Immunization not only induces the generation of antigen specific effector 
lymphocytes, but also the generation of antigen specific immunological memory. 
In general, immunological memory is defined by a more vigorous and faster 
immune response after secondary contact with the specific antigen. B cell as well 
as T cell memory occur (39). 
8 cell memory is characterized by quantitative as well as qualitative differences 
as compared to the naive situation (40). T cell memory, on the other hand, is 
characterized by a quantitative change only (41, 42). T cell memory is the result of 
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an increased frequency of antigen specific T lymphocytes. In contrast to virgin 
lymphocytes, memory lymphocytes are long-lived small lymphocytes. For 
secondary type humoral immune responses (43, 44) and fora memory phenomenon 
of cellular immunity like resistance against Bacillus Calmette Guerin (45), it has 
been shown that the memory T cells have the capacity to recirculate. 
In vitro assays for mixed lymphocyte reactions and cytotoxic T cell responses 
demonstrate more vigorous responses after secondary than after primary contact 
with the antigen (46, 47). Limiting dilution analyses show a considerablefrequency 
raise of proliferating T cell precursors (PTL-P) and cytotoxic T cell precursors 
(CTL-P) (47). However, the results from in vitro studies are not necessarily 
representative for the in vivo situation. Ryser eta!. (47) have shown that in vivo 
immunization with H-21 alloantigens hardly affects the frequency of the alia-
antigen specific PTL-P, while the 3 to 4 times increase of the H-2K and H-2D 
specific CTL~P upon in vivo immunization with these antigens is relatively small 
as compared with the increase under in vitro conditions. 
1.3.2. Enhancing T- T cell interactions 
Synergism between T cells has been first described by Cantor and Asofsky 
(48, 49). They found that two populations ofT lymphocytes synergize in GvH 
reactions, measured with a splenomegaly assay. One class, T1 cells, is found 
mainly in spleen and thymus and is resistant to in vivo treatment with anti-
thymocyte serum (ATS) and sensitive to adult thymectomy (ATx). The second 
class, T2 cells, is susceptible to ATS treatment in vivo and is ATx resistant. 
T1-T2 cell synergism has also been demonstrated in vitro for the helper 
function in anti-hapten antibody formation (50) and in mixed lymphocyte reactions 
(51, 52) and in vivo in alloantigen specific DTH assays (53, 54). In the DTH 
studies, the T1 and T2 cells were activated against alloantigens under GvH 
conditions. It could be demonstrated that DTH effector T cells specific 
for alloantigens coded for by genes of the H-21 region (53) or the Mls locus 
(54) were the progeny of long-lived, recirculating T2 cells. The responses could 
be amplified by short-lived, sessile T1 cells. Activation of amplifier cells was 
induced by H-2K or minor-H coded alloantigens. 
1.3.3. Suppressor T lymphocytes 
The induction of immune reactivity and tolerance depends on the dose of 
antigen (55, 56), on the route of antigen administration (56, 58) and on the 
antigen form (57 - 59). Tolerance may depend on either shortage of antigen 
reactive cells or on active suppression mediated by suppressor T cells (58, 60, 
61 ). 
The first description of suppressor T (Ts) cell activity was given in 1970 by 
Gershon eta/. (62). From that moment on, Ts cell activity has been established 
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in a variety of assays, concerning different immune functions. 
Suppression of cellular immunity of mice by intravenous (iv) preimmunization 
is a well-known phenomenon. Most of the studies deal with suppression of DTH 
reactivity against heterologous erythrocytes (63, 64) and haptens (56, 58 - 60). 
Some of them have shown that the development of suppressor cell activity 
depends upon complex interactions of three subsets of Ts cells in a regulatory 
circuit under control of lgh and H-2 genes (61). The first subset of suppressor 
cells, Ts1, affects the induction phase of the immune response, while Ts2 and 
Ts3 are involved in suppression of the expression phase. These suppressor cells 
are acting by means of suppressor factors (TsF). Since T cell hybridomas have been 
made from the three different subsets of Ts cells, producing TsF1, TsF2 and 
TsF3, respectively (65), the function and composftion of the suppressor factors 
can be studied (66). 
lv induction of Ts cells have also been described in assays dealing with cellular 
immunity against H-antigens, e~g., suppression of skin and heart allograft rejection 
(67- 69). However, in these experiments, in addition to iv preimmunization with 
donor antigen, pretreatment with antilymphocyte serum (67) or cyclophospha-
mide (68) is necessary to reveal the suppressive effect by the Ts cells. 
1.4. Anti-allograft reactivity 
Antibody as well as cellular mechanisms may account for allograft rejection, 
Generally, antibody plays a minor role. Most attempts to reproduce organ graft 
rejection by adoptive transfer of immune sera have been unsuccessful (70, 71). 
Administration of antibodies specific for the alloantigens of the graft can even 
result in a prolonged survival (72, 73). This phenomenon has been called 
enhancement (74), and is highly dependent on the lg (sub)class of the specific 
antibodies, lgG1 and lgG2 being the most effective (75). An oversimplification 
should not be made, because antibodies can also cause 'hyperacute' allograft 
rejection, e.g., in the case of kidney allografts (72). 
Medawar eta!. (76) described already in 1958 the correlation between DTH 
reactivity and skin graft rejection. Govaerts (77) suggested in 1960 the 
involvement of cytotoxic lymphocytes in allograft rejection. 
For a long period the cytotoxic T cell was supposed to be the major effector 
of graft rejection (78). However, recent immunogenetic studies showed a strict 
correlation between (H-Y specific) DTH and skin graft rejection. Both events 
appeared to be controlled by the same lr genes, while H-Y specific cytotoxic T 
cells are controlled by other lr genes (79, 80). Transfer studies with different T 
cell subpopulations in mouse (81) and rat (82) showed that skin and organ 
allograft rejection is mainly dependent on lymphoid cells of the T helper/DTH 
phenotype. Moreover, these studies also showed a close correlation between skin 
graft rejection and DTH reactivity after reconstitution of the irradiated recipients 
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with lymphoid cells of the T helper!DTH phenotype. Thus, helper/DTH reactive 
T cells play an important role in allograft responses. 
1.5. Clinical transplantation 
After blood transfusion, kidney transplantation is the most common application 
of clinical transplantation. Also in the human situation the MHC coded antigens 
(H LA) induce the strongest allograft reactions. Therefore, H LA typing is done of 
the kidney donor and prospective recipients, in order to be able to choose the 
most compatible combination (83, 84). Because of the polymorphism of the 
H LA loci, incompatibilities between donor and recipient are, with some 
exceptions, inevitable. The anti~allograft response of the recipient is still the 
major problem of clinical organ transplantation. All patients, who receive 
allogeneic transplants, are treated with immunosuppressive drugs like cyclo-
phosphamide, azathioprine and cortison to prevent or minimize allograft rejections 
(85). Another example of immunosuppression is treatment of patients with anti-
thymocyte serum (ATS) (86). This is a xenogeneic antiserum specific for the 
recipients' lymphocytes, particularly T lymphocytes. These agents nonspecifically 
affect the immune system. As a consequence, they decrease the general 
body resistance against infections. Furthermore, they increase the incidence 
of malignancies and have several other undesirable side effects (85). More 
recently a promising immunosuppressive drug, the antibiotic cyclosporin A, has 
been introduced. The first randomized clinical trials on the effect of cyclosporin 
A as compared to conventional immunosuppressive therapy seem to show an up 
to 20% increased survival after 1 year in patients receiving cyclosporin A (87). 
Among other effects cyclosporin A has been claimed to interfere with the 
acquisition of responsiveness to growth factors byT lymphocytes (88, 89). 
In 1973 Opelz eta!. (90) described the beneficial effect of preoperative blood 
transfusion on kidney transplant survival. Initially, the report about the 
beneficial effect of blood transfusion was a matter of disagreement. Since other 
studies confirmed the original observation, the beneficial effect of blood 
transfusion by itself has become generally accepted (83, 91 ). Several explanations 
for the phenomenon have been given (92). The possibility that the transfusion 
effect may depend on selection of 'nonresponder' patients has been rejected by 
most of the investigators who are studying the transfusion effect. Several studies 
suggest that specific anti-idiotypic antibodies and/or enhancing antibodies 
play a role in the transfusion effect. Many investigators suggest that Ts cells are 
involved in the blood transfusion effect. 
Recently, Terasaki (93) presented the hypothesis that the blood transfusion 
effect is due to priming for a secondary anti-allograft response. A patient primed 
by preoperative blood transfusions should respond with a strengthened and 
accelerated anti-allograft response. An earlier appearing anti-allograft response 
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should be more vulnerable for the immunosuppressive drugs which are 
applicated in highest dosages during the period just after transplantation. This 
hypothesis is attractive by its simplicity. However, it bypasses the dominant 
suppression by blood transfusion, which has been demonstrated in several 
studies (67- 69, 92). 
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CHAPTER II 
INTRODUCTION TO THE EXPERIMENTAL WORK 
Delayed type hypersensitivity reactions can be elicited in sensitized individuals 
by local application of antigen. The expression of a local DTH response is 
characterized by infiltration of inflammatory cells and accumulation of 
edematous fluid at the site of antigen application (1 ). The onset of this inflam-
matory reaction is strictly dependent on the activation ofT lymphocytes by the 
specific antigen. The activated lymphocytes release vasoactive factors which 
cause influx of other lymphocytes, mononuclear cells and granulocytes to the 
site of antigen application (2, 3). DTH responses are maximal about 24 to 96 hr 
after elicitation. The phenomenology of DTH varies considerably and depends on 
the species tested and the antigen used (4). 
In mice, DTH can be elicited easily by subcutaneous (sc) injection of a 
'challenge' dose of the specific antigen in a hind foot of sensitized mice. The 
increase of foot thickness of the sensitized animals is corrected for the non-
specific swelling caused by antigen injection in the foot of naive animals. The 
corrected response is the antigen specific DTH response. DTH responses in mice 
have been induced with a variety of antigens e.g., fungal, protozoal and viral 
components, chemically defined molecules, serum proteins, heterologous 
erythrocytes and H-antigens (1 ). The DTH assay is a quick and reliable assay for 
in vivo studies on cellular immunity. 
In this thesis the genetic and cellular regulation of in vivo cellular immunity of 
mice against conventional- and H-antigens was studied by means of the DTH assay. 
The existence and the availability of a large number of different congenic 
mouse strains and of different H-2 recombinant mouse strains make the mouse 
very suitable for these studies (5). DTH constitutes one aspect of the in vivo 
cellular immune response, and plays an essential role in anti-allograft reactions 
(viz. 1.4). Earlier studies on our laboratory were focussed a.o. on the role ofT 
cell subsets in DTH against S R BC (6) and H-antigens (6-8), on the requirements 
for H-2 restricted recognition of DTH against minor H·antigens (9) and on the 
induction and expression of secondary type DTH against SRBC (1 0, 11) and 
minor H-antigens (12). 
The studies described in this thesis throw light upon new aspects like the 
relation between helper T cells and DTH reactive T cells, the recirculation 
properties of memory cells involved in secondary type DTH responses, the genetic 
requirements for the induction of primary and secondary DTH reactivity against 
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H-2 coded alloantigens, and upon the specificity of and the cellular and genetic 
requirements for iv induced suppression of alloantigen specific DTH. 
A better understanding of the regulation of cellular immunity against H-anti-
gens will be useful for a better understanding of immune reactivity against 
'natural' antigens. Furthermore, it will, in the long run, be helpful to develop 
more specific immunosuppression therapies for clinical transplantation. 
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It is now well established that in the mouse, helper T cells and killer T cells 
are two distinct thymus-derived lymphocyte subpopulations, differing from each 
other in Lyt phenotype and H-2 restriction, among other parameters. Helper T 
cells are Lyt-1+ and their action in immune responses involves restriction at the 
H-21 region of the major histocompatibility complex (MHC) (1, 2). Killer cells, 
on the other hand, are Lyt-23+ and their activity is restricted by H-2K/D (1, 3). 
In most instances, T cells mediating delayed-type hypersensitivity (DTH) responses 
share the Lyt phenotype and H-2 restriction of the helper T cell (4-7). This raises 
the question of whether or not helper activity and DTH can be mediated by the 
same activated T cell. Arguments for both views have been reported (8-12). We 
analysed this question using clones of specific helper T cells, which were obtained 
by long-term culture in vitro of in vivo primed T cells, followed by single-cell 
cloning (13-15). Here we show that these clones of helper T cells mediate 
antigen-specific and fully H-2-restricted DTH. The restricting element lies to the 
left of the 1-B region in genetic maps of the mouse MHC. 
Long-term cultured, cloned and subcloned sheep or horse red blood cell-
specific helper T cells (T' SRC• T' H RC respectively). which have been maintained 
for 5-24 months in culture and previously shown to function as helper T cells 
in vitro (13-15) and in vivo (15), were examined for DTH activity. This DTH 
responsiveness was assayed by means of the immune lymphocyte transfer assay 
(16). As few as 1,000 cloned helper T cells, injected together with SRC into 
syngeneic recipients, caused a significant DTH response which increased in 
severity as the dose ofT cells increased (Fig. 1). In comparison with in vivo 
activated lymph node cells, the cloned helper T cells were far more effective on 
a per cell basis. At least 1 o3 times more in vivo activated cells were required to 
induce a response of similar magnitude (Fig. 1, right). As controls, the other 
footpad of the mice was injected with cloned helper T cells without antigen or 
with an irrelevant antigen - in neither case was a DTH response induced. DTH 
responses were mediated equally well by other clones of T'sRC and T'HRC and 
by four different clones of egg albumin-specific helper T cells when injected 
together with the relevant antigen. 
The H-2 restriction of cellular interactions involved in DTH responses (17) 
was examined using a clone of T'sRC and a subclone of T'HRC· Absolute H-2 
restriction was observed in both instances. Results obtained with T'sRC (clone 
26-14) are shown in Fig. 2. The C578 L/6J-derived cloned helper T cells mediated 
DTH responses only in the C57BL/6J and B10.A(5R) recipients. B10.HTT mice 
(incompatible with C57BL/6J mice for the whole H-2 complex) and B10.A(4R) 
mice (incompatible at H-2K and 1-A) did not show any DTH reactivity on 
injection of the cloned helper T cells plus antigen. It should be stressed that this 
results was found after transfer of 3.3 x 104 viable T cells, which is about 30 
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times the number of cells required to induce a significant response in a syngeneic 
combination. This result shows that the T cell-macrophage interactions which 
underlie these DTH responses (17) are restricted by either H-2K or 1-A. 
Appropirate congeneic strains were not available at the time of these experiments 
for distinguishing between K- or !-A-region restriction. However, the action of 
helper T cells in immune responses in vivo has been demonstrated to involve 
restriction only at 1-A (2). 
The antigen-specific and H-2-restricted induction of DTH response with 
cloned helper T cells in normal mice does not exclude the participation of host T 
cells at the effector level. We have therefore the DTH response induced by cloned 
helper T cells in congeneic nu/nu mice (Fig. 2). The DTH response in these T 
cell-deficient animals showed the same kinetics as and was of similar magnitude 
to that observed in thymus-bearing, !-A-compatible mice. This result indicates 
that host T cells are not essential for the response and that the cloned helper T 
cells are the DTH effector cells. 
Many investigations have attempted to establish the relationship between 
helper T cells and DTH effector cells (8-12). Although some studies pointed to 
an inverse relationship between the in vivo occurrence of activated helper T cells 
and DTH effector cells (8-1 0), others have found that helper activity and DTH 
can coincide (11, 12). These experiments were carried out with uncloned T-cell 
populations and failed to prove that both responses can be mediated by the same 
cell. However, our experiments show unequivocally that helper T cells can 
mediate DTH responses which were observed not only in the local immune 
lymphocyte transfer assay, but also after intravenous injection of these cells. 
Mice infused with 1-3 x 106 cloned helper T cells responded to antigen challenge 
to the hind footpad with a smaller but significant DTH response. This requirement 
for much higher numbers of cells may be due to changes in recirculation and 
homing properties brought about by long-term in vitro propagation. Similar 
observations were made in clonally reconstituted nu/nu mice where 1-5 x 106 
of the same cloned helper T cells were required to induce specific antibody 
responses comparable with or higher than those observed in thymusbearing mice 
(15). 
Obviously, our results do not argue against the possibility that T cells other 
than helper T cells may also mediate DTH reactivity. Several studies have shown 
that DTH to allogeneic cells can be transferred by Ly-2+ cells (7) and that 
contact sensitivity to dinitrofluorobenzene (6) and DTH to non-H-2 alloantigens 
(18) and viral antigens (19) can be H-2K/D restricted. Indeed, it has been reported 
that T cells mediating DTH and cytotoxic T cells could not be separated by size, 
density or antigen-binding properties (20). 
The clones of helper T cells used for these studies have been shown to release 
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Fig. 1. DTH sensitivity by different numbers of long-term cultured C57BL/6J-derived, SAC-
specific helper T cells (clone 526-14) (left), and by different numbers of lymph node cells 
which were activated in vivo by subcutaneous immunization of C57BL/6J mice with 2 x 
107 SRC (right). The cells to be tested were injected together with 5 x 107 SRC in a volume 
of 50 ,u:l into the instep of the right hind leg of C57BL/6J female mice (lnstitut fOr Biologisch-
Medizinische Forschung AG). Recipient mice injected with cloned SRC-specific helper T cells 
plus SRC in the right hind leg received the same number of H RC-specific helper T cells (sub-
clone 18-33-3) together with 5 x 107 SRC in the lett hind leg. Recipient mice which received 
in vivo activated lymph node cells plus SRC in the right hind leg received the same number of 
non-activated lymph node cells and 5 x 107 SRC in the left hind leg. At 24 h after injection 
the thickness of the h"md feet was measured. DTH responses are expressed as the specific% ·In-
crease in foot thickness, and were calculated as (thickness right foot- thickness left foot}/ 
thickness left foot x 100%. Horizontal bars represent 1 s.e.m. (n = 7). ND, not determined.*, 
The establishment and maintenance of the long-term cultured specific helper T cells has been 
described previously (13-15). t. The activated lymph node cells were obtained by collecting 
the inguinal and axillary lymph nodes of C57BL/6J mice 4 days after subcutaneous immuni-
zation with 2 x 107 SRC, equally distributed over the inguinal and axillary areas. The non-
activated lymph node cells were obtained from naive C57BL/6J mice. 
several biologically active mediators, the induction of which is strictly antigen 
specific and H-2 restricted (13, 14, 21-23). So far, factors affecting B-cell (21, 
22) and T-cell (14) growth and in vitro colony formation by granulocytic, 
macrophage and erythroid precursor cells (23) have been discerned. Soluble 
factors have been indicated in the induction of the DTH lesion (24). Histo-
logically, the DTH response mediated by cloned helper T cells ·m nu/nu and 
normal mice was indistinguishable from other Jones-Mote-type DTH responses. 
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Fig. 2. DTH reactivity mediated by cloned SRC-specific helper T cells was tested for H-2 
restriction. Recipient mice (all from the lnstitut fUr Biologisch-Medizinische Forschung AG) 
were injected with 3.3 x 104 SRC-specific helper T cells (clone 526-14) and 5 x 107 SRC 
in a volume of 50 Jll in the instep of the right hind foot, and with 3.3 x 104 HRC-specific 
helper T cells (subclone 18-33-31 and 5 x 107 SRC in the instep of the left hind foot. At 24 h 
after transfer the thickness of the hind feet was measured. DTH responses are expressed as the 
specific percentage increase in foot thickness and calculated as described in Ftg. 1 legend. 
Horizontal bars represent 1 s.e.m. (n = 7). 
The nature of the cellular infiltration strongly indicates the release of chemotactic 
factors. Clones of helper T cells may help to characterize these activities. In 
addition, the DTH response is the most rapid assay to date for screening cloned 
and uncloned helper T cells for specificity and H-2 restricted activity. The assay 
is as sensitive and reproducible as the in vitro assay for specific helper activity. 
Moreover, the cellular nature of the 1-A-bearing, antigen-presenting cells may be 
identified by their simultaneous injection with helper T cells into 1-A-incom-
pati ble hosts. 
We thank Drs. K. Fischer-Lindahl and H. v. Boehmer for their critical reading 
of the manuscript. The Basel Institute for Immunology was founded and is 
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ABSTRACT 
Secondary delayed-type hypersensitivity iDTH} in mice to sheep red blood cells {SRBC) 
and minor histocompatibility (H) antigens is dependent on long-lived memory T cells. In this 
paper we investigated whether these memory T cells recirculate. It was shown that late phase 
'immune' thoracic duct lymphocytes {TDL) from mice which were immunized with SRBC or 
non-H-2-incompatible spleen cells several weeks previously could adoptively transfer secondary 
DTH to these antigens. Passing the immune TO L through intermediate recipients demonstrated 
that these SRBC- or minor H-antigen-reactive memory T cells recirculate from blood to lymph. 
In contrast to mice immunized with minor H antigens, no secondary type DTH reactivity 
could be demonstrated in mice immunized with H-2-incompatible spleen cells. Also after 
adoptive transfer of TDL from mice immunized with H-2 a11oantigens, it was impossible to de· 
monstrate an accelerated DTH reactivity. 
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INTRODUCTION 
Previous studies from our laboratory have shown that the secondary type 
responsiveness for delayed-type hypersensitivity (DTH) to sheep red blood cells 
(SRBC) (1) and to minor histocompatibility (H) antigens (2) in mice is a long-
lived memory phenomenon. The secondary type DTH is characterized by an 
accelerated reappearance of the state of DTH after booster injection of the 
antigen. Adoptive transfer experiments with spleen cells from mice primed with 
SRBC or minor H antigens indicate that this memory phenomenon is dependent 
on Thy-1.2+ cells (1, 2). Parabiosis of nonprimed mice and mice primed with 
SRBC indicate that these DTH-related memory T cells are long-lived potentially 
circulating cells (3). 
Studies by others investigating as to whether the long-lived memory cells 
responsible for secondary type cellular immune responses recirculate or mainly 
belong to a resident population suggest that memory T cells can have a variable 
nature. 
Sprent and Miller {4, 5) have shown by means of thoracic duct cannulation 
that the progeny of T cells activated in vivo against H-2 antigens were highly 
enriched in long-lived recirculating T lymphocytes reactive to determinants 
expressed by particular tumor allografts. However, the same population of 
recirculating thoracic duct lymphocytes was unable to mediate increased graft-
versus-host (GvH) or mixed lymphocyte reactivity. Hall eta/. (6) have confirmed 
the data of Sprent and Miller (4, 5) that memory T cells involved in second-set 
allograft rejection can occur in the lymph of sensitized donors but, in contrast, 
showed that the bulk of these long-lived memory T cells are non-recirculating. 
Other memory phenomena in cell-mediated immunity were also found to be 
heterogeneous with respect to the characteristics of the cells involved (7, 8). 
In this paper we investigate by means of thoracic duct drainage whether the 
long-lived memory T cells responsible for secondary DTH to SRBC and minor H 
antigens occur in the lymph of sensitized mice and whether these memory T 
cells recirculate. 
MATERIALS AND METHODS 
Animals 
Female BALB/c (H-2d) mice were purchased from the Laboratory Animals 
Centre of the Erasmus University, Rotterdam, The Netherlands. Female B 1 O.ScSn 
(H-2b) and 810.02 (H-2d) mice were purchased from Olac Ltd., Bicester, U.K. 
The age of the responder mice varied between 12 and 24 weeks. 
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Preparation of cell suspensions 
Mice were killed by carbon dioxide. Spleens or lymph nodes were removed, 
brought into a balanced salt solution (BSS), and squeezed through a nylon gauze 
filter to give single cell suspensions. Bone marrow was collected from femora and 
tibiae and prepared for a single cell suspension as described previously (9). 
Nucleated cells were counted with a Coulter counter Model B. Viable nucleated 
cells were counted in a hemocytometer using 0.2·%trypan blue in BSS as a diluent. 
Antigen and immunization 
Sheep red blood cells were kindly provided by the Central Veterinary Institute, 
Rotterdam, The Netherlands. The cells were stored and washed as described in a 
previous paper from our laboratory (10). Primary and secondary immunization 
was done by i.v. injection of 3 x 104 and 105 SRBC in 0.5 ml of saline, respectively. 
Primary and secondary immunization with H antigens was performed by sub-
cutaneous (s.c) injection of 1 o7 and 1 o6 allogeneicspleen cellsfromtheappropriate 
mouse strain in 0.1 ml BSS, respectively. These doses have previously been 
shown to be optimal (1 ). The antigen dose was equally distributed over both 
inguinal areas. The spleen cells used for primary immunization were ultrasonically 
disrupted to prevent proliferation of the injected allogeneic cells and, thereby, to 
reduce the persistence of the antigen. 
Selective depletion of 8 lymphocytes 
The method described by Julius, Simpson and Herzenberg (11) forthe depletion 
of 8 lymphocytes was used. After incubation for 45 min at 37"C on prewashed 
nylon wool (Fenwall Laboratories, Morton, Grove, Illinois U.S.A.), approxima· 
tely 90% of the recovered lymphoid cells were Thy·1.2·positive (12). 
Thoracic duct drainage 
Thoracic duct fistulas were established essentially according to techniques 
previously described (13). The surgery of the mice was done under Avertin 
(Merck·Schuchardt) anesthesia (14). During drainage, the mice were infused with 
saline at a flow rate of 0.5 ml/hr. Thoracic duct lymphocytes (TDL) were 
collected in 10 ml of Dulbecco's BSS that was supplemented with 50 to 100 I U 
preservative·free heparine. The mice were cannulated for 24 or 48 hrs, and the 
lymph was stored at 4"C. The yield of TDL after 24 hrs drainage of BALB/c 
mice varied between 5 and 10 x 107 cells, and 72% of these cells were Thy·1.2· 
positive (15). The viability of the collected cells was usually 95%. 
Irradiation 
For adoptive transfer, the recipient mice received 5.0 to 6.0 Gy whole body 
irradiation, generated in a Philips·Muller MG 300 X·ray machine (1 ). The recipient 
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mice were i.v.-injected with 3 x 106 bone marrow cells in 0.5 ml BSS within 4 hrs 
after irradiation. One day later, the mice were i.v.-injected with the appropriate 
number of TDL suspended in 0.5 ml BSS. 
Assay for DTH 
DTH reactions were determined by measuring the difference in thickness of 
the hind feet 24 hrs after s.c. injection of 1 x 108 SRBC or 2 x 107 allogeneic 
spleen cells suspended in 0.05 ml BSS into the dorsum of the right hind leg. As a 
control for background DTH reactivity, naive responder mice were used which 
only received the challenge dose. The specific DTH response was calculated as 
the relative increase in foot thickness of the immune mice minus the relative 
increase of the control mice. The foot swelling of the control mice ranged 
between 10 and 15o/. 
RESULTS 
Adoptive transfer of secondary DTH to SRBC and H antigens by thoracic duct 
lymphocytes 
The occurrence of memory T cells for DTH to SRBC and minor H antigens in 
the lymphs of immunized mice was investigated by means of adoptive transfer of 
thoracic duct lymphocytes. In the case of SRBC, female BALB/c mice were 
primed with 3 x 104 SRBC i.v. Three months later, thoracic duct fistulas were 
established, and the 'immune' TDL were collected during 24 hrs. A number of 1 
x 1 o7 viable TDL was adoptively transferred to lethally irradiated BALB/c mice. 
Furthermore, one group of recipients received 1 x 107 viable TDL from non-
immunized donors ('naive' TDL). Both groups of recipients were reconstituted 
with 3 x 106 BALB/c bone marrow cells and immunized with 1 x 105 SRBC i.v. 
On days 2, 3 and 4 after immunization of the recipients, separate groups of 
mice were challenged. The DTH response was measured 24 and 48 hrs later (Fig. 
1 ). The difference in time course of the DTH reactivity between the recipients of 
'immune' TDL and 'naive' TDL indicates that DTH-related memory to SRBC 
can be transferred with TDL derived from immunized donors. 
Essentially the same results were obtained with BALB/c mice that were s.c.-
immunized with 1 x 1 o7 sonicated B1 O.D2 spleen cells. These cells are H-2-com-
patible with BALB/c, but non-H-2-incompatible. Three months later, TDL were 
collected from these immunized mice. A number of 1 x 107 viable 'immune' 
TD L was adoptively transferred to irradiated and with syngeneic bone marrow 
cells reconstituted BALB/c mice. A control group which received 1 x 107 'naive' 
TDL was included. On days 3, 4, and 5 after s.c. immunization with 1 x 106 
B10.D2 spleen cells, separate groups of mice were challenged, and the DTH 
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Fig. 1. Adoptive transfer of secondary DTH to SRBC by TDL. Letha\ly irradiated BALB/c 
recipient mice were i.v. injected with 3 x 106 BALB/c bone marrow cells and one day later 
with 1 x 107 viable 'immune' (o) or 'naive' TDL (e). 'Immune' TDL were obtained from 
BALB/c mice i.v. primed with 3 x 104 SRBC 3 months previously. The recipients were i.v. 
immunized with 1 x 105 SRBC immediately after adoptive transfer, and were challenged 2, 3 
or 4 days later. The asterix indicates the persistent DTH reactivity after passive transfer of 1 x 
107 viable 'immune' TDL (a). These latter recipients were challenged one day after the passive 
transfer of TDL. In all recipients the specific increase of foot thickness was determined at 
24 and 48 hr after challenge. Vertical bars represent SE (n""6). 
response was measured 24 and 48 hrs later (Fig. 2). 
The inability of 'immune' TDL induced by SRBC or minor H antigens to 
passively transfer DTH reactivity shows that the 'immune' TDL mediate a 
typical secondary type DTH response after adoptive transfer (Figs. 1 and 2). 
However, TDL from BALB/c mice immunized with B10.ScSn spleen cells, which 
are incompatible for non-H-2 as well as H-2 antigens, did not transfer secondary 
DTH responsiveness to naive recipients (Fig. 3). This is in line with the inability 
of mice to mount secondary type DTH to H-2 alloantigens after multiple 
immunization (data not shown; 2). 
Recirculation of DTH-re!ated memory T cells specific for SRBC or non-H-2 
antigens 
The capacity of DTH-related memory T cells to recirculate was investigated 
by adoptive transfer of TO L from naive recipients inoculated either with spleen 
and lymph node cells from immune mice, or with TDL from such immune mice. 
In the case of inoculation of spleen and lymph node cells, the total cell yield 
from spleen, inguinal, axillary, and mesenteric lymph nodes from a single with 
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Fig. 2. Adoptive transfer of sedondary DTH to minor H antigens by TDL. Lethally irradiated 
BALB/c recipient mice were i.v. injected with 3 x 106 BALB/c bone marrow cells and one day 
later with 1 x 107 viable 'immune' (o) or 'naive' TDL (e). 'Immune' TDL were obtained from 
BALB/c mice s.c. primed with 1 x 107 sonicated B10.D2spleen cells 3 months previously. The 
recipients were s.c. immunized with 1 x 106 810.02 spleen cells immediately after adoptive 
transfer, and were challenged 3, 4 or 5 days later. The asterix indicates the persist~nt DTH 
reactivity after passive transfer of 1 x 107 viable immune TDL (m). These latter recipients 
were challenged one day after the passive transfer of TD L. In all recipients the specific ·Increase 
of foot thickness was determined at 24 and 48 hr after challenge. Vertical bars represent SE 
(n•6). 
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Fig. 3. Inability of secondary DTH to major and minor H antigens by adoptive transfer of 
'immune' TDL. 'Immune' TDL were obtained from BALB/c mice s.c. primed with 1 x 107 
sonicated B10.ScSn spleen cells 3 months previously. The other experimental details are the 
same as in Figure 2. 
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SRBC immunized donor was transferred to a naive intermediate recipient. After 
one day, TDL were collected from such intermediate recipients during 48 hrs. At 
24 and 48 hrs, the collected TDL were transferred to irradiated and with 
syngeneic bone marrow cells reconstituted BALB/c mice. Each recipient received 
a total number of 4 x 107 'immune' TDL from the intermediate hosts. A control 
group which received 4 x 107 'naive' TDL was included. Both groups were 
immunized with 1 x 105 SRBC i.v. and challenged 3 days later. The DTH 
response was measured 24 and 48 hrs later. It was found that the 'immune' TDL 
mediated a clear-cut secondary type DTH response (Table 1, exp. A). This 
indicates that these 'immune' TDL include DTH-related memory T cells. 
Subsequently, we investigated whether the memory T cells among TD L from 
immune mice recirculate. Therefore 1 x 108 TDL from immunized donors were 
i.v.~transferred into naive intermediate recipients. Subsequently, the intermediate 
recipients were also cannulated. These 'double-drained' TDL were transferred 
into irradiated and with syngeneic bone marrow cells reconstituted BALB/c 
mice. Each recipient received 4 x 107 'double-drained' 'immune' TDL. A control 
group received 4 x 107 'double-drained' 'naive' TD L. Both groups were immunized 
with 1 x 105 SRBC i.v. and challenged 3 days later. The DTH response was 
measured 24 and 48 hrs later. Again, a clear-cut secondary type DTH response 
Table 1. Recirculation of DTH-related memory T cells specific for SRBC 
Adoptive transfer a 
A. 'immune' TD L 
'naive' TDL 
B. 'immune' TDL 
'naive' TDL 
24 hr 
11.1 ± 3.1 
4.5 ± 2.9 
20.3 ± 3.4 
8.6 ± 5.4 
DTH responseb 
48 hr 
16.7 ± 3.9 
2.9 ± 3.6 
37.1 ± 5.4 
24.4 ± 6.7 
a. Lethally irradiated BALB/c recipient mice were i.v. injected with 3 x 106 BALB/c bone 
marrow cells and one day later with 4 x 107 viable 'immune' or 'naive' TDL. 'Immune' 
TDL were obtained from intermediate BALB/c mice which had been i.v. injected with 
the spleen and lymph node cells of one immunized donor each (A) or with 1 x 108 TDL 
of immunized donors (8). The immunized donors had been i.v. primed with 3 x 104 SRBC 
3 months previously. The secondary recipient mice were i.v. immunized with 1 x 105 
SRBC immediately after adoptive transfer, and were challenged 3 days later. 
b. The DTH response was determined at 24 and 48 hr after challenge. Figures represent mean 
DTH responses± SE (n=6). 
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was found (Table 1; exp. B), indicating that the memory T cells that 
mediate this response do recirculate. 
In subsequent experiments we investigated whether DTH-related memory T 
cells induced by minor H antigens also recirculate. Therefore BALB/c mice were 
s.c.·immunized with 1 x 107 sonicated B10.D2 spleen cells. Three months later, 
naive intermediate recipients were i.v.~inpculated with the nylon-wool-purified T 
cells from spleens and lymph nodes of these immune donors. Each recipient 
received a number of purified T cells equivalent to the number isolated from two 
donors. The TDL from these recipients were transferred to irradiated and with 
syngeneic bone marrow cells reconstituted BALB/c mice. Each recipient received 
a total number of 1 x 108 'immune' TD L from the intermediate hosts. A control 
group which received 1 x 108 'naive' TDL was included. Similarly, 2 x 108 
'immune' TDL wece transferred to intermediate BALB/c mice, from these mice, 1 
x 108 'double-drained' TDL were transferred to irradiated and with syngeneic 
bone marrow cells reconstituted BALB/c mice. Again, a control group was 
included that received 1 x 108 'naive' TDL. All groups were s.c. immunized with 
•r. specific increase 
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F;g. 4. Recirculation of DTH-related memory T cells specific for minor H antigens. lethally 
irradiated BALB/c recipient mice were i.v. injected with 3 x 106 BALB/c bone marrow cells 
and one day later with 1 x 108 viable 'immune' (o) or 'naive' TDL (e), 'Immune' TDL were 
obtained from intermediate BALB/c mice which were either i.v. injected with the nylon-wool-
purified T cells from the spleens and lymph nodes of two immune donors each {A) or with 2 x 
108 TDL from immunized donors {B). The immune BALB/c donor mice had been s.c. primed 
with 1 x 107 sonicated 810.02 spleen cells 3 months previously. The secondary recipient 
mice were s.c. immunized with 1 x 106 B 10.02 spleen cells immediately after adoptive transfer, 
and were challenged 3 days later. In all recipients the specific increase of foot thickness was 
determined at different intervals after challenge. Vertical bars represent SE (n=6). 
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1 x 106 810.02 spleen cells and challenged 3 days later. The DTH response was 
measured at various intervals after challenge. It was found that in both 
experimental systems 'immune' TDL were able to transfer secondary DTH to 
non-H-2 antigens (Fig. 4). Thus DTH-related memory T cells induced by minor 
H antigens do recirculate. 
DISCUSSION 
This paper shows that a substantial portion of the memory cells, capable of 
adoptive transfer of secondary type DTH to SRBC and minor H antigens, occur 
in the thoracic lymph of primed mice during the late phase of the response. TDL 
from primed mice were found to be incapable of passive transfer of DTH reactivity. 
After immunization of recipients of 'immune' TO L, a faster sensitization for 
DTH occurred than in recipients of 'naive' TDL. Passing the 'immune' TDL 
through intermediate recipients showed that these memory cells recirculate from 
blood to lymph. Previous studies from our laboratory (2, 3) have shown that 
such memory T cells are vinblastine-resistant, while after booster immunization, 
the passive transfer of DTH-mediating T cells can be completely abolished by 
vinblastine treatment. Thus the memory T cells involved in secondary DTH to 
SRBC and minor H antigens have the same characteristics as the memory cells 
involved in secondary type humoral immune responses (6, 16-18). 
Memory phenomena of cellular immunity to intracellularly growing organisms 
are heterogeneous with respect to the characteristics of the cells involved. 
Memory cells involved in the cellular resistance to Bacillus Calmette Guerin 
(BCG) infection have been isolated from the lymphs of immunized rats (17). 
These cells have the capacity to recirculate and are vinblastine¥resistant. Thus 
they are very similar to the memory cells described in this paper. In addition to 
cellular resistance, BCG-infected rats display persisting anti-tuberculin DTH. 
However, passive transfer of anti-tuberculin DTH by TDL was not possible (19). 
It has been stated that secondary type tuberculin DTH can be adoptively 
transferred with 'immune' TO L (7), although there is, as yet, only limited 
evidence concerning this. 
In contrast to BCG, the acquired resistance to intracellular growth of L. 
monocytogenes is mainly dependent on a resident population of immune 
lymphocytes (2, 20-23). This cellular resistance is associated with DTH, but the 
DTH wanes more rapidly than the resistance (24). This DTH could not be 
passively transferred with 'late phase' TDL. It has been suggested that in Listeria-
infected mice, non-dividing DTH effector cells with a long life span account for 
the ongoing, but gradually decreasing DTH reactivity, and that the state of DTH 
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represents the state of T-cell memory (22). Our previous and present studies 
show that persistence of OTH and OTH-related memory are two independent 
phenomena, because immunization of mice with SRBC or non-H-2-incompatible 
sonicated spleen cells does not induce persisting OTH (2), while secondary OTH 
to these antigens (2), and transfer of this secondary OTH by 'immune' TOL, is 
easily achieved. 
Van der Kwast eta!. (3) have shown that ongoing OTH reactivity and the 
capacity of secondary type OTH reactivity are based upon two separate 
populations of T cells with different characteristics. Ongoing OTH reactivity is 
based upon proliferating T cells with a short functional life span that require 
specific antigenic stimulation for their generation {25). The capadty of secondary-
type OTH, on the other hand, is dependent upon hardly or not proliferating T 
cells that persist for long periods, even in the apparent absence of antigen (3). 
Van der Kwast eta!. (2) explain the persistence of OTH reactivity to minor H 
antigens by proposing a continuous activation, by the persisting antigen, of a 
small portion of the memory cell population. This might account for an ongoing 
production of OTH effector cells. This view is supported by the observation that 
persistent DTH to minor H antigens does occur when living cells, which survive 
for a long period (26). are used for immunization (2). 
The finding that in BCG and Listeria-infected animals OTH reactivity cannot 
be passively tranferred with 'late phase' TO L possibly depends on the number of 
OTH effector cells in the lymph, which might be too small to detect in a passive 
transfer system. In Listeria-infected mice the antigen is rapidly eliminated in 
contrast to BCG-infected animals (23). This correlates with the decline of 
anti-Listeria OTH (24). In BCG-infected rats, on the other hand, it was found 
that the persisting tuberculine DTH reactivity remained at the same level for a 
long period (27), which might be due to persisting antigen. This is supported by 
the observation that in man, tuberculine hypersensitivity disappeared after 
elimination of viable BCG by antimycobacterial drugs (28-30). This effect was 
not apparent in rats (27). However, it cannot be excluded that killed BCG persist 
for long periods. 
In contrast to mice immunized with minor H antigens, no secondary type 
OTH reactivity could be demonstrated in mice immunized with H-2-incompatible 
spleen cells {2). Also after adoptive transfer of 'immune' TOL to irradiated 
recipient mice, it was impossible to demonstrate an accelerated DTH reactivity 
as compared to recipients of naive TO L. Apparently, reactivity to non H-2 
alloantigens is low in naive cells and elevated in primed cells, whereas reactivity 
to H-2 alloantigens is relatively high already in naive cells and not delectably 
enhanced in immune cells. In studies concerning graft rejection (31, 32) and 
graft-versus-host {33, 34), it has also been shown that there is no marked 
acceleration of the response by prior immunization when major H antigens are 
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involved. However, Hall eta!. (6) have shown that in rats, demonstration of a 
dramatic and specific increase of allograft reactivity after immunization with 
major H antigens depends on the use of an adoptive transfer system. The effect 
of booster immunization of mice primed with class· I or class· II histocompatibility 
antigens is subject of our present studies and will be discussed in a following 
paper. 
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ABSTRACT 
Secondary type delayed type hypersensitivity (DTH) in mice against class I alloantigens 
or non-H-2 alloantigens is characterized by an earlier appearance of DTH reactivity after 
booster immunization compared with the development of DTH reactivity after primary 
immunization. In contrast to the primary and secondary DTH against class I or non-H-2 
alloantigens, the development of secondary OTH against class II alloantigens or a set of alia-
antigens that includes class II alloantigens is not faster than the development of primary DTH. 
We conclude that priming with class II al!oantigens has a dominant effect which prevents 
secondary DTH reactivity to class I alloantigens and non-H-2 alloantigens. 
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INTRODUCTION 
The in vivo immune response of mice against histocompatibility (H) antigens 
has been extensively studied by skingraft experiments (1-3). These investigations 
have shown that the effect of priming on a second set skingraft is inversely 
related to the immunogenicity of the presented alloantigens (3-5). Thus, the 
difference in survival time between first- and second set minor-H incompatible 
skingrafts in H-2 compatible mice is much greater than the difference in survival 
time of first- and second set H-2 incompatible skingrafts. 
Some aspects of the in vivo cellular immune response against H-antigens can 
be studied in rather detail by the delayed type hypersensitivity (DTH) assay. 
DTH against alloantigens can be readily induced by allogeneic skin and tumor 
grafts (6, 7) and by subcutaneous (sc) injection of allogeneic lymphoid cells 
(8, 9). 
In previous studies we have extensively investigated DTH reactivity in mice sc 
injected with allogeneic cells and cell fragments (8, 10, 11 ). We have shown, a.o., 
that priming with alloantigens not only can lead to the accelerated rejection of 
second set minor-H-incompatible skingrafts, but also to a state of secondary 
DTH responsiveness (1 0). The state of immunological memory is characterized 
by an accelerated reappearance of the DTH reactivity after booster immunization. 
The sc route of priming is obligatory as intravenous (iv) immunization induces a 
state of antigen specific suppression (11, 12). 
It appeared that the secondary DTH responsiveness against minor-H-antigens 
depended on the induction of a population of long-lived non-dividing T memory 
cells I 1 0). Transfer of thoracic duct lymphocytes from immunized mice to naive 
recipients has shown that a substantial portion of these T memory cells recirculate 
(13). 
In this paper we extensively investigated the kinetics of the secondary DTH 
response of mice to H-2 and non-H-2 alloantigens and, furthermore, investigated 
secondary DTH responsiveness after immunization with class I (H-2K and/or 
H-2D) and class II alloantigens (H-21) separately. 
MATERIALS AND METHODS 
Mice 
Female A.SW (H-2s), BALB/c (H-2d), B10.A (H-2a) and B10.ScSn (H-2b) mice 
were purchased from the Laboratory Animals Centre of the Erasmus University, 
Rotterdam, The Netherlands. Female DBA/2 (H-2d) mice were purchased from 
the Radiobiological Institute TNO, Rijswijk, The Netherlands. Female A.TL 
( H-2t1), A.TH (H-2t2). 81 O.D2 (H-2d), B 10.AQR (H-2Y1), B 1 O.T(6R) (H-2Y2), 
B10.A(2R) (H-2h2) and DBA/1 (H-2q) were purchased from OLAC Ltd., 
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Bicester, U.K. Female A.AL(H-2a1) mice were purchased from Yeda Research 
and Development Co. Ltd., Weizmann Institute, Rehovot, Israel. The age of all 
responder mice varied between 12 and 24 weeks. 
Preparation of cell suspensions 
Mice were killed by carbon dioxide vapour exposition. Spleens were removed, 
brought into balanced salt solution (BSS). minced with scissors and squeezed 
trough a nylon gauze filter to give a single cell suspension. Nucleated cells were 
counted with a Coulter counter Model BZI. 
Antigen and immunization 
Primary and secondary immunization with allogeneic histocompatibility {H) 
antigens was performed by sc injection of 107 allogeneic spleen cells from the 
appropriate mouse strain in 0.1 ml BSS. This dose has previously been shown to 
be optimal {10). The antigen dose was equally distributed over both inguinal 
areas. The spleen cells used for primary immunization were ultrasonically 
disrupted to prevent proliferation of the injected allogeneic cells and, thereby, to 
reduce the persistence of the antigen. Mice used for comparison of primary and 
secondary DTH were of the same delivery and the same age. 
Assay for DTH 
DTH reactions were determined by measuring the difference in thickness of 
the hind feet 24 hr after sc injection of 2 x 107 allogeneic spleen cells suspended 
in 0.05 ml BSS into the instep of the right hind foot of appropriately immunized 
mice. As a control for background DTH reactivity, naive responder mice were 
used, which only received the challenge dose. The specific DTH response was 
calculated as the relative increase in foot thickness of the immune mice minus 
the relative increase of the control mice. The foot swelling of the control mice 
ranged between 15 and 20o/~ 
RESULTS 
Effect of booster immunization with non-H-2 or H-2 coded al/oantigens 
In order to investigate the effect of booster immunization of mice primed 
with multiple minor-H-antigens, groups of DBA/2 and BALB/c responder mice 
were sc immunized for primary DTH or primed and boosted for secondary DTH 
by injection with minor-H incompatible 81 O.D2 spleen cells. Priming for 
secondary DTH was always performed with ultrasonically disrupted spleen cells, 
while for booster immunization and for induction of primary DTH viable spleen 
cells were used. The interval between priming and booster immunization for 
secondary-DTH was 3 to 5 months. In order to compare the kinetics of primary 
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Fig. 1. Primary and secondary DTH responsiveness to allogeneic non-H-2 {A,B) and H-2 (C, D) 
incompatible spleen cells. The graphs respresent the time course of the primary DTH (e) and 
secondary DTH (o) response of DBA/2 mice to the non-H-2 incompatible 810.02 spleen cells 
(A), of BALB/c mice to the non-H-2 incompatible 810.02 spleen cells (B), of B10.ScSn mice 
to the H-2 incompatible 810.02 spleen cells (C) and of DBA/2 mice to the H-2 incompatible 
DBA/1 spleen cells (0). In all strain combinations the mice were sc immunized for primary 
DTH with 1 x 107 viable spleen cells or sc primed with 1 x 107 sonicated spleen cells and sc 
boosted with 1 x 107 viable spleen cells for secondary DTH. The persistent primary DTH 
reactivity (•) due to priming with 1 x 107 sonicated spleen cells was determined at the 
moment of booster, 3 to 5 months after priming. Vertical bars represent SE (n = 6). 
and secondary DTH, the booster immunization for secondary DTH was done on 
the same day as the immunization for primary DTH. At different days after 
immunization for primary DTH and booster immunization, groups of mice were 
55 
challenged with 810.02 spleen cells. In both strain combinations it appeared 
that the time course of the primary and secondary DTH response was different 
(Fig. 1 A and 1 B). At 2 days after booster immunization, the mice showed a clear 
DTH response, while primary DTH was hardly detectable by day 3. Secondary 
DTH was found to be maximal 3 of 4 days after booster immunization, while 
maximal primary DTH was found on day 5 or later. The kinetics of the foot-
swell reaction after challenge did not differ for primary and secondary DTH 
(data not shown). As a control for persistent DTH responsiveness due to the 
primary immunization, one group of mice was challenged for DTH reactivity 
3 months after priming. In both strain combinations no significant persistent 
DTH response could be measured. 
Different results were obtained in mice immunized with H-2 coded alloantigens. 
Therefore, DBA/2 and 81 O.ScSn responder mice were tested for primary and 
secondary DTH against H-2 incompatible DBA/1 and 810.02 spleen cells, 
respectively. Significant primary and secondary DTH responses against H-2 alia-
antigens were found on day 3 and maximal responses were found on day 4 after 
primary or secondary immunization (Fig. 1 C and 1 D). In contrast to the primary 
and secondary DTH against non-H-2 alloantigens, the development of secondary 
DTH against H-2 alloantigens was not faster than the development of primary 
DTH. Furthermore, in both strain combinations secondary DTH reactivity was 
weaker or equal to primary DTH reactivity to H-2 alloantigens. 
Effect of booster immunization with class I of class II alloantigens. 
We have also investigated whether class I or class II H-2 alloantigens separately 
are able to induce a secondary type DTH response. The same immunization 
protocol was used as described above. At first we tested the effect of immuni-
zation with class I alloantigens only in the strain combinations B10.A-B10.AQR 
(Fig. 2A) and A.TL-A.AL (Fig. 28), which are both H-2K incompatible, and in 
the H-2K/D incompatible combination of B10.AOR-B10.A(2R) mice (Fig. 2C). 
In all three combinations a secondary type DTH response could be elicited. 
Significant primary DTH responses were found on day 4 or later after immuni-
zation, while after booster immunization substantial DTH responses were found 
already on day 3. The kinetics of the foot-swell reaction after challenge, however, 
did not differ for primary and secondary DTH (data not shown). Mice used for 
control of persisting DTH responsiveness due to the primary immunization 
showed no significant DTH response. 
The capacity of class II coded alloantigens to induce secondary type DTH 
responses was studied in the H-21 incompatible strain combinations B 1 O.AOR-
B10.T(6R) (Fig. 3A) and A.TL-A.TH (Fig. 38). Both combinations showed a 
similar development of primary and secondary DTH responsiveness. Also in the 
strain combinations B10.A-B10.T(6R) (Fig. 3C) and A.TL-A.SW (Fig. 30) in 
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Fig. 2. Primary and secondary DTH responsiveness to allogeneic H-2K and H-2K/D incompa-
tible spleen cells. The graphs represent the time course of the primary DTH (e) and secondary 
DTH (o) of B10.A mice to H-2K incompatible B10.AQR spleen cells (A), of A.TL mice to 
H-2K incompatible A.AL spleen cells {B) and of 81 O.AOR mice to H-2K/D incompatible 
B10.A(2R) spleen cells (C). The other experimental details are the same as described in the 
legend to Fig. 1, 
which a H-2K and a H-20 incompatibility, respectively, is presented in combi-
nation with a H-2 I incompatibility, no significant difference was found between 
the development of the primary and the secondary DTH responsiveness. 
Thus, in donor-recipient combinations in which class II alloantigenic differen-
ces are included, it is not possible to induce secondary type DTH against class I 
alloantigens. 
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Fig. 3. Primary and secondary DTH responsiveness·to allogeneic H-21, H-2K/I and H-21/D 
incompatible spleen cells. The graphs represent the time course of the primary DTH (e) and 
secondary DTH (o) response of BlO.AQR mice to H-21 incompatible B10.T(6R) spleen cells 
(A), of A.TL mice to H-21 incompatible A.TH spleen cells (8), of B10.A mice to H-2K/l 
incompatible B10.T(6R) spleen cells (C) and of A.TL mice to H-21/D incompatible A.SW 
spleen cells (D). The other experimental details are the same as described in the legend to 
Fig. 1. 
DISCUSSION 
The data presented in this paper show that minor H antigens (Fig. 1) and class 
I alloantigens (Fig. 2) can induce secondary type DTH. No secondary type DTH, 
however, could be demonstrated in mice primed and boosted with a set of H-
antigens that includes class II alloantigens (Fig. 1 and 3). The inability to induce 
secondary type anti-allograft responses against class II alloantigens was also 
described by Zacharova eta/. (14) in skingraft experiments. However, McKenzie 
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eta!. (15} demonstrated an accelerated second set skingraft rejection in the H-21 
(class II) incompatible mouse strain combinations 81 O.AQR-8 1 O.T(6R} and 
A.TH-A.TL. In precisely the same strain combinations we failed to demonstrate 
anamnestic DTH. Also for fully H-2 incompatible skingrafts accelerated second 
set graft rejection has been found (3, 16, 17}, which is in contrast to our DTH 
experiments (Fig. 1 C and 1 D). 
In transplantation experiments with allogeneic, MHC-incompatible heart 
grafts, Hall eta!. (18} could not demonstrate an accelerated heart graft rejection 
in sensitized rats. Transfer of thoracic duct lymphocytes (TDL} from sensitized 
rats, on the other hand, showed that on a per cell base these "immune" TD L 
were more potent to restore the capacity of irradiated recipients to reject heart 
grafts from the relevant allogeneic donor strain than "naive" TDL. In previous 
studies ( 13} we failed to demonstrate a memory effect in comparable transfer 
experiments with "immune" TO l from mice which were primed with spleen 
cells that were incompatible for H-2 as well as non-H-2 alloantigens. 
The above discrepancies between graft rejection and DTH might be due to a 
more dominant role of class II alloantigens in DTH alloreactivity than in other 
in vivo anti-allograft reactions. I region encoded alloantigens activate in naive 
animals 10 times more proliferative T cell precursors than do H-2K or H-2D 
encoded alloantigens (19}. Ryser eta!. (20} showed that in vivo immunization 
hardly affects the frequency of H-21 specific proliferative T lymphocyte 
precursors. This can explain why priming with class II alloantigens does not lead 
to secondary type DTH. Immunization with H-2K or H-2D alloantigens, however, 
causes a 3 to 4 times higher frequency of K/D specific cytotoxic T lymphocyte 
precursors (20}. As cytotoxic T lymphocytes are able to mediate DTH (21, 22}, 
an increase of the frequency of cytotoxic T lymphocyte precursors may account 
for the observed secondary type DTH to class I alloantigens. 
The above explanation, however, does not fit properly with all results we have 
obtained. In the first place, the relatively high frequency of alloreactive T cells 
specific for class II alloantigens is not expressed in the magnitude of the maximal 
DTH response, since immunization with non-H-2 alloantigens is often leading to 
higher peak DTH responses than immunization with H-2 alloantigens (Fig. 1; 
refs. 10, 23}. Secondly, the height of the primary and secondary DTH against 
completely H-2 (K, I and D) incompatible spleen cells is not in harmony with 
the sum of the primary or secondary anti H-21 (Fig. 3A} and anti H-2K/D 
responses together (Fig. 1 C and 1 D and Fig. 2C). Furthermore, the secondary 
anti H-2 response is even somewhat lower than the primary anti H-2 response 
(Fig. 1 C and 1 D). The data even suggest that class II alloantigens have a suppressive 
influence upon the secondary DTH response to other alloantigens. 
Enhancing antibodies might play a role in this phenomenon. McKenzie eta!. 
(15, 24, 25} have shown that enhancing antibodies are mainly directed against 
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H-21 alloantigens. Moreover, H-21 induced antibodies can also influence the anti 
H-2K or anti H-2D allograft response, when the H-2K/D alloantigens are presented 
in combination with the H-21 alloantigens. However, induction of hyporeactivity 
in skingraft experiments due to enhancing antibodies requires several injections 
of allogeneic cells. Furthermore, Capel eta/. (26) have shown that enhancement 
requires persisting antigen and enhancing antibodies. In our DTH experiments, 
on the other hand, the mice were primed by a single injection of allogeneic 
spleen cell fragments only. By purpose we used allogeneic spleen cell fragments 
for priming in order to avoid long persistence of the injected alloantigens, and 
thereby an ongoing immune response. 
Just like in the above host versus graft DTH experiments it is impossible to 
show any effect of priming in graft versus host (GvH) responses (18, 27-28). 
Ford and Simonsen (29) have shown with bursectomized chickens that enhancing 
antibodies were not responsible for the absence of a priming effect in GvH 
reactions. Thus, there is little evidence for the involvement of enhancement in 
the lack of secondary DTH against H-2 alloantigens that include H-21. 
It is also not likely that the failure to elicit secondary type DTH responses to 
H-2 alloantigens that include H-21 subregion coded antigens is due to restricted 
recognition of the alloantigens. Restricted recognition of H-2 coded alloantigens 
has been demonstrated in GvH (30, 31) and DTH (31) experiments. However, 
the present data show that H-2 incompatible spleen cells, which do not express 
restriction elements syngeneic with the responder mice, are still able to elicit a 
primary DTH response. We have previously shown that allogeneic H-2 molecules 
can also act as restriction elements for the DTH response to other H-2 alia-
antigens expressed on the same cell (31). Therefore, the lack of secondary type 
anti H-2 DTH reactivity cannot be explained by supposing a requirement for 
syngeneic restriction elements by alloreactive T memory cells. Furthermore, 
Van der Kwast eta!. (1 0) have shown that secondary type anti H-2 DTH reactivity 
was also not found when the H-2 alloantigens were presented in combination 
with syngeneic H-2 molecules by using F1 hybrid cells. 
Thus, we have to conclude that priming with class II alloantigens has a 
dominant effect which prevents secondary type DTH reactivity to class I alia-
antigens and non-H-2 alloantigens. The secondary type DTH response in H-21 
incompatible strain combinations is often somewhat lower than pnmary DTH 
responses (Fig. 1C and 1 D). This seemingly suppressive effect is not comparable 
with the firm suppression found after iv preimmunization with al!oantigens {32), 
which is not H-21 dependent. The mechanism underlying this H-21 dependent 
suppressive effect on the secondary DTH response against H-antigens is subject 
of our present studies. 
60 
ACKNOWLEDGMENT 
This investigation was supported by the Dutch Kidney Foundation, Bussum, The 
Netherlands. 
REFERENCES 
1. Billingham, R.E., W.F.R.S. Silvers, and D. B. Wilson, 1968. Further studies on adoptive 
transfer of sensitivity to skin homografts. J. Exp. Med. 118: 397. 
2. Klein, J.1966. Strength of some H-2 antigens in mice. Folia biologica 12: 169. 
3. Wilson, D.B. 1974. Immunological reactivity to major histocompatibility alloantigens. 
HARC, effector cells and the problem of memory. In: Progress in Immunology II (eds. 
Brent and Holborow). N-Holland Publishing Camp. Amsterdam, p. 145. 
4. Hildeman, W.H. 1970. Components and concepts of antigenic strength. Transplant. Rev. 
3: 5. 
5. Eichwald, E.J., R. Barstad, and G. Graves. 1981. Cell-mediated hyperacute rejection. Ill. 
Genetic determinants. Immunogenetics 14: 351. 
6. Brent, L., J.B. Brown, and P.B. Medawar. 1962. Quantitative studies on tissue transplan-
tation immunity. VI. Hypersensitivity reactions associated with rejection of homografts. 
Proc. R. Soc. Land. B. 156: 187. 
7. Kon, N.D., and P.A. Klein.1976. Measurement of H-2 and non-H-2 antigens in the mouse 
with the footpad swelling test. J. lmmunol. 117: 413. 
8. Vander Kwast, Th.H., and R. Benner. 1978. T1 and T2 lymphocytes in primary and 
secondary delayed type hypersensitivity of mice. I. Contribution in the response to sheep 
red blood cells and to allogeneic spleen cells. Cell. lmmunol. 39: 194. 
9. Smith, F., and J.F.A.P. Miller. 1979. Delayed type hypersensitivity to allogeneic cells in 
mice. I. Requirements for optimal sensitization and definition of the response. Int. Archs 
Allergy appl. lmmun. 58: 285. 
10. Vander Kwast, Th.H., J.G. Olthof, and R. Benner.1979. Primary and secondary delayed 
type hypersensitivity to minor histocompatibility antigens in the mouse. Cell. lmmunol. 
47: 182. 
11. Van der Kwast, Th.H., A.T.J. Bianchi, H. Bril, and R. Benner. 1981. Suppression of anti-
graft immunity by preimmunization. I. Kinetic aspects and specificity. Transplantation 
31: 79. 
12. Liew, F. Y. 1 982. Regulation of delayed type hypersensitivity. IV. Antigen specific 
suppressor T cells and suppressor factor for delayed type hypersensitivity to histo-
compatibility antigens. Transplantation 33: 69. 
13. Bianchi, A.T.J., H. de Ruiter, L.M. Hussaarts-Odijk, and R. Benner. 1983. Secondary 
delayed type hypersensitivity to sheep red blood cells and minor histocompatibility 
antigens in mice: Transfer of memory by recirculating thoracic duct lymphocytes. lmmu-
nobiol. 165: 200. 
61 
14. Zacharova, G., L. Renckova, A. Dux, and P. Demant. 1975. ]-region associated histo-
compatibil"lty with absence of accelerated rejection of second set skin grafts detected in 
tests with a new haplotype, H-2dx. J. Immunogenetics 2: 323. 
15. McKenzie, I.F.C., and M.M. Henning. 1977. The I region transplantation antigens: lmmu-
nogenicity and enhancement. J. Immunogenetics 4: 259. 
16. Eichwald, E.J., B. Wetzelland, and E.A. Lustgraaf. 1966. Genetic aspects of second set 
grafts in mice. Transplantation 4: 260. 
17. Klein, J., and D.B. Murphy. 1973. The role of "private" and "public" H-2 antigens in 
skin graft rejection. Transplant Proc. V: 261. 
18. Hall, B.M., S. Dorsch, and B. Roser. 1978. The cellular basis of allograft rejection in vivo. 
II. The nature of memory cells mediating second set heart graft rejection. J. Exp. Med. 
148: 890. 
19. Kr6nke, M., P. Scheurich, K. Pfizenmaier, M. ROilinghoff, and H. Wagner. 1982. T-T 
cell interactons during in vitro cytotoxic T lymphocyte responses. V. Precursor frequen-
cies and specificity of alloreactive helper T cells. J. Exp. Med. 156: 41. 
20. Ryser, J.E., and R. McDonald. 1979. Limiting dilution analysis of alloantigen-reactive 
T lymphocytes. Ill. Effect of priming on precursor frequencies. J. lmmunol. 123: 128. 
21. Weiss, S., and G. Dennert. 1981. T cell lines active in delayed type hypersensitivity 
reactions (DTH). J. lmmunol. 126: 2031. 
22. lin, Y.L., and B.A. Askonas. 1981. Biological properties of an influenza A virus specific 
killer T cell clone. Inhibition of virus replication in vivo and induction of delayed type 
hypersensitivity reactions. J. Exp. Med. 154: 225. 
23. Smith, F.J., and J.F.A.P. Miller. 1979. Delayed type hypersensitivity to allogeneic cells 
in mice. Ill. Sensitivity to cell-surface antigens coded by the major histocompatibility 
complex and by other genes. J. Exp. Med. 150: 965. 
24. McKenzie, I.F.C., and M.M. Henning. 1977. The H-2 complex: immunogenicity and 
enhancement studies of H-2K region alloantigens. J. Immunogenetics 4: 249. 
25. McKenzie, I.F.C., M.M. Henning, and G.M. Morgan. 1980. Skin graft enhancement 
studies with antigenic differences arising from the H-2K, H-20 and H-2L loci. Trans-
plantation 29: 439. 
26. Capel, P.J.A., S.P.M. Lems, and R.A.P. Keene. 1982. Antibody response to allogeneic 
and xenogeneic skin grafts in nude mice. In: Proc. Third Int. Workshop on Nude Mice, 
Gustav Fischer inc. New York, p. 275. 
27. Simonson, M. 1962. The factor of immunization: clonal selection theory investigated by 
spleen assays of graft versus host reaction. In: Ciba Foundation Symposium on Trans-
plantation (eds. Wolstenholme & Camerson) J & A Churchill Ltd. p. 185. 
28. Sprent, J., and J.F.A.P. Miller. 1976. Fate of H-2 activated T lymphocytes in syngene'1c 
hosts. IV. Differentiation into long-lived recirculating memory cells. Cell. Jmmunol. 21: 
314. 
29. Ford, W.L., and M. Simonsen. 1971. The factor of immunization in the rat. The effect of 
allogeneic tmmunization on graft-versus-host activity. J. Exp. Med. 133: 938. 
62 
30. Kindred, B. 1983. H-2 restricted GVHR: Foreign determinants and restriction elements. 
Immunogenetics 18: 57. 
31. Bianchi, A.T.J., H. Bril, L.M. Hussaarts-Odijk, and R. Benner. Restricted recognition of 
H-2 subregion coded alloantigens in delayed type hypersensitivity. (Submitted for publi-
cation). 
32. Bianchi, A. T.J., L.M. Hussaarts-Odijk, and R. Benner. 1983. Suppression of delayed type 
hypersensitivity to third party "bystander" alloantigens by antigen-specific suppressor T 
cells. Cell. lmmunol. 81: 333. 
63 

CHAPTER VI 
RESTRICTED RECOGNITION OF H-2 SUBREGION CODED ALLOANTIGENS 
IN DELAYED TYPE HYPERSENSITIVITY 
A.T.J. BIANCHI, H. BRIL, L.M. HUSSAARTS-ODIJK and R. BENNER 
Department of Cell Biology and Genetics, Erasmus University, Rotterdam, The Netherlands 
lmmunogeneticsi in press. 
65 
ABSTRACT 
Subcutaneous (sc) immunization of mice with H-2K, I or D incompatible spleen cells 
induces a state of host-versus-graft (HvG) delayed-type hypersensitivity (DTH). The DTH 
reaction is elicited by challenging the immunized mice in a hind foot with similar allogeneic 
spleen cells and is measured as the subsequent foot swelling. DTH effector T cells specific for 
H-21 coded alloantigens, but not for H-2K/D coded alloantigens, can be induced in a Graft-
versus-Host (GvH) model as well. In this paper we report that under HvG as well as under GvH 
conditions the recognition of class 11 antigens by DTH effector T cells is restricted by class I 
molecules. Furthermore, DTH effector T cells induced by sc immunization with class I 
antigens appear to be restricted by class II molecules. 
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INTRODUCTION 
Since the original observation of Zinkernagel and Doherty ( 1974) that T 
lymphocytes from lymphocytic choriomeningitis virus ( LCMV)-infected mice 
lysed LCMV-infected target cells only if they expressed the same H-2 haplotype 
as the donor of the effector cells, many data have been gathered concerning 
major histocompatibility complex (MHC) restricted immune responses. In 
several other viral systems, restricted recognition of infected target cells has been 
shown (Gardner eta!., 1974; Koszinowski and Thomssen, 1975; Doherty eta!., 
1976). In some of these systems the H-2 subregion involved in the MHC 
restriction was identified, e.g., H-2K and/or H-2D were found to be the restriction 
elements for LCMV-specific cytotoxic T lymphocytes (Zinkernagel and Doherty, 
1975). The cytotoxic response to trinitrophenyl-modified syngeneic cells 
(Shearer eta/., 1975) as well as the cytotoxic response to minor histocompatibility 
(H) antigens (Bevan, 1975) was also found to be restricted by products coded 
for by the H-2K and/or H-2D subregions. 
The in vivo relevance of the phenomenon of H·2 restriction has also been 
shown. DTH reactions against virus-infected cells were H-2K/D restricted 
(Zinkernagel, 1976) and DTH against Listeria monocytogenes was found to be 
restricted by H·21 coded molecules (Zinkernagel eta!., 1977). Furthermore, 
transfer of DTH effector T cells specific for fowl-,-globulin appeared to be 
H-21A restricted (Miller et a!., 1975), while H-2K, I or D subregion coded 
molecules functioned equally well as restriction element in the dinitrofluoro-
benzene induced DTH response (Miller eta!., 1975; Vadas eta/., 1977). DTH 
reactivity can also be induced by H-2 and minor H antigens. DTH effector T 
cells specific for minor H antigens appeared to be H-2K/D restricted (Smith and 
Miller, 1979: Vander Kwast, 1980). Restricted recognition of minor H antigens 
in vivo was also shown by Korngold and Sprent (1981, 1982) in a GvH mortality 
assay. 
Most literature data indicate that recognition of H~2 alloantigens is an 
exception to the general rules of H·2 restricted recognition of antigen by T cells 
(Klein eta/., 1977; Smith and Miller, 1979; Weiss and Dennert, 1981; Swain, 
1981: Vadas and Greene, 1981). However, recently a few papers appeared 
suggesting that under certain conditions the recognition of H-2 subregion coded 
antigens in vitro (Minami and Shreffler, 1981; Rocket a/., 1983) and in vivo 
(Kindred, 1981, 1983a,b) can be restricted by other H-2 coded molecules. 
In this paper we present data which show that the recognition of H-2 subregion 
coded alloantigens by DTH effector T cells in vivo is H-2 restricted. Using both 
a Host-versus-Graft (HvG) and a Graft-versus-Host (GvH) assay, we show that 
DTH effector T cells specific for class II antigens are restricted in their antigen 
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recognition by class I molecules. On the other hand, DTH effector T cells 
activated in a HvG assay by class I antigens, are restricted by class II molecules. 
MATERIALS AND METHODS 
Mouse strains 
B10.A (H-2a) and A.SW (H-2s) mice were purchased from the Laboratory 
Animals Centre of the Erasmus University, Rotterdam, The Netherlands. 
B10.AQR (H-2Y1). B10.TI6R) (H-2Y2), B10.A(2R) (H-2h2), B10.BR (H-2k). 
A.TL (H-2t1) and A.TH (H-2t2) mice were purchased from OLAC Ltd., Bicester, 
United Kingdom. A/J (H-2a) mice were purchased from Bomholtgard Ltd, Ry, 
Denmark. A.AL (H-2a1) mice were purchased from YEDA Research and 
Development Co. Ltd. at the Weizmann Institute of Science, Rehovot, Israel. 
B10.BYR (H-2by1), (B10.A x B10.T(6R))F1 (H-2a/y2). (B10.TI6R) x 
B10.A(2R))F1 (H-2y2/h2). and (A/J x A.TH)F1 (H-2a/t2) mice were bred at 
our own department. B10.8YR breeding pairs were kindly provided by Prof. J. 
Klein, Max-Planck-Institute fiir Biologie, Tiibingen, W.-Germany. The age of the 
responder mice varied between 10 and 24 weeks. Only female mice were used. 
Preparation of cell suspensions 
Spleens or lymph nodes were removed, placed in a balanced salt solution 
(BSS) and squeezed through a nylon gauze filter to provide a single cell 
suspension. Nucleated cells were counted with a Coulter Counter Model B. 
Irradiation 
The recipient mice received 7.5 Gy whole body irradiation, generated in a 
Philips Muller MG 300 X-ray machine. Radiation control mice died in 14 to 21 
days. 
Host-versus-Graft reactions 
Induction of DTH reactivity was done by subcutaneous (sc) immunization 
with 1 x 107 of the appropriate allogeneic spleen cells, suspended in a volume 
of 0.1 mi. A total volume of 50 Ill of this spleen cell suspension was injected in 
both inguinal areas. 
Acute Graft-versus-Host reactions 
Acute GvH reactions were elicited by intravenous (iv) injection of 2 x 107 
nucleated spleen cells into lethally irradiated allogeneic recipients within 4 h 
after irradiation. The cells to be injected were suspended in a volume of 0.5 ml 
BSS. 
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Assay for delayed type hypersensitivity 
The DTH assays for measuring HvG and GvH immune reactivity have been 
described in detail in previous papers (Vander Kwast and Benner, 1978; Wolters 
and Benner, 1978). HvG DTH responses were elicited by sc injection of a 
challenge dose of 2 x 107 allogeneic spleen cells into the dorsum of the right 
hind foot, five or six days after the sc jmmunization in the inguinal area. The 
DTH response to this challenge was measured as the difference in thickness of 
the hind feet 24 h later. The specific increase in foot thickness was calculated 
as the relative increase in foot thickness of the immune mice minus the relative 
increase in foot thickness of control mice, which received only the challenge. 
The swelling of these control mice varied between 12 and 20%. For measuring 
GvH-related DTH reactivity we transferred iva number of cells equivalent to the 
total cell yield obtained from spleen, inguinal, axillary and mesenteric lymph 
nodes from an irradiated and reconstituted mouse into a normal secondary 
recipient five days after reconstitution. The secondary recipients were syngeneic 
to the original spleen donors. Twenty million spleen cells, syngeneic with the 
irradiated recipients were administered as a challenge into the dorsum of the 
right hind foot of the secondary recipient mice. The subsequent DTH response 
was measured and calculated as described above for the HvG DTH response. 
Assay for immune lymphocyte transfer reactivity 
The immune lymphocyte transfer (I L T) reactivity in lymph node cells from 
immunized donors, directed against H antigens of a particular recipient, was 
determined by sc injection of 5 x 106 of these lymph node cells into the dorsum 
of the right hind foot of the recipients to be tested. The recipients received a sc 
injection into the left hind foot consisting of 5 x 106 lymph node cells from 
non-immune mice, syngeneic with the immunized donor mice. This latter 
injection results in a normal lymphocyte transfer (N L T) reaction. For I L T and 
N L T the cells were injected in a volume of 50 pl. A control group consisting of 
recipient mice syngeneic to immunized donor mice was included. These mice 
were similarly injected with immune and non-immune lymph node cells in the 
right and left hind feet, respectively. The thickness of both injected feet was 
measured as in the DTH assay. The specific I L T reactivity was calculated as 
(I L T-N L T)test-( I L T-N L T)control, and was expressed in 1 o·2mm. 
RESULTS 
H-2 restricted recognition of H-2 subregion coded a/!oantigens during the 
expression of primary DTH reactivity 
To investigate whether the recognition of H-2 subregion coded alloantigens 
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by DTH effector T cells is restricted by other H-2 molecules, B10.A responder 
mice were sc immunized with (H-2) K incompatible B10.AQR spleen cells, or 
with (H-2) K+l incompatible B10.T(6R) spleen cells. Five days later the 
responder mice were challenged with B10.AQR (K), B10.T(6R) (K+I) or (B10.A 
x 810.T)6R)F1 (K+I) spleen cells. The results show that DTH reactions to K and 
K+l coded alloantigens can be demonstrated (Fig. 1, lines 1, 4 and 6). However, 
when responder mice were immunized to K antigens only and subsequently 
challenged with 810.T(6R) spleen cells, which express the same K antigens in a 
context of allogeneic I molecules, only a marginal reaction occurred (Fig. 1, line 
2). On the other hand, mice immunized with K+l alloantigens and challenged 
with K alloantigens only, displayed a clear DTH response (Fig. 1, line 5). In 
combinations of 810 congenics involving B10.AQR there is the possibility of 
reactivity to non-H-2 antigens on the 81 O.AQR strain, which has been 
insufficiently back crossed onto 81 0( K. Fischer-Lindahl, personal communication). 
To investigate whether the 81 O.A anti-81 O.AGR DTH response is directed 
against other alloantigens than K coded alloantigens, 810.A mice primed with 
B10.AQR spleen cells were also challenged for anti-K reactivity with (810.A x 
RESPONDER IMMUNIZING IMMIJNIZING K"Z CHALLENGE ~SPECIFIC INCREASE FOOT THICKNESS SHARED REGIONS 
STRAIN CELLS SUBREGION OF K-2 COMPLEX 
BID. A BIO.AQR BIO.AQR 
" 
610.A BIO.AQR 610,T(6R) 
=-
BIO.A BIO.AQR (61 O.A~Bl O. T( OR)) F 1 m 
BIO.A 610.T(5R) 
" 
810. T(OR) 0 
BlO.A 810. T(ORI 
" 
~IO.AQR 
" 
810.A 810. T{6R) 
" 
(81 O.AxB 10. T( 6R) )F l 
'" 
B10.A 810.AQR 810.AQR 
" 810. TI6RI 0 
'" '" '" "" 
Fig. 1. H-2 restricted recognition of H-2K coded alloantigens in DTH. B10.A responder mice 
were sc immunized with 1 x 107 B10.AOR or B10.T(6R) spleen cells and challenged with 
2 x 107 BlO.AQR, B10.TI6R), (BlO.A x B10.T(6R))F1 or a mixture of BlO.AQR and 
B10.T(6R) spleen cells 5 days later. DTH responses were measured 24 h later. Each column 
represents the mean response ± SE (n=6). 'Shared regions of H-2 complex' relates to the 
responder-challenge combinations. 
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B10.T(6R))F1 spleen cells. These F1 spleen cells bear both the self I molecule 
and the allogeneic K molecule against which the responder is putatively 
immunized. The results show that the response against the F1 spleen cells is 
equivalent to the response against B 1 O.AQR spleen cells (Fig. 1, lines 1 and 3, 
respectively). Thus, in this DTH assay B10.AQR spleen cells do immunize B10.A 
mice for anti-K reactivity. To exclude any suppressive influence of K+l 
incompatible B10.T(6R) spleen cells, these cells were mixed with K incompatible 
B10.AQR cells in the challenge inoculum of K primed mice. As can be seen from 
Fig. 1, line 7, no suppressive influence could be detected. In conclusion DTH 
effector T cells from mice primed with K coded alloantigens recognize these 
alloantigens in the context of syngeneic I molecules irrespective of whether they 
are induced with K alloantigens in the context of syngeneic or allogeneic I 
molecules. The induction of a sufficient number of DTH effector T cells which 
recognize the K alloantigens in the context of the allo I molecules occurs only 
when the responder mice are primed with K antigens in a context of allogeneic 
I molecules. 
The recognition of I alloantigens by DTH effector T cells was also found to be 
restricted by other H-2 subregion coded molecules. When B10.T(6R) responder 
mice were immunized with I incompatible B 1 O.AQR spleen cells and subsequently 
challenged with K+I+D incompatible B10.A(2R) spleen cells, only a marginal 
reaction occurred (Fig. 2, line 2). This indicates that DTH effector T cells primed 
for I alloantigens in the context of syngeneic K+D molecules do not recognize 
these I alloantigens in the context of allogeneic K+D molecules. To verify the 
induction of anti- I reactivity by sc immunization of B10.T(6R) responder mice 
with B10.AQR spleen cells, the primed responders were challenged for anti-1 
reactivity with (B10.T(6R) x B10.A(2R))F1 spleen cells. The results show that 
challenge with (B10.T(6R) x B10.A(2R))F1 spleen cells was as effective as 
challenge with 810.AQR spleen cells (Fig. 2, lines 3 and 1, respectively). 
Responder mice activated to I alloantigens in the context of allogeneic K+D 
molecules recognized the I alloantigens on a background of the syngeneic K+D 
molecules or the original allogeneic K+D molecules (Fig. 2, lines 5 and 4, 
respectively). Again no suppressive influence of K+I+D incompatible 81 O.A(2R) 
spleen cells could be detected on the DTH reaction to I alloantigens on a 
syngeneic K+D background (Fig. 2, line 7). 
H-2 restricted recognition of H-21 a!/oantigens during the expression of GvH 
related DTH 
We investigated whether the recognition of H-2 subregion coded alloantigens 
under GvH conditions is also restricted by other H-2 subregion coded molecules. 
The GvH assay used is based upon iv transfer of GvH-activated lymphoid cells 
to secondary recipients, which are syngeneic with the spleen cells donors to 
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Fig. 2. H-2 restricted recognition of H-21 subregion coded al!oantigens in DTH. B10.T(6R) 
responder mice were sc immunized with 1 x 107 B10.AQR or B10.A{2R) spleen cells and 5 
days later challenged with 2 x 107 BlO.AQR, 810.A(2R), (B10.T(6R) x B10.A(2R))F1 or a 
mixture of B10.AOR and B10.A(2R) spleen cells. DTH responses were measured 24 h later. 
Each column represents the mean response± SE (n=6). 
reconstitute the irradiated allogeneic recipients, and measurement of their DTH 
reactivity. Therefore, after transfer the secondary recipients were challenged in 
the right hind foot with spleen cells syngeneic to the irradiated primary recipients. 
The subsequent footpad swelling was determined 24 h after challenge. In this 
assay, only DTH reactions to H-21 and Mls-coded alloantigens can be determined 
(Wolters and Benner, 1979; Wolters eta!., 1981 ). For the present studies, B 1 O.T-
(6 R) responder cells were used to reconstitute irradiated I incompatible 81 O.AQR 
mice. Five days later, spleen and lymph node cells form these irradiated and 
reconstituted mice were iv transferred to naive B10.T(6R) secondary recipients. 
These recipients were subsequently challenged with either B10.AQR (I incom-
patible), B10.BR (K+I+D incompatible), B10.A (K+I incompatible) or B10.BYR 
(I+D incompatible) spleen cells. When B10.AQR spleen cells were used, i.e. when 
the I alloantigens were presented in the context of syngeneic K+D molecules, a 
significant response occurred (Fig. 3, line 1 ), However, when the I alloantigens 
were presented in the context of foreign K+D, K or D molecules, only marginal 
DTH reactions were found (Fig. 3, lines 2, 3 and 4). The same phenomenon 
occurred in the A.TH-A.TL-A/J combinations: when the I alloantigens were 
presented on a background of foreign K molecules, no reaction was found. Thus, 
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RESPONDER RECIPIENT IMMUNIZING H-l CHALLENGE ~SPECIFIC INCREASE SHARED REGIONS 
STRAIN STRAIN SUBREGION FOOT THICKNESS OF H-l COMPLEX 
8\0. Tl6Rl BlO.AQR 6\0.AQR 
" 
8\0. T{6R) 8\0.AQR 8\0.BR c:::=::J-
8\0.T(6Rl 810.AQR 610.6YR 
810. T{6R) 8\0.AOR 8\0.A 0 
A. TH A. TL A. TL 
" 
A. TH A.TL w ~ 0 
A. TH A.TL (AIJxA. THJF 1 "0 
'" '" " 
Fig. 3. H-2 restricted recognition of H-21 coded alloantigens by DTH reactive T cells in a GvH-
related DTH assay. Lethally irradiated B10.AQR and A.TL mice were reconstituted with 
2 x 107 spleen cells from B10.T(6R) and A.TH donors, respectively. Five days later, spleen 
and lymph node cells were transferred iv to naive B10.T(6R) and A.TH secondary recipients, 
respectively. Immediately after transfer, these mice were challenged with 2 x 107 810.AQR, 
810.BR, B10.BYR, B10.A, A.TL, (A/J x A.TH)F1 or A/J spleen cells, which differ in the 
indicated H-2 subregions from B10.T(6R) and A.TH responder mice. DTH responses were 
measured 24 h after challenge. Each column represents the mean response± SE (n'='6). 
I alloantigens have to be presented with syngeneic K+D molecules to ensure 
optimal GvH-related DTH reactivity. 
For the combinations of B10 congenic lines it has been shown already in the 
experiments described above (Figs. 1 and 2) that non-H-2 incompatibilities of 
the B10.AQR are not involved in the DTH responses observed. Moreover, as we 
stated earlier, in GvH related DTH only reactions to H-21 and Mls coded antigens 
occur (Wolters and Benner, 1979; Wolters eta!., 1981 ). Nevertheless, we verified 
whether the Qa/Tia region incompatibilities between A.TH and A.TL might 
account for the GvH related DTH response. Therefore, the anti- I reactivity of 
A.TH against A.TL was determined by challenging the responders with (A/J x 
A.TH)F1 spleen cells (Fig. 3, line 7). These F1 cells do express the same I 
molecules as A.TL cells but not the Qa/Tia region incompatibilities of A.TL. 
The results show that a clear anti- I response is induced by A.TL. 
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H-2 restricted recognition of H-2 subregion coded alloantigens during the 
expression of I L T-reactivity 
The influence of H-2 restriction on the effector function of DTH-reactive T 
cells directed against H-2 subregion coded alloantigens was also investigated with 
the I L T assay, which can be viewed as a local GvH assay. This assay, which was 
ortnally developed by Brent eta!., (1962) is based upon local transfer of 5 x 
10 immunized lymphoid cells to naive recipients, which are either identical or 
partially identical to the original spleen cell inoculum used for immunization. 
The lymphoid cells from immunized donors were transferred into the dorsum 
of a hind foot of naive recipients five days after sc immunization. The foot 
swelling of the secondary recipients was measured 24 h after transfer. Fig. 4, 
line 1, shows that 81 O.A responder cells, immunized to K incompatible B10.AQR 
spleen cells, produced a significant I L T response when transferred to K incom-
patible B10.AQR recipients, whereas after transfer to K+l incompatible B10.T-
IMMUNIZING IMMl.JNIZED IMMUNIZING H-2 RECIPIENT RESPONSE SHARED REGIONS 
CELLS DONOR STRAIN SUBREGION STRAIN ILT-NLT X 10- 2 MM OF H-2 COMPLEX 
BlO.AQR BlO.A 
" 
BIO.AQR c::=::J-< 'D 
BlO.AQR BlO.A 
" 
810. T(6R) ~ D 
A.TL A.AL 
' 
A. TL ~ 'D 
A. TL A.AL 
' 
A. TH ~ D 
810.AQR 810.T(6R) BlO.AQR 
' D 
810.AQR B10,T(6R} BlO.BR 
A.TH A.SW D A.TH 
' ' 
A,TH A.SW D A.TL c::::J-< K 
'" 
., 
Fig. 4. H-2 restricted recognition of H-2K, I or 0 subregion coded alloantigens by DTH 
reactive T cells in the immune lymphocyte transfer assay. B10.A, A.AL, B10.T(6R) and 
A.SW mice were immunized with 1 x 107 B10.AOR, A.TL, B10.AOR and A.TH spleen 
cells, respectively. Five days later the draining lymph nodes from these mice were taken 
out, and cell suspensions were made. A number of 5 x 106 of these cells were transferred 
into the right hind foot of the indicated recipient mice. After 24 hr the foot thickness was 
measured. The response was calculated as indicated in the Materials and Methods section. 
The column; represent the mean response {I L T-N L T) ± SE in 10-2 mm (n=6). 
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(6R) recipients no reaction was observed (Fig. 4, line 2). The same was found for 
the A.TL-A.AL-A.TH combination (Fig. 4, lines 3 and 4). Furthermore, when 
B10.T(6R) responder mice were immunized with I incompatible B10.AQR 
spleen cells and lymphoid cells from these mice were transferred to I incompa-
tible B 1 O.AQR naive recipients, a clear I L T response was found, whereas transfer 
to K+I+D incompatible B10.BR recipients did not result in a significant ILT 
response (Fig. 4, lines 5 and 6). Moreover, when lymphoid cells from A.SW mice, 
immunized to D alloantigens from A.TH mice, were transferred to D incompa-
tible A.TH naive recipients, they produced a significant I L T response, whereas 
after transfer to I+D incompatible A.TL naive recipients a much lower I L T 
response was found (Fig. 4, lines 7 and 8). 
DISCUSSION 
In this paper we report that DTH reactions to H-2 subregion coded alloantigens 
are restricted by other H-2 subregions, i.e., reactions to class I (H-2K/D) alia-
antigens are restricted by class II (H-21) molecules and reactions to class II alia-
antigens are restricted by class I molecules. This can be demonstrated in a Host-
versus-Graft, a local Graft-versus-Host and a systemic Graft-versus-Host assay. 
Thus, DTH reactions to MHC subregion coded alloantigens do not basically 
differ from DTH reactions to Listeria monocytogenes (Zinkernagel eta!., 1977), 
lymphocytic choriomeningitis virus (Zinkernagel et a!., 1 976), fowl-r-globulin 
(Miller eta!., 1975), dinitrofluorobenzene (Vadas eta/., 1977), sheep red blood 
cells (Bianchi et al., 1981 ), and minor histocompatibility antigens (Van der 
Kwast, 1980), which all have been shown to be MHC restricted. 
However, there are several reports in which the authors come to opposite 
conclusions with regard to the MHC restricted recognition of H-2 subregion 
coded alloantigens. Klein eta/. (1977) have shown that cytotoxic lymphocytes, 
primed in vivo to lA alloantigens and subsequently restimulated in vitro with the 
same lA alloantigens, were able to lyse target cells bearing these lA alloantigens 
without a concomitant need for the target cells to bear the same K/D molecules 
as the killer T cells. Thus, K/D region compatibility was not needed for I region 
specific cell-mediated lymphocytotoxicity. In contrast, Kindred (1981, 1983a,b) 
has shown that T cells from radiation chimeras cause a lethal GvH reaction in 
irradiated bone marrow protected recipients only if the recipient shares a 
restriction element with the T cell donor. In her model, K and D molecules were 
found to act as restriction elements in lethal GvH induced by I coded alia-
antigens. 
Restricted recognition of K and D alloantigens by I molecules has been 
investigated by Swain (1981). She has found that primed helper T cells directed 
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against allogeneic K + D alloantigens are not restricted by syngeneic I molecules. 
However, studies in which Ia positive cells were eliminated {Minami and Shreffler, 
1981) and Ia blocking studies {Rock et at., 1983) have shown that mixed 
lymphocyte responses to class I alloantigens are Ia restricted. 
The conclusions from studies on restricted recognition of H~2 alloantigens 
from different laboratories seem to be mutually exclusive: the reaction to H-2 
subregion alloantigens is either restricted or unrestricted. However, one must 
bear in mind that the results from Klein eta!. {1977) and Swain {1981) were 
obtained with assay systems in which secondary type reactions are elicited, while 
the studies of Minami and Shreffler {1981) and Kindred {1981, 1983a,b) deal 
with primary responses. Moreover, Kindred showed by using different mouse 
strain combinations and by using T cells from normal mice and from radiation 
chimeras, that different H-21 specific T cell populations causing lethal GvH exist, 
which are either K/D restricted or unrestricted. Thus, it might be that the 
assay systems of Klein eta/. {1977) and Swain {1981) select for unrestricted T 
cells. 
In contrast to our conclusion, Smith and Miller {1979) and Weiss and Dennert 
{1981) have stated that H-2 specific DTH effector cells are unrestricted. These 
authors have shown that in vivo activated H-2 specific DTH effector T cells and 
Ia specific T cell lines can express DTH reactivity after transfer to H-2 incompa-
tible naive recipients. The allogeneic cells used for elicitation of the DTH 
response in their experiments were similar to the allogeneic cells used for 
activation of the DTH effector T cells. 
Our opinion is that these results do not exclude the possibility that these 
responses were actually H-2 restricted. We shall explain this in the following 
hypothetical model {Fig. 5). During the induction of DTH effector T cells to 
H-2 subregion coded alloantigens, these antigens are recognized in the context of 
other H-2 molecules on the surface of the same allogeneic cells or, after 
processing by antigen-presenting cells {APC), in the context of the H-2 molecules 
of the APC. When the injected alloantigens occur on cells from which the other 
H-2 molecules are syngeneic with the responder mouse, only synrestricted DTH 
effector T cells will be induced. On the other hand, when the particular H-2 
alloantigens are presented on an allogeneic H-2 background, the DTH effector 
T cells induced by direct interaction with the allogeneic cells will beal/orestricted, 
while the DTH effector T cells induced by alloantigen processing and presentation 
by APC will be synrestricted. 
Van der Kwast {1980) has shown in studies concerning H-2 restricted 
recognition of minor H antigens in DTH that macrophage processing of antigen 
is only important during the induction of DTH reactivity and not during the 
expression phase. Thus, when H-2 subregion coded alloantigens are presented 
during the sc induction of the DTH reactivity on cells which are syngeneic to the 
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Fig. 5. Model for syngeneically 
and allogeneica!ly H-2 restricted 
recognition of H-2 subregion 
coded alloantigens. 
DTH 
Reactive 
Cell 
"Syn" restricted 
"Aile" restricted 
"Syn" restricted 
responder mouse strain for the other H-2 molecules, the activated T cells will not 
recognize these H-2 subregion coded alloantigens in combination with other H-2 
alloantigens during the expression phase of DTH (Fig. 1 and 2, line 2). However, 
induction of DTH reactivity by allogeneic cells incompatible for several H-2 sub-
regions (viz. Figs. 1 and 2, lines 3 and 4) will lead to activation of two subsets of 
DTH reactive T cells, one synrestricted (due to APC-processing) and one alia-
restricted. Consequently, the mice will respond to a challenge of these alia-
antigens on the original allogeneic H-2 background as well as on a syngeneic 
H-2 background, which is precisely what we found (Figs. 1 and 2, lines 3 and 4). 
This model of generation of 'allo' and 'syn' restricted DTH effector T cells, can 
thus explain all the data presented in this paper. Furthermore, it can explain the 
data from Smith and Miller (1979) and Weiss and Dennert (1981) in that their 
DTH reactive T cells recognized the H-2 coded alloantigens in an allorestricted 
manner. 
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SUMMARY 
Intravenous injection with 2,000 rad irradiated allogeneic cells can suppress the development 
of antigraft delayed type hypersensitivity (DTH) to major and minor histocompatibility (H) 
antigens which normally arises after s.c. immunization. Secondary type DTH responses to 
minor H antigens were also largely suppressed by an i.v. injection of irradiated allogeneic 
cells 1 week preceding the s.c. priming injection. The extent of suppression of primary DTH 
to allogeneic H-2-incompatible celts depended on the dose of i.v. injected irradiated cells. 
After a dose of 1 x 107 irradiated spleen cells i.v., the suppression persisted for at least 40 
days. Intravenous injection of cells incompatible for minor H antigens could not suppress the 
DTH to H-2 al!oantigens and vice versa. Suppression of DTH to H-2 alloantigens was haplotype 
specific. 
Proliferation studies indicated that the immunosuppressed mice do not respond upon s.c. 
immunization with an increased proliferative activity in the draining lymph nodes, in contrast 
to nonsuppressed mice. 
The data suggest that i.v. preimmunization with allogeneic cells induces specific suppression 
of antigraft immunity acting at the induction stage of the immune response. 
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INTRODUCTION 
Suppression of immune responsiveness has been demonstrated in vivo for T 
helper function (1), DTH (2, 3), allograft rejection (4), graft-versus-host reactivity 
(5, 6), and in vitro for mixed lymphocyte reactivity (7, 8) and cell-mediated 
lympholysis (9, 1 0). Suppression may act upon the afferent as well as upon the 
efferent limb of the immune response (11 ). Suppression of alloreactivity can be 
antigen specific as well as nonspecific and may be mediated by humoral factors 
(e.g., antibodies or antigen-antibody complexes) as well as by T suppressor cells 
and macrophages (12, 13). 
Immunization of mice for DTH to alloantigens is highly dependent on the 
route of antigen administration. Thus, some authors demonstrated that i.v. or 
i.p. immunization with allogeneic cells induces a poor state of DTH (14, 15), 
whereas s.c. immunization results in a good and stable DTH response to both 
major and minor H antigens (15, 16). Similarly, graft rejection seems to depend 
on the site of the graft, i.e., skin allografts are more prone to rejection than 
kidney allografts (17). Intravenous preimmunization of mice with allogeneic 
lymphoid cells could specifically prolong skin allograft rejection in a proportion 
of mice, if they were pretreated with either antithymocyte serum and 
procarbazine hydrochloride vaccine or cyclophosphamide (4, 18, 19). In the 
former model it was shown that T suppressor cells were present in mice which 
carried a skin allograft for a long time. 
In experiments on DTH to hapten-modified syngeneic cells and on contact 
sensitivity to haptens, it was demonstrated that i.v. injection of hapten-modified 
cells to mice could inhibit the development of DTH after subsequent s.c. 
immunization or skin painting with the specific antigen (20, 21 ). 
This paper deals with the suppressive effect of i.v. preimmunization with allo-
geneic lymphoid cells on allograft immunity to major and minor H antigens as 
determined with the DTH assay. The kinetics, specificity, and mode of action of 
suppression was investigated. 
MATERIALS AND METHODS 
Animals 
(C57BL/Rij x CBA/Rij)F 1 (H-2b/q), BALB/c (H-2d), DBA/2 (H-2d), C3H/Lw 
(H-2k), and AKR (H-2k) mice were purchased from the Radiobiological Institute 
TNO, Rijswijk, The Netherlands. C3Hf (H-2k), B10.A (H-2a), and A.SW (H-2s) 
mice were purchased from the Laboratory Animal Centre of Erasmus University, 
Rotterdam, The Netherlands. B10.G (H-2q), BALB.K (H-2k), and BALB.B 
(H-2b) mice were purchased from OLAC Ltd., Bicester, United Kingdom. Swiss 
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(H-2s) and B10.ScSn (H-2b) mice were purchased from the Central Institute for 
the Breeding of Laboratory Animals, TNO, Zeist, The Netherlands. CWB (H·2b) 
mice were obtained from the lnstitut fur Biologisch-Medizinische Forschung AG, 
Fullinsdorf, Switzerland. The age of the responder mice varied between 12 and 
24 weeks. All mice used were females. 
Preparation of cells suspensions 
Spleens and lymph nodes were removed, placed in a balanced salt solution, 
and squeezed through a nylon gauze filter to provide a single-cell suspension. 
Nucleated cells were counted with a Coulter Counter model B. 
Antigen and immunization 
Primary and secondary immunization were performed with the appropriate 
allogeneic spleen cells, suspended in a volume of 0.1 mi. The priming and 
boosting dose was always 1 x 107 spleen cells. These cells were injected s.c., 
equally distributed over both inguinal areas. In a previous paper, it was shown 
that this dose induces maximal DTH responses in primary and secondary DTH to 
H-2 and non-H-2 alloantigens. In primary DTH to minor H antigens, peak DTH 
reactivity is generally found on day 5 after immunization (16). Suppressive 
injections of allogeneic cells suspended in a volume of 0.5 ml of balanced salt 
solution were given i.v., in doses as stated in the experiments. Immediately 
before the i.v. injection, the cell suspensions were irradiated in vitro with 2,000 
rad, generated in a Phillips-Muller MG 300 X-ray machine as described in detail 
prevoiously (22). 
EstimatJ'on of cell proliferation in vivo 
For estimation of the cell proliferation in inguinal lymph nodes, the method 
described by North et al. (23) was used. Briefly, at varying intervals after s.c. 
immunization with 1 x 107 allogeneic spleen cells, the mice were given i.v. 
injections of 20 MC of [methyi.3H]thymidine {specific activity, 5 c/mM). Thirty 
minutes later their inguinal lymph nodes were taken out and suspended in 5% ice 
cold trichloroacetic acid. Each cell suspension was extracted twice for 1 hr with 
20 ml of cold 5% trichloroacetic acid. Thereafter, the suspension was extracted 
in 6 ml of 5% trichloroacetic acid at 90 C for 1 hr. After cooling, 1 ml of the 
supernatant was added to 9 ml of scintillant consisting of 3 ml of Triton X-100 
and 6 ml of toluene containing 4 mg of PPO per liter, and counted in a liquid 
scintillation counter {Packard model 3375). Radioactivity was corrected for 
background and quenching, and expressed as cpm. Background activity was 30 
to 35 cpm. 
Assay for DTH 
DTH reactions were determined by measuring the difference in thickness of 
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the hind feet 24 hr after s.c. injection of 8 x 106 spleen cells into the instep of 
the right hind leg. The challenge dose was administered s.c. in a volume of 20 
1LI by means of a 28-gauge needle. The thickness of the left and right hind feet 
was measured with a footpad meter with a 0.05 mm accuracy. During 
measurement the mice were anesthetized with ether. 
A control group consisting of nonimmune mice challenged with the same 
number of spleen cells as the mice to be tested was always included. The specific 
increase in foot thickness was calculated as the relative increase in foot thickness 
of the control mice. The swelling in control mice ranged between 18 and 26%. 
RESULTS 
Suppression of the capacity of DTH reactivity by i. v. injection of allogeneic 
spleen cells 
The influence of i.v. injection of allogeneic spleen cells upon subsequent 
induction of DTH reactivity by s.c. immunization with spleen cells from the 
same donor strain was investigated. Groups of (C57BL x CBA)F 1 mice were 
given i.v. injections of either 1 x 107 of 2,000 rad of irradiated allogeneic H-2-
incompatible BALB/c spleen cells or of the same number of syngeneic spleen 
cells. For comparison, groups of (C57BL x CBA)F 1 mice were given s.c. 
injections of 1 x 107 irradiated BALB/c or (C578L x CBA)F 1 spleen cells. 
Seven days later all mice were immunized with 1 x 107 BALB/c spleen cells 
s.c. and another 6 days later a challenge injection of BALB/c spleen cells was 
given. At 24 hr the DTH reactivity was determined. It seemed that i.v. preim-
munization with irradiated BALB/c spleen cells caused a significant immuno-
suppression of DTH reactivity, whereas no suppression was found in the other 
groups of mice (Table 1 ). The extent of suppression of DTH induced by i.v. 
preimmunization was not affected by the age of the responder mice used (data 
not shown). 
The determination of the optimal dose of i.v. injected spleen cells was done 
with different groups of (C57BL x CBA)F 1 mice that were injected with 104, 
105, 106, or 107 irradiated BALB/c or (C57BL x CBA)F 1 spleen cells. Seven 
days later all mice were immunized s.c. with 1 x 107 BALB/c spleen cells and 
tested for DTH again 6 days later. The immunosuppression appeared to be dose 
dependent and maximal when induced by 1 x 107 or more irradiated allogeneic 
spleen cells (Fig. 1 A). 
The optimal dose of i.v. injected spleen cells was also determined in a 
combination differing for minor H antigens only. For this purpose Swiss mice 
were given i.v. injections of 1 x 106, 3 x 106, 1 x 107, 3 x 107, or 1 x 108 
irradiated A.SW or Swiss spleen cells, S.C. immunized with 1 X 1 o7 A.SW spleen 
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TABLE 1. Preimmunization with allogeneic cells 
Preirnmunization3 
Inoculum 
(C57BL x CBA)F1 
BALB/c 
{C57BL x CBA)F1 
BALB/c 
Route 
S.C. 
S.C. 
i.v. 
i.v. 
%specific 
increaseb 
28 ± 1 
22 ± 2 
25 ± 2 
5±3 
a (C57BL x CBA)F 1 mice were given i.v. or s.c. injections of 1 x 10
7 irradiated syngeneic 
or H-2-incompatible allogeneic BALB/c spleen cells. Seven days later all mice were immunized 
s.c. with 1 x 107 BALB/c cells and challenged another 6 days later. 
b Mean responses± 1 SE (n = 5). 
cells 7 days later, and tested for anti-A.SW DTH reactivity again 5 days later. 
Also, in this combination i.v. preimmunization by 1 x 107 or more irradiated 
allogeneic spleen cells induced maximal suppression {Fig. 1 B). The same result 
was obtained with DBA/2 responder mice immunized with BALB/c spleen cells, 
another combination only differing for minor H antigens (data not shown). 
Effect of i.v. preimmunization upon the kinetics of the DTH reactivity 
To assess the suppressive effect of i.v. preimmunization upon the kinetics of 
the DTH response to H-2-incompatible allogeneic cells, groups of (C57BL x 
CBA)F1 mice were given i.v. injections of either 1 x 107 irradiated BALB/c or 
1 x 1 Q7 irradiated (C57B L x CBA) F 1 spleen cells. Seven days later all mice were 
s.c. immunized with 1 x 107 normal BALB/c spleen cells and challenged on day 
1, 3, 5, 6, 8, or 15 after immunization. The immunosuppressed group of mice 
did not show significant DTH reactivity at any of the tested time points. The 
nonsuppressed mice reached peak levels of antigraft DTH reactivity between 
days 5 and 6 after immunization (Fig. 2). The same results were obtained in a 
similar set up with another strain combination, in which C3Hf mice were immu· 
nized with C57BL/Rij spleen cells (data not shown). 
Time course of the immunosuppression induced by i. v. preimmunization 
The duration of the suppressive effect induced by i.v. injection of irradiated 
allogeneic spleen cells was investigated in the combination of BALB/c {H-2d) 
and BALB.K (H-2k) mice, which have distinct H-2 haplotypes, and in the 
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combination of C3H/Lw (H-2k) and AKR (H-2k) mice, which only differ for 
minor H antigens. 
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foot thickness 
30 
20 
!0 
0 r' 
PBS 
" 
30 f 
20 
!0 
A 
m' m' !0' 
B 
0 r• I I jiillj I I I jiillj I I I jilllj IIi liiij 
PBS 106 107 108 109 
dose i.v. injected cells 
Fig. 1. Determination of the optimal dose of i.v. injected spleen cells for suppression of DTH 
reactivity to allogeneic spleen cells. A; (C57BL x CBA)F 1 mice were given injections of 1 x 
104, 1 x 105, 1 x 106, or 1 x 107 irradiated BALB/c (e) or (C57BL x CBA)F1 spleen cells 
(o). Seven days later all mice were s.c. immunized with 1 x 107 BALB/c spleen cells, and 
another 6 days later tested for DTH. B: Swiss mice were given injections of 1 x 106, 3 x 106, 
1 x 107,3 x 107, or 1 x 108 irradiated A.SW {e) or Swiss spleen cells (o). Seven days later all 
mice were immunized s.c. with 1 x 107 A.SW spleen cells, and another 5 days later tested for 
DTH. Each experimental group represents the arithmetic mean± 1 SE (n = 5). 
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Fig. 2. Effect of i.v. preimmunization upon the kinetics of the DTH reactivity to allogeneic 
spleen cells. (C57BL x CBA)F 1 mice were given i.v. injections of 1 x 107 irradiated BALB/c 
(o) or (C57BL x CBA)F 1 spleen cells (o). Seven days later all mice were s.c. immunized with 
1 x 107 BALB/c spleen cells, and challenged on day 1, 3, 5, 6, 8, or 15 after immunization. 
Each experimental group represents the arithmetic mean± 1 SE (n = 5). 
Groups of BALB/c mice were given i.v. injections of 1 x 107 irradiated BALB.K 
or BALB/c spleen cells on days -43,-23,-16,-7, and -3. On day 0 groups of these 
mice were s.c. immunized with BALB.K spleen cells, and on day 6 all mice were 
challenged. It seemed that the suppression of DTH reactivity by i.v. preimmuni-
zation lasted for at least 43 days (Fig. 3A). The data tend to indicate that the 
suppression slightly diminished in course of time. 
For the suppression of DTH to non-H-2 alloantigens, C3H/Lw mice were given 
i.v. injections of 1 x 107 irradiated AKR or C3H/Lw spleen cells on days -41, 
-27, -14, -8, and -5. On day 0 groups of these mice were s.c. immunized with 
AKR spleen cells, and on day 5 all mice were challenged. It was found that the 
suppression did not diminish during the experimental period of 41 days (Fig. 
3B). 
Effect of f. v. preimmunization upon the secondary DTH response to non-H-2 
al!oantigens 
To investigate whether i.v. preimmunization could also lead to suppression 
of secondary type DTH reactivity to minor H antigens, groups of DBA/2 mice 
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Fig. 3. Time course of the immunosuppression induced by i.v. preimmunization. A: Groups 
of BALB/c mice were given i.v. injections of 1 x 107 irradiated BALB.K (e) or BALB/c spleen 
cells (O) on days -43,-23,-16,-7, and -3. On day 0, groups of these mice were s.c. immunized 
with BALB.K spleen cells, and on day 6 all mice were challenged. B: Groups of C3H/Lw mice 
were given i.v. injections of 1 x 107 irradiated AKR (e) or C3H/Lw spleen cells (o) on days 
A 1, -27, -14, -8, and -5. On day 0, groups of these mice were s.c. immunized with AKR spleen 
cells, and on day 5 all mice were challenged. Each experimental point represents the arithmetic 
mean ± 1 SE (n = 5). 
were given i.v. injections of irradiated H-2-compatible allogeneic BALB/c spleen 
cells or syngeneic DBA/2 spleen cells. Seven days later all mice were s.c. 
immunized with 1 x 107 BALB/c spleen cells and boosted with similar cells 6 
weeks later. Three, 5 and 7 days after the booster immunization, all mice were 
challenged to measure the secondary DTH reactivity. Primary DTH reactivity 
was determined as well on days 3, 5, and 7 after immunization. BALB/c mice 
that were given i.v. injections of irradiated syngeneic spleen cells showed a clear 
secondarv type DTH response to the DBA/2 minor H antigens, in contrast to the 
BALB/c mice preimmunized with irradiated DBA/2 cells (Fig. 4). Thus, secondary 
type DTH reactivity to minor H antigens was largely suppressed in the mice 
that received an i.v. injection of allogenic irradiated cells 1 week before s.c. 
priming. 
Specificity of suppression of DTH to H-2 and minor H-incompatib/e spleen cells 
Different groups of BALB/c (H-2d) mice were given i.v. injections of either 
1 x 107 irradiated H-2-incompatible BALB.K (H-2k). 1 x 107 minor H-
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incompatible DBA/2 (H-2d), or 1 x 107 syngeneic BALB/c spleen cells. Seven 
days later all mice were s.c. immunized with BALB.K or DBA/2 spleen cells and 
challenged with similar cells another 6 days later. Intravenous preimmunization 
with the H-2-incompatible BALB.K cells did not interfere with the development 
of DTH after s.c. injection with minor H-incompatible DBA/2 spleen cells. 
Similarly, i.v. preimmunization with DBA/2 cells did not significantly affect 
the anti·BALB.K DTH reactivity. Suppression of anti-BALB.K or anti-DBA/2 
"I& specific increase 
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6 8 
Fig. 4. Effect of i.v. preimmunization upon the secondary DTH response to non-H-2 alto-
antigens. Groups of DBA/2 mice were given i.v. injections of 1 x 107 irradiated BALB/c {e) 
or DBA/2 spleen cells (o). Seven days later all mice were s.c. immunized with 1 x 107 BALB/c 
spleen cells, and another 6 weeks later boosted with similar cells. Three, 5 and 7 days after 
booster immunization, different groups of mice were challenged with BALB/c spleen cells to 
measure the secondary DTH reactivity to these cells. Primary anti-BALB/c DTH reactivity 
(o) was determined as well on days 3, 5, and 7 after immunizaf1on. Each experimental point 
represents the arithmetic mean± 1 SE (n = 5). 
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Fig. 5. Specificity of i.v. induced suppression for H-2 and non-H-2 alloantigens. Responder 
mice were given i.v. injections of 1 x 107 irradiated allogeneic or syngeneic spleen cells and 
s.c. immunized with 1 x 107 allogeneic spleen cells 7 days later. Challenge for DTH was 
performed on day 6 after s.c. immunization. Each column represents the mean response 
± 1 SE of five mice. 
DTH reacttvtty only occurred when the i.v. and s.c. injections were done with 
identical spleen cells (Fig. 5). 
Similar experiments were done with B10.ScSn (H-2b) responder mice given i.v. 
and s.c. injections of either H-2-incompatible B10.G (H-2q) spleen cells or minor 
H-incompatible spleen cells. These experiments also revealed that suppression of 
anti-B10.G or anti-BALB.B DTH reactivity only occurred when the i.v. and s.c. 
injections were done with identical spleen cells (Fig. 5). The same results were 
91 
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Fig. 6. Specificity of i.v. induced suppression for different H-2 haplotypes. Responder mice 
were given i.v. injections of 1 x 107 irradiated allogeneic or syngeneic spleen cells and s.c. 
immunized with 1 x 107 allogeneic spleen cells 7 days later. Challenge for DTH was 
performed on day 5 after s.c. immunization. Each column represents the mean response 
± 1 SE of five mice. 
obtained in a similar protocol with C3H/Lw (H-2k) responder mice, CWB (H-2b) 
spleen cells, and AKR (H-2k) spleen cells (Fig. 5). 
Specificity of suppression of DTH to H·2 a//oantigens 
After having established that it is impossible to suppress the induction of 
DTH reactivity to H·2-incompatible cells by i.v. preimmunization with minor H-
incompatible spleen cells and vice versa, we investigated whether or not the 
suppression of the DTH reaction to H-2 alloantigens is haplotype specific. There-
fore, groups of BALB/c (H-2d) mice were given i.v. injections of either 1 x 107 
irradiated H-2-incompatible BALB.K (H-2k), 1 x 107 H-2-incompatible BALB/B 
(H-2b), or 1 x 107 syngeneic BALB/c spleen cells. Seven days later all ofthese 
mice and a group of BALB/c mice that had not been preimmunized were s.c. 
immunized with 1 x 107 BALB.K or 1 x 107 BALB.B spleen cells. Another six 
days later the mice were challenged with similar spleen cells as used for the s.c. 
immunization. Significant suppression was only found in the groups of BALB/c 
mice given i.v. and s.c. injections of H-2-incompatible cells of the same 
haplotype (Fig. 6). 
According to the same protocol, 810.ScSn (H-2b) mice were given i.v. 
92 
injections of either B10.A (H-28 ), 810.G (H-2q), or B10.ScSn (H-2b) spleen 
cells. Seven days later all of these mice and a control group of untreated 
B10.ScSn mice were s.c. immunized with B10.A spleen cells. Another six days 
later all mice were challenged with B10.A cells. Again, suppression seemed to be 
specific for the H-2 haplotype of the i.v. injected cells. Thus, the DTH reactivity 
to B10.A spleen cells could only be suppressed by i.v. preimmunization with 
810.A cells (Fig. 6). 
Proliferative activity in lymph nodes of immunosuppressed mice after s.c. 
immunization 
Groups of (C57BL x CBA)F 1 mice (H-2b/q) were given i.v. injections of 
either 1 x 107 irradiated H-2- and minor H-incompatible BALB/c (H-2d) or syn-
geneic (C57BL x CBA)F 1 spleen cells on day -7. On day 0, the mice of both 
specific response 
(cpm x1lh 
0 
days after immunization 
Fig. 7. Proliferative activity in the draining lymph nodes of immunosuppressed mice after 
s.c. immunization. Groups of (C57BL x CBA)F 1 mice were given i.v. injections of 1 x 107 
irradiated BALB/c (e) or (C57BL x CBA)F 1 (o) spleen cells on day -7. On day 0, the mice 
of both groups were s.c. immunized with BALB/c spleen cells, and on days 1, 3, 4, 6, and 8 
the proliferative activity in the draining inguinal lymph nodes was determined. Similarly, 
proliferation was determined in lymph nodes of BALB/c mice i.v. preimmunized with 1 
x 107 irradiated DBA/2 (a) or BALB/c spleen cells (o). On day 0, the mice of both groups 
were s.c. immunized with DBA/2 spleen cells and on day 5 the proliferative activity in the 
draining inguinal lymph nodes was determined. For each experimental point there was a 
control group included which was not i.v. and s.c. immunized. The proliferative activity in 
the lymph nodes of these mice was the same as in the immunosuppressed mice. Each point 
represents the arithmetic mean± 1 SE {n == 5). 
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groups were s.c. immunized with BALB/c spleen cells, and on days 3, 4, 6, and 
8 the proliferative activity in the draining inguinal lymph nodes of the different 
groups of mice was determined. (C57BL x CBA)F 1 mice given i.v. injections of 
syngeneic cells showed peak proliferative activity at 4 to 6 days after s.c. 
immunization with BALB/c spleen cells. However, in the immunosuppressed 
mice no apparent increase in prol"lferative activity of lymph node tissue was 
observed at any of the tested intervals after s.c. immunization (Fig. 7). Similarly, 
proliferation was determined in lymph nodes of BALB/c mice i.v. preimmunized 
with minor H·incompatible DBA/2 or syngeneic BALB/c spleen cells, and s.c. 
immunized with allogeneic H·2·compatible DBA/2 (H·2d) spleen cells. Again, 
significant inhibition of proliferative activity was observed in the lymph nodes 
of the immunosuppressed mice (Fig. 7). 
DISCUSSION 
This paper demonstrates that a single i.v. Injection of mice with irradiated 
(2,000 rad) allogeneic spleen cells can induce an antigen·specific suppression of 
primary and secondary antigraft DTH responsiveness. The extent of suppression 
can vary between different experiments, but usually accounts for a reduction 
of the response by 70 to 90%. In some experiments a complete suppression of 
the antigraft DTH reactivity was found. The i.v. route of preimmunization is 
obligatory for the suppression (Table 1 ). This suggests that the spleen is directly 
involved, which is supported by experiments involving splenectomy (Bianchi 
et a!., to be published). Since the suppression can be induced by heavily 
irradiated cells as well as by crude membrane preparations (data not shown), 
the suppression of DTH to alloantigens must be mediated by the host. The 
suppression cannot be explained as a recruitment phenomenon, because recruit· 
ment is a short·lasting process (24) and the suppression described here lasts for 
at least 40 days (Fig. 3). From the reduced proliferative activity in the regional 
lymph nodes of s.c. immunized immunosuppressed mice (Fig. 7), it can be 
concluded that the suppressive mechanism affects the "afferent" limb of the 
immune response. Recently, it was found that Thy·1.2+ spleen cells from 
immunosuppressed mice were also capable to suppress the "efferent" limb of the 
DTH response (Bianchi et a/., to be published). Experiments that will reveal 
whether or not similar suppressor T cells are also responsible for the suppression 
of the "induction" phase of the DTH response are in progress. 
A number of studies have revealed antigen·nonspecific T cell·mediated 
suppression of mixed lymphocyte reaction and cell·mediated lympholysis to H·2· 
incompatible cells. The nonspecific suppressor T cells were induced in vivo by 
s.c. or i.v.Jnjection of alloantigens, and could only be recovered from the spleen 
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(7, 25). Recently, however, it was found that injection of heat-treated allogeneic 
cells could induce alloantigen-specific suppression of cytotoxic T cell responses 
in a large proportion of mice (26). In this latter study the i.v. route of injection 
was obligatory for induction of suppression. 
A DTH model with some similarity to the one presented here is that of Miller 
eta!. (20, 27, 281. who induced suppression of contact sensitivity to haptens by 
i.v. preimmunization with hapten·modified syngeneic or allogeneic lymphoid 
cells. Both in their model and in the experiments reported here, suppression of 
DTH react;vity could be induced for antigenic determinants presented on H-2-
compatible or H-2-incompatible lymphoid cells. Intravenous injection of hapten-
modified syngeneic cells induced a clonal inhibition of immune reactive cells 
directed against the hapten as well as induced the generation of antigen-specific 
suppressor T cells (27). These suppressor T cells affected the efferent limb of the 
DTH immune response. Contrarily, i.v. injected hapten-modified H-2-in-
compatible lymphoid cells induced suppressor T cells acting at the afferent 
limb of the immune response only. These suppressor T cells exerted their 
suppressive effect only upon transfer to the mouse strain from which the hapten-
modified allogeneic cells were derived (28). Furhter investigations are required 
to fit these data of contact sensitivity into our antigraft DTH model. 
Others have reported that i.v. injection of alloantigens can also prolong graft 
survival. However, such results were only found when the preimmunization was 
done in combination with treatment with immunosuppressive drugs or anti-
lymphocyte serum (4, 18, 19), and only in certain donor-host strain combi-
nations. Even under these conditions only a proportion of the treated mice 
showed a delayed graft rejection. This is in clear contrast to our studies on 
suppression of DTH reactivity to histocompatibility antigens where no 
significant recovery of DTH responsiveness arose at any time interval after the 
s.c. immunization. Thus, suppression of DTH is not based on a mere shift of the 
moment of peak responsiveness (Fig. 2). 
From the foregoing it is clear that i.v. preimmunization more easily induces 
suppression of antigraft DTH reactivity than suppression of allograft rejection. 
This is probably related to the different types ofT effector cells mediating these 
immune responses and may point to the complexity of the process of graft 
rejection. 
DTH responses are mediated by lymphokine-producing T cells that require 
proliferation for full development of their reactivity (29). Skin graft rejection, 
on the other hand, is mainly dependent upon cytolytic T lymphocytes (CTLs). 
This may be inferred from the experiments of Rouse and Wagner (30) showing 
that CBA CTLs, activated by BALB/c stimulator cells in vitro, specifically 
rejected BALB/c allografts upon transfer into thymectomized, lethally irradiated, 
bone marrow-reconstituted CBA mice. Although generation of active CTLs from 
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their Lyt-2,3+ precursors is dependent upon the presence of an amplifying factor 
derived from antigen-activated Lyt-1 + T cells (31), the production of this factor 
does not require proliferation (32). This might explain why a suppressor system 
that inhibits proliferation (Fig. 7) can account for complete inhibition of the 
development of DTH reactivity, although it hardly affects transplant rejection. 
Alternatively, the i.v. preimmunization might lead to a selective stimulation of 
the precursors of CTLs. 
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SUMMARY 
Immunization of mice with irradiated (20 Gy) or non-irradiated allogeneic spleen cells 
iv induces delayed type hypersensitivity (DTH) reactive T cells, as well as suppressor T cells, 
against histocompatibility (H) antigens. The suppressor T cells are unable to suppress the 
induction and functional activity of the simultaneously activated DTH reactive T cells. 
However, the suppressor T cells do suppress the generation of DTH reactive T cells after 
subsequent sc immunization of the same mice and after transfer into secondary recipients. 
Systemic transfer of suppressor T cells is effective the first few days after their induction 
only, and affects the afferent limb of the DTH response. The population of suppressor T cells 
which is essential for the systemic transfer of suppression, appeared to by Lyt·1+2+. 
Splenectomy experiments showed that the spleen is not essential for induction of the 
suppressor T cells. The precursors of the suppressor T cells belong to the pool of recirculating 
T lymphocytes; they are insensitive to adult thymectomy and can be depleted by anti 
thymocyte serum treatment. 
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INTRODUCTION 
Induction of immune reactivity and tolerance in vivo has been shown to 
depend on the dosage of antigen (1-3). on the route of antigen administration 
(2, 4, 5) and on the antigen form (4-6). As far as cell-mediated immune reactions 
are concerned, most studies deal with the induction or suppression of delayed 
type hypersensitivity (DTH) or contact sensitivity (CS) against haptens (2, 6, 7). 
These studies suggest that unresponsiveness may depend on a shortage of antigen 
reactive cells or on an active suppression mediated by suppressor T cells (5, 8, 9). 
Some of the suppressor T cell systems were found to affect either the induction 
phase (1 0, 11) or the effector phase I 12, 13) of the immune response, but other 
systems affect both (5, 8). 
Studies aimed at manipulation of the immune response against histocompati-
bility (H) antigens are of special interest in view of their potential application in 
influencing the anti-graft immune response of transplant recipients. Several 
studies with mice have shown that infusion of blood cells or lymphoid cells can 
prolong skin (14, 15) or heart (16, 17) transplant survival. In most of these 
studies additional immunosuppression (e.g., by antilymphocyte serum or cyclo-
phosphamide) appeared to be required in order to reveal the suppression by the 
suppressor T cells (14-16, 18). 
In previous studies we have shown that sc induction of host-vs-graft DTH 
reactivity of mice against H antigens can be prevented by iv preimmunization of 
the responder mice with similar irradiated allogeneic spleen cells (3). Preim-
munization iv with alloantigens can also suppress the development of graft-vs-
host (GvH) related DTH effector T cells after inoculation of irradiated, allogeneic 
recipients with the preimmunized donor cells (19). 
The iv induced suppression appears to be antigen-dose dependent and the 
suppressive effect is a long-lasting phenomenon (3). Specificity studies have 
shown that the iv induced suppression can only be elicited by the antigen(s) 
originally used for induction of the state of suppression (19, 20). However, 
after elicitation of the suppressive effect with the relevant antigen, the immune 
response against third party antigens is also suppressed (1 9, 20). Preliminary 
studies (20, 21) have shown that suppressor T cells account for the iv induced 
suppression of DTH to H-antigens. Antigen specific suppression can be induced 
by minor H antigens as well as by H-2K, H-21 or H-2D antigens (19, 22, 23). 
By using our protocol for iv induction of suppression there is, in contrast to the 
protocol of Liew (23), no special need for allo-1-J antigens for iv induction of 
suppression to H-2 coded alloantigens (24). 
The requirements for the induction and expression of the suppressive effect, the 
requirements for transfer of the suppressive effect to syngeneic recipients and the 
characterization oft he T cells involved in th istypeofsuppression are discussed here. 
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MATERIALS AND METHODS 
Mice 
(C57BL/Rij x CBA/Rij)F1 (H-2b/q), BALB/c (H-2d) and A.SW (H-2s) mice 
were purchased from the Laboratory Animals Centre of the Erasmus University, 
Rotterdam. DBA/2 (H-2d) mice were purchased from the Radiobiological 
Institute TNO, Rijswijk, The Netherlands. Swiss IH-2s) mice were purchased 
from the Central Institute for the Breeding of Laboratory Animals TNO, Zeist, 
The Netherlands. C3H/Tif IH-2k) mice were purchased from Bomholtgard, Ry, 
Denmark. B10.D2 IH-2d) and B10.BR (H-2k) mice were purchased from OLAC 
Ltd., Bicester, United Kingdom. The age of the responder mice varied between 
10 and 24 weeks. All mice used were females. 
Preparation of cell suspensions 
Mice were killed using carbon dioxide. The spleens or lymph nodes were 
removed, placed in balanced salt solution (BSS) and squeezed through a nylon 
gauze filter to provide a single cell suspension. Nucleated cells were counted with 
a Coulter counter model B. The viability of the cell suspensions obtained was at 
least 90o/~ 
Immunization 
Suppression was induced by iv preimmunization with 5 x 107 irradiated 
(20 Gy) allogeneic spleen cells, unless indicated otherwise. In general, DTH was 
induced by sc immunization with 1 x 107 nonirradiated allogeneic spleen cells. 
There was an interval of 7 days between iv induction of suppression and sc 
immunization for DTH. Five or six days after the sc immunization the mice were 
tested for DTH reactivity by injection of a challenge dose into the dorsum of the 
right hind foot. The H-2 and non-H-2 compatibilities and incompatibilities of the 
mouse strain combinations used in this study are listed in Tabel 1. 
Transfer of suppression 
The state of suppression was transferred to recipient mice by iv injection of 
spleen and lymph node cells from mice which were iv suppressed several days 
previously. The interval between iv suppression and transfer is given in the 
Results section for each experiment separately. A few hours after transfer, the 
recipients were sc immunized, unless indicated otherwise. 
Splenectomy 
Splenectomy (Sx) and sham-splenectomy IShSx) were performed 1 month 
before iv suppression. Mice were anesthetized by an ip injection of 0.1 ml/1 0 g 
body weight of a 1 :40 diluted stock solution of Avertin (25). The incision was 
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TABLE 1. H-2 and non-H-2 compatibilities and incompatibilities of the mouse strain 
combinations used for induction of delayed type hypersensitivity reactions 
Responder Donor H-2 compatible non-H-2 compatible 
Swiss A.SW +1) 
(C57Bl x CBA)F1 BALB/c 
B1 O.BR B10.D2 + 
BALB/c B10.D2 + 
(C57BL x CBA)F1 DBA/2 
DBA/2 BALB/c + 
C3H/Tif (C57Bl x CBA)F1 
1) The plus sign means that that particular donor-recipient combination is compatible, whereas 
a minus sign means that that combination is incompatible with regard to the H-2 or non-H-2 
histocompatibility antigens. 
made in the left upper abdomen. For splenectomy, the splenic blood vessels were 
tied in a single suture, then cut and the spleen was removed. The incision was 
closed in two layers. There was no postoperative mortality. 
Adult thymectomy 
Adult thymectomy (ATx) and sham-thymectomy (ShTx) were performed 
when the mice were 6 weeks old. The operation was performed as described by 
Miller 126). Avertin was used for anesthesia. The ATx and ShTx mice were 
rested for 10 weeks before experimental use. Mice used at least 6 weeks after 
ATx are considered to be depleted of short-lived, sessile T cells (T1 cells). 
Anti-thymocyte serum 
Anti-thymocyte serum lA TS) was prepared in New Zealand White rabbits by 
two iv injections of 5 x 108 BALB/c thymocytes, according to the method of 
Jooste eta/. (27). Before use in vivo, the ATS and normal rabbit serum (NRS) 
were absorbed once with an equal volume of mouse red blood cells. For the 
elimination of long-lived recirculating T cells (T2 cells) a total volume of 0.2 ml 
ATS was subcutaneously injected, equally distributed over the inguinal and 
axillary areas. These injections were given 5 and 2 days before iv suppression. 
We have previously shown that the above procedure depletes the T2 cells (28). 
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Selective elimination of Thy-1.2, Lyt-1.1 and Lyt-2 positive cells 
Monoclonal lgM anti-Thy-1.2 antibodies (clone F7D5) were purchased from 
OLAC Ltd., Bicester, U.K. Monoclonal lgG2a anti-Lyt-1.1 (clone 7-20.6/3) was 
purchased from Cedar Lane Laboratories Ltd., Hornby, Ontario, Canada. Mono-
clonal lgM anti-Lyt-2 was obtained by the in vitro culture of an lgM anti-Lyt-2 
producing hybridoma, which was kindly provided by Dr. F.W. Fitch, Department 
of Pathology, University of Chicago. Cell suspensions were treated for 30 min at 
4 C with anti-Thy-1.2, anti-Lyt-1.1 or anti-Lyt-2 antibodies. After incubation 
the cells were centrifuged, resuspended in BSS, and incubated with guinea pig 
complement (Flow Laboratories, Irvine, Scotland) for 15 min at 37 C. The cells 
were then washed three times and resuspended in BSS. The applied procedure 
eliminated at least 90% of the viable lymphocytes that were positive for the 
marker detected by the monoclonal antibody used. 
Estimation of cell proliferation in vivo 
For estimation of the cell proliferation in the inguinal lymph nodes, the 
method described by North eta/. (29) was used. Briefly, 5 days after sc immuni-
zation with 1 x 1 o7 allogeneic spleen cells, the mice were given iv injection of 20 
pCi of methyi-3H-thymidine (specific activity: 5 Ci/mM). Thirty minutes later 
their inguinal lymph nodes were taken out and suspended in 5% ice cold tri-
chloroacetic acid. Each cell suspension was extracted twice for 1 hr with 20 ml 
cold 5% trichloroacetic acid and then once with 6 ml 5% trichloroacetic acid for 
1 hr at 90 C. After cooling, 1 ml of the supernatant was added to 9 ml scintillant 
consisting of 3 ml of Triton X-100 and 6 ml of toluene containing 4 mg PPO per 
liter, and counted in a liquid scintillation counter (Packard, model 8375). Radio-
activity was corrected for background and quenching and expressed as cpm. 
Assay for DTH 
DTH reactions were determined by measuring the difference in thickness of 
the hind feet 24 hr after sc injection of a challenge dose of 2 x 107 of the 
appropriate allogeneic spleen cells into the dorsum of the right hind foot. As a 
control for background DTH reactivity, naive syngeneic mice were used which 
only received the challenge dose. Foot thickness was measured with a footpad 
meter with a 0.05 mm accuracy and a 0.05 mm reproducibility. The specific 
DTH response was calculated as the relative increase in foot thickness of the 
immune mice minus the relative increase in foot thickness of the control mice. 
The swelling of the control mice ranged between 15 and 25o/~ 
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RESULTS 
Induction and suppression of D TH against histocompatibility antigens 
Immunization of mice with allogeneic spleen cells sc induces a state of DTH 
reactivity (30). In order to investigate whethter iv immunization with allogeneic 
spleen cells also induces DTH reactivity, different groups of Swiss responder mice 
were immunized with various doses of irradiated or nonirradiated A.SW spleen 
cells and tested for DTH reactivity 5 days later. Increasing doses of irradiated 
and nonirradiated A.SW spleen cells induced an increasing DTH reactivity. 
Maximal DTH responses were found after iv injection of 1 x 1 o7 irradiated and 3 
x 107 non irradiated spleen cells, respectively (Fig. 1 A). Nonirradiated cells were 
found to be more effective in the induction of DTH reactivity than the same 
dose of irradiated cells. Similar data were obtained in other combinations 
involving H-2 alloantigens. 
In previous studies (3, 19, 20, 22) suppression of DTH was found when sc 
immunized mice had been iv preimmunized with similar, but irradiated allogeneic 
cells. Now we investigated whether suppression can also be found when non* 
~specific increase 
foot thickness 60 
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20 20 
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Fig. 1. {A) Induction of DTH reactivity by iv immunization with allogeneic cells. Swiss mice 
were iv injected with either 1 x 104, 1 x 105, 1 x 106 , 3 x 106 , 1 x 107, 3 x 107 or 1 x 108 
irradiated (e) or nonirradiated (o) A.SW spleen cells. Five days later all mice were challenged 
for DTH. (B) Suppression of DTH reactivity to allogeneic spleen cells by iv preimmunization 
with non irradiated spleen cells. Swiss mice were iv pre immunized with either 1 x 104 , 1 x 105 , 
1 x 106 , 3 x 106, 1 x 107 , 3 x 107 or 1 x 108 nonirradiated ASW (e) or Swiss (o) spleen 
cells. Seven days later all mice were sc immunized with 1 x 107 ASW spleen cells and another 
5 days later challenged for DTH. Each experimental point respresents the arithmetic mean 
of the DTH response± SE (n=B). 
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irradiated cells are used for iv preimmunization. Therefore, groups of Swiss 
responder mice were iv preimmunized with various doses of nonirradiated 
allogeneic A.SW or syngeneic Swiss spleen cells. Seven days later all mice were 
sc immunized with A.SW spleen cells and tested for DTH another 5 days later. 
Indeed, the nonirradiated cells also induced suppression. The suppression 
appeared to be dose dependent and maximal when induced by about 1 x 106 
allogeneic cells (Fig. 1 B). In contrast to the suppression induced by irradiated 
allogeneic spleen cells (3), higher doses of non·irradiated cells induced less 
suppression. 
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Fig. 2. Systemic transfer of iv induced suppression. Groups of (C57BL x CBA)F1 mice were 
iv preimmunized with 5 x 107 irradiated BALB/c spleen cells, At each of the indicated inter-
vals after iv preimmunization, one group of mice was sc immunized with 1 x 107 BALB/c 
spleen cells (e), while spleen and lymph node cells from another group of mice were iv 
transferred to naive (C57BL x CBA)F1 mice (o). A few hours after transfer, the recipient mice 
were sc immunized with 1 x 107 BALB/c spleen cells. At all intervals a group of (C57BL x 
CBA)F1 mice was included, this group received spleen and lymph node cells from naive F1 
mice (positive control). Also these mice were sc immunized a few hours after transfer. DTH 
reactivity was tested 6 days after sc immunization. Each experimental point respresents 
the arithmetic mean of the suppress'1ve effect ± SE (n=6) calculated as a percentage of the 
positive controL The specific DTH response of this positive control ranged from 24-31%. 
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Transfer of iv induced suppression 
Groups of (C57BL x CBA)F1 mice were iv immunized with an optimal dose 
of 5 x 107 irradiated BALB/c spleen cells. Atdifferentdaysafterthissuppressive 
immunization, one group of 6 mice was sc immunized with 1 x 107 BALB/c 
spleen cells, and from another group of 6 mice the spleen and lymph node 
cells were transferred into 6 naive syngeneic (i.e., (C57BL x CBA)F1) mice. A 
few hours later the recipients of 'suppressed' spleen and lymph node cells were 
also sc immunized with 1 x 107 BALB/c spleen cells. Both groups of mice were 
tested for DTH 6 days later. The date from these experiments, depicted in Fig. 2, 
'1. suppression of 
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Fig. 3. Effect of infusion of activated suppressor cells at different intervals after sc immunization 
of the recipient mice. Spleen and lymph node cells from (C57BL x CBA)F1 mice, which were 
iv preimmunized with 5 x 107 irradiated BALB/c spleen cells, were systemically transferred 
at the same day or 1, 2, 3, 4, 5 or 6 days after sc immunization of the recipient mice with 
1 x 107 BALB/c spleen cells. As positive controls, groups of (C57BL x CBA)F1 mice received 
spleen and lymph node ce\\s from F1 mice at the same day or 1, 2, 3, 4, 5 or 6 days after 
sc immunization with BALB/c spleen cells. DTH reactivity was tested 6 days after sc 
immunization. Each experimental point represents the arithmetic mean of the suppressive 
effect± SE in=6), calculated as a percentage of the positive control. 
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show that transfer of the suppressive effect was possible only during a short 
period, and optimal on day 4 after the iv preimmunization. However, in the iv 
preimmunized mice themselves, the state of suppression persisted for at least 70 
days. 
Subsequently, the suppression was investigated after transfer of 'suppressed' 
spleen and lymph node cells at different intervals after the sc immunization of 
the recipient mice. (C57BL x CBA)F1 recipient mice received 'suppressed' spleen 
and lymph node cells from syngeneic donor mice on the same day as the sc 
immunization or 1 to 6 days later. The donor mice were always iv suppressed 
with 5 x 107 irradiated BALB/c spleen cells 4 days before transfer. Transfer of 
the suppressive effect was found to be maximal when it was performed on the 
same day as the sc immunization of the recipient mice (Fig. 3). The ability to 
transfer the suppression was found to be inversely propartional to the interval 
between sc immunization and transfer. Transfer of 'suppressed' spleen and 
lymph node cells on day 6, when the mice were challenged for DTH reactivity, 
hardly influenced the response. 
The role of the spleen in the development of suppression after iv immunization 
Splenectomized and sham-splenectomized (C57BL x CBA)F1 mice were iv 
immunized with 5 x 107 irradiated H-2 and non-H-2 incompatible BALB/c 
spleen cells or the same number of irradiated syngeneic spleen cells. Seven days 
later all mice were sc immunized with 1 x 107 BALB/c spleen cells and tested 
for DTH another 6 days later. The iv preimmunization appeared to induce 
suppression in both the splenectomized and the sham-splenectomized mice 
(Fig. 4A). The same results were obtained with splenectomized and sham-
splenectomized B10.BR responder mice that were immunized with H-2 
incompatible 81 O.D2 spleen cells, and with splenectomized and sham-
splenectomized BALB/c responder mice that were immunized with non-H-2 
incompatible B10.D2 spleen cells (Fig. 4A). 
Subsequently, we investigated whether the spleen of suppressed mice is the 
principal site of residence of the suppressor cells. Therefore we transferred 
1 x 108 spleen cells, 1 x 108 lymph node cell or 2 x 108 of a mixture of both 
cells types from suppressed (C57BL x CBA)F1 donor mice to naive :·ec'1pients. A 
few hours later the recipient mice were sc immunized with 1 x 107 H-2 and non-
H2 incompatible DBA/2 spleen cells and tested for DTH reactivity 6 days later. 
The lymph node cells appeared to be at least as capable as spleen cellsoftransferring 
suppression. Even lymph node cells from mice that were splenectomized before 
the iv preimmunization, could transfer suppression to naive recipients (Fig. 48). 
Similar data were obtained with spleen and lymph node cells from BALB/c mice 
suppressed to non-H-2 incompatible B10.D2 spleen cells (Fig. 48). 
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Fig. 4. (A) Effect of splenectomy on the iv induction of suppression. Responder mice were 
splenectomized (Sx) or sham-splenectomized (ShSxl four weeks before iv preimmunization 
with 5 x 107 irradiated allogeneic or syngeneic spleen cells. Seven days later all mice were sc 
immunized with 1 x 107 allogeneic spleen cells. Challenge for DTH was performed on day 6 
after sc immunization. Each column represents the mean response ± SE (n=6). (B) Effect of 
splenectomy on the ability of lymph node cells to transfer the iv induced state of suppression. 
Donor mice were splenectomized (Sx) or sham-splenectomized (ShSx) 4 weeks before iv 
preimmunization with 5 x 1 o7 irradiated allogeneic spleen cells. Four days after iv preim-
munization, 1 x 108 spleen and/or 1 x 1081ymph node cells from the ShSx mice and 1 x 108 
lymph node cells from the Sx mice were systemically transferred to syngeneic recipient mice. 
As a positive control, another group of recipient mice received spleen and lymph node cells 
from non-suppressed donors. One hour after transfer all mice were sc immunized with 1 x 
107 allogeneic spleen cells and tested for OTH another 6 days later. Each column represents 
the mean response± SE (n=6). The percentages specific suppression are shown in parentheses. 
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The role of Tl and T2 cells in the development of suppression after iv 
immunization 
The development of suppression was investigated in ATx and ShTx DBA/2 
mice, which were iv injected with either 5 x 107 irradiated non-H-2 incompatible 
BALB/c spleen cells or the same number of irradiated syngeneic spleen cells. 
Seven days later all mice were sc immunized with 1 x 107 BALB/c spleen cells 
and tested for DTH reactivity another 5 days later. The results show that 
depletion of T1 cells due to ATx did not interfere with the induction of 
suppression (Fig. 5A). The same results were obtained with ATx and ShTx 
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Fig. 5. (A) Effect of adult thymectomy on the iv induction of suppression. Responder mice 
were thymectomized (ATx) or sham-thymectomized (ShTx) ten weeks before iv preim-
munization with 5 x 107 irradiated allogeneic or syngeneic spleen cells. Seven days later all 
mice were sc immunized with 1 x 107 allogeneic spleen cells. Challenge for DTH was per-
formed on day 6 after sc immunization. Each column represents the mean response ± SE 
(n=6). (B) Effect of thymectomy on the abil'1ty to transfer the iv ·Induced state of suppression. 
Donor mice were thymectomized (ATx) or sham-thymectomized (ShTx) ten weeks before 
iv preimmunization with 5 x 107 irradiated allogeneic spleen cells. Four days after iv preim-
munization, the spleen and lymph node cells from these ATx and ShTx donor mice were 
systemically transferred to syngeneic recipient mice. Another group of recipient mice 
received normal spleen and lymph node cells from nonsuppressed donors (positive control). 
A few hours after transfer all mice were sc immunized with 1 x 107 allogeneic spleen cells. 
Challenge for OTH was performed on day 6 after sc immunization. Each column represents 
the mean response± SE (n=6). The percentages specific suppression are shown in parentheses. 
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{C57BL x CBA)F1 responder mice immunized with H-2 and non-H-2 incompa-
tible BALB/c spleen cells. The possibility to transfer suppression with spleen and 
lymph node cells from ATx suppressed mice was also investigated. Therefore, 
ATx and ShTx {C57BL x CBA)F1 donor mice were iv preimmunized with 
5 x 107 irradiated H-2 and non-H-2 incompatible DBA/2 cells. Their spleen and 
lymph node cells were transferred into naive, syngeneic recipients 4 days later. 
A control group which received spleen and lymph node cells from naive ShTx 
mice was included. A few hours after transfer all recipient mice were sc 
immunized with 1 x 1 o7 DBA/2 spleen cells and tested for DTH another 6 days 
later. The results show that T1 cell depletion also did not affect the capacity to 
transfer suppression {Fig. 58). 
The influence of T2 cell depletion was studied in {C57BL x CBA)F1 mice 
treated with A TS or N RS before iv injection of 5 x 10 7 irradiated H-2 and non-
H-2 incompatible BALB/c spleen cells. Four days after iv suppression their 
spleen and lymph node cells were transferred into naive syngeneic recipients. 
A control group received spleen and lymph node cells from naive donor mice. 
A few hours later, all recipient mice were sc immunized and tested for DTH 
against BALB/c spleen cells. The data show that transfer of suppression was 
impossible after ATS treatment of the donor mice. The same result was obtained 
in a similar protocol with DBA/2 responder mice and H-2 and non-H-2 in-
compatible {C57BL x CBA)F1 spleen cells {Fig. 6). 
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Fig. 6. Effect of anti-thymocyte serum (ATS) treatment on the transfer of suppression. Donor 
mice were treated with ATS or NRS on day -5 and day -2 and iv preimmunized with 5 x 107 
allogeneic spleen cells on day Q_ Four days later the spleen and lymph node cells were 
systemically transferred to syngeneic recipient mice. One hour after transfer all mice were sc 
immunized with 1 x 107 allogeneic spleen cells and tested for DTH another 6 days later. 
Each column represents the mean response± SE (n=6). The percentages specific suppression 
are shown in parentheses. 
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Surface markers of the suppressor cells 
The effect of ATS treatment shows that iv induced suppression of DTH to 
alloantigens is dependent on T cells. The Thy-1, Lyt-1 and Lyt-2 surface markers 
of these T cells were investigated. Thus, the spleen and lymph node cells from 
C3H/Tif mice suppressed to (C57BL x CBA)F1 alloantigens were depleted forT 
cells by anti-Thy-1.2 and complement, or for Lyt-1+ cells by anti-Lyt-1.1 and 
complement or for Lyt-2+ cells by anti-Lyt-2 and complement. After depletion, 
the residual cells were transferred into naive syngeneic recipients. As positive 
control, one group of recipient mice received normal spleen and lymph node 
cells. A few hours after transfer all mice were sc immunized with 1 x 107 alia-
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Fig. 7. (A) Surface markers of the suppressor cells involved in suppression of DTH to histo-
compatibility antigens, By means of systemic transfer, groups of responder mice received 
spleen and lymph node cells from normal, syngeneic mice or from syngeneic mice that had 
been iv injected with 5 x 107 irradiated allogeneic spleen cells 4 days previously ('suppressed 
cells'). Before transfer the suppressed cells were treated with the indicated monoclonal anti-
bodies and complement (C). A few hours after transfer, all mice were sc immunized with 
1 x 107 allogeneic spleen cells and tested for DTH another 6 days later. Each column 
represents the mean response ± SE (n""6). The percentages specific suppression are shown in 
parentheses. (B) Effect of depletion of suppressor T cells on the proliferative activity in the 
draining lymph nodes of sc immunized mice. Groups of responder mice received spleen and 
lymph node cells from normal, syngeneic mice or from syngeneic mice which had been iv 
injected with 5 x 107 irradiated allogeneic spleen cells 4 days previously ('suppressed cells'). 
On the day of transfer a!l mice were sc immunized with 1 x 107 allogeneic spleen cells and 
the proliferative activity in the draining lymph nodes was measured 5 days later. 
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geneic spleen cells and tested for DTH reactiVIty another 6 days later. The 
results (Fig. 7A) show that depletion of either Thy-1+, Lyt-1+ or Lyt-2+ cells 
from the transferred suppressor cell population abrogates the suppression. 
Transfer of a combination of two suppressor population equivalents treated 
with either anti-Lyt-1.1 and complement or anti-Lyt-2 and complement, 
respectively, did not reestablish the suppressive effect. Moreover, the same 
results were obtained in a combination of DBA/2 responder mice and H-2 and 
non-H-2 incompatible (C57BL x CBA)F1 spleen cells (data not shown). Thus, 
the suppression induced by iv preimmunization with allogeneic spleen cells is 
dependent on suppressor T cells expressing Lyt-1 as well as Lyt-2 antigens. 
In the combination of DBA/2 responder mice and immunizing (C57BL x 
CBA)F1 spleen cells we also studied the effect of suppressor cell transfer on 
the proliferative activity in the draining lymph nodes of the responder mice. 
Transfer of suppressor cells decreased the proliferative activity in the draining 
lymph nodes, and treatment of the suppressor cell population with anti-Thy-1.2 
and complement abrogated the suppression of the proliferation (Fig. 7B). These 
results reinforce the conclusion from the transfer experiments shown in Fig. 3, 
which is that the suppressor T cells influenced the induction phase of the DTH 
response. 
DISCUSSION 
The data presented here show that iv immunization of mice with irradiated or 
non-irradiated allogeneic spleen cells can induce a state of DTH reactivity (Fig. 
1 A) as well as a state ofT cell dependent suppression (Fig. 1 B). The suppressive 
effect caused by the iv immunization becomes manifest only after secondary sc 
immunization (cf. (3) and Fig. 1 B). When mice are sc preimmunized 1 to 7 days 
before secondary sc immunization, the subsequent DTH response is hardly 
affected (3), but at longer intervals and especially in the case of immunization 
with minor H antigens, secondary type responses can occur (30). So, the iv route 
of preimmunization seems to be obligatory for induction of suppression of DTH 
to H antigens. 
In previous studies (3, 19, 20, 22) we always used irradiated allogeneic cells 
for the iv preimmunization in order to avoid anti-host reactivity by the injected 
allogeneic cells, which might confuse studies of the suppressor mechanism. Here 
we show that DTH reactivity can also be effectively suppressed by iv preim-
munization with non-irradiated spleen cells (Fig. 1 B). In the latter case, maximal 
suppression was already induced by a dose of 1 x 106 allogeneic spleen cells, 
which is about 50 times lower than in the case of irradiated allogeneic spleen 
cells (3). At higher doses, a smaller suppressive effect was found. The different 
dose response relationship of iv induced suppression by irradiated and non-
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irradiated allogeneic spleen cells may be due to allogeneic effects and longer 
persistence of the antigen in the case of non-irradiated allogeneic cells. 
It is remarkable that iv immunization with irradiated allogeneic spleen cells 
simultanously induces DTH reactive T cells and suppresssor T cells. Apparently, 
the suppressor T cells are unable to suppress the induction and functional activity 
of simultaneously activated DTH reactive T cells, but they do suppress the 
generation of DTH effector T cells after secondary sc immunization (Fig. 1 B) 
and after transfer into secondary recipients (Fig. 78). This is in harmony with 
studies of others showing that for suppression of the expression phase of DTH 
to haptens an additional suppressor T cell population is needed, which only 
occurs after sc immunization of the iv preimmunized animals (6, 8, 9, 31). 
However, as yet we have no real evidence that such an additional suppressor T 
cell subset is also involved in our model of suppression of DTH to H-antigens. 
The suppressive effect induced by iv preimmunization with irradiated allo-
geneic spleen cells can be systemically transferred by spleen and lymph node 
cells only during the first few days after the iv induction (Fig. 2). However, 
when iv preimmunized mice themselves are sc immunized, a clear suppression 
of DTH reactivity is found up to 70 days after iv preimmunization. Similar 
results have been obtained in studies of suppression of DTH against haptens (32) 
and heterologous erythrocytes (33, 34) and in studies of CS (10). The authors 
of these studies suggest that this type of unresponsiveness is based on clone 
inactivation, as well as on active suppression. The clone inactivation was found 
to be a long-lived phenomenon and could not be transferred, while the transferable 
suppressor T cells only occurred during a short period after induction. 
The inability to transfer suppression with spleen and lymph node cells at 
longer intervals after iv preimmunization might be due to the short life span of 
of activated suppressor T cells. Liew (35) has shown in a, to some extent, 
comparable system, that after booster immunization secondary type suppressor 
T cells appear in spleen and lymph nodes, suggesting the occurrence of suppressor 
memory T cells. The existence of alloantigen-specific suppressor memory T cells 
is further substantiated by our own studies showing that thoracic duct lympho-
cytes can adoptively transfer suppression during a substantial period following 
iv preimmunization (data not shown). 
Suppressor T cells have been described for the afferent (1 0, 11, 32) as well as 
for the efferent limb (5, 8, 9, 13) of the immune response. Transfer of suppressor 
cells to recipient mice at different times after sc induction of DTH reactivity 
shows that maximal suppression occurs when the activated suppressor T cells are 
infused shortly after the sc immunization of the recipient mice (Fig. 3). Similar 
results have been found in systems employing hapten induced suppressor T cells 
by transferring so-called afferent phase suppressor T cells (10, 32). So-called 
efferent phase suppressor T cells, on the other hand, could suppress the DTH 
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response of recipient mice even when transferred on the day of challenge (5, 13). 
In our system of iv induced suppression of DTH against H-antigens we found 
that the proliferative response in the draining lymph nodes due to sc immuni-
zation can be suppressed by systemic transfer of suppressor T cells from recently 
iv preimmunized donor mice (Fig. 7B). This brings us to the conclusion that 
systemic transfer of iv induced suppressor T cells mainly affects the afferent 
limb of the DTH response against H-antigens. 
It is often suggested that overwhelming of the spleen with a high dose of iv 
administered antigen bypasses the presentation of antigen by antigen-presenting 
cells, which would favor suppression instead of activation (2, 5, 36, 37). The 
requirement of the spleen for the induction of suppression was shown by 
Lagrange et a!. (38). They were unable to induce suppression of DTH against 
SRBC by iv preimmunization of splenectomized mice. Sy eta/. (39), on the 
other hand, showed that splenectomy did not prevent suppression of CS against 
2,4-dinitro-1-fluorobenzene, but they could not transfer the suppression by 
lymph node cells from splenectomized mice. They concluded that the iv 
suppressive injection caused clone inactivation but did not induce transferable 
suppressor T cells. However, other studies showed that induction of afferent 
phase (5) and efferent phase (40) suppressor T cells was insensitive to 
splenectomy. The experiments presented in Fig. 4A show that suppression of 
DTH against H~antigens can be induced in mice splenectomized 4 weeks before 
iv preimmunization. Suppression could also be transferred with lymph node cells 
from mice splenectomized before the iv suppressive injection (Fig. 48). So, we 
did not find the spleen to be essential in the induction of suppression of DTH 
against H-antigens. 
From the typing experiments it appeared that the suppressor T cells essential 
for transfer of suppression are Lyt-1+2+ (Fig. 7A). In the literature it has been 
shown that especially the population of Lyt-1+2+ T cells is sensitive for ATx 
(41, 42). suggesting that this population constitutes mainly of T1 cells. Our data, 
showing the induction of suppressor T cells several months after ATx, indicate 
that the Lyt-1+2+ T cell population must be heterogeneous with regard to 
life-span and consists of ATx-resistant T2 cells as well as short-lived T1 cells (43). 
Recent flow cytofluorometry studies by Scollay (44) showed that ATx did not 
change the ratios between the different Lyt-subsets in spleen and lymph nodes, 
which also indicates the occurrence of long-lived Lyt-1+2+ T cells. 
Although the suppressor T cells described in other assays were found to 
belong mostly to the Lyt-1+2- (8, 33, 35, 45) and Lyt-1·2+ (8, 33, 46) T cell 
subsets, also Lyt-1+2+ suppressor T cells have been described (35, 47). Thus, 
Liew described a Lyt-1+2+ suppressor T cell acting in suppression of DTH 
against H antigens (35). This cell was activated by a suppressive booster immuni-
zation, but the suppressor T cell induced by a single suppressive injection 
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appeared to be Lyt~1+T. In our system, primary iv immunization activated a 
Lyt-1+2+ suppressor T cell (Fig. 78), which is essential for transfer of the 
suppressive effect. However, we cannot exclude that other Lyt-1 +2- or Lyt-1·2+ 
suppressor populations are involved as well. The occurence of a cascade of 
several phenotypically different, T cell subsets in suppression of DTH to 
haptenated syngeneic spleen cells and CS to certain haptens has been extensively 
documented by the group of Benacerraf (2, 8). 
ACKNOWLEDGMENTS 
We gratefully acknowledge Mrs. Cary Meijerink-Cierkx and Mrs. Rita Boucke for typing the 
manuscript, and Mr. T. van Os for skillful photographic assistance. 
REFERENCES 
1. Lagrange, P.H., Mackaness, G.B., and Miller, T.E. Influence of dose and route of antigen 
injection on the immunological induction ofT cells. J. Exp. Med. 1974; 139,528. 
2. Greene, M. 1., and Benacerraf, B. Studies on hapten specific T cell immunity and suppression. 
lmmunol. Rev. 1980; 50, 163. 
3. Vander Kwast, Th.H., Bianchi, A.T.J., Bril, H., and Benner, R. Suppression of antigraft 
immunity by preimmunization. I. Kinetic aspects and specificity. Transplantation 1981; 
31, 79. 
4. Miller, S.D., and Claman, H.N. The induction ofT cell tolerance by using hapten-modified 
lymphoid cells. I. Characteristics of tolerance induction. J. lmmuno/. 1976; 117, 1519. 
5. Cia man, H.N., Mil!er, S.D., Sy, M.S., and Moorhead, J.W. Suppressive mechanisms involving 
sensitization and tolerance in contact allergy. lmmunol. Rev. 1 980; 50, 105. 
6. Claman, H.N., Miller, S.D., Conlon, P.J., and Moorhead, J.W. Control of experimental 
contact sensitivity. Adv. Jmmunol. 1 980; 30, 121. 
7. Asherson, G.L., and Zembala, M. T suppressor cells and suppressor factor which act at the 
efferent stage of contact sensitivity skin reaction: their production by mice injected with 
water soluble, chemically reactive derivates of oxazolone and picryl chloride. Immunology 
1980; 42,1005. 
8. Germain, R.N., and Benacerraf, B. A single major pathway ofT lymphocyte interactions 
in antigen-specific immune suppression. Scand. J. lmmunol. 1981; 13, 1. 
9. Zembala, M., Asherson, G. L., and Colizzi, V. Hapten-specific T suppressor factor recognizes 
both hapten and 1-J region products on haptenized spleen cells. Nature 1982; 297,411. 
10. Moorhead, J.W. Tolerance and contact sensitivity to DNFB in mice. VI. Inhibition of 
afferent sensitivity by suppressor T cells in adoptive tolerance. J. Jmmunol. 1976; 117, 
807. 
116 
11. Miller, S.D., Sy, M.S., and Claman, H.N. Suppressor T cell mechanisms in contact sensitivity. 
II. Afferent blockade by alloinduced suppressor T cells. J. lmmunol. 1978; 121, 274. 
12. Asherson, G. L., and Zembala, M. Suppression of contact sensitivity by T cells in the 
mouse. I. Demonstration that suppressor T cells act on the effector stage of contact 
sensitivity; and their induction following in vitro exposure. Proc. R. Soc. Lond. B. 1974; 
187, 329. 
13. Miller, S.D., Sy, M.S., and Claman, H.N. SuPpressor T cell mechanisms in contact sensitivity. 
I. Efferent blockade by syninduced suppressor T cells. J. lmmunol. 1978; 121, 265. 
14. Pinto, M., Brent, L., and Thomas, A.V. Specific unresponsivenesstoskinallograftsinmice. 
I II. Synergistic effect of tissue extract, Bordetella pertussis and antilymphocyte serum. 
Transplantation 1974; 17,477. 
15. Brent, L., and Opara, S.C. Specific unresponsiveness to skin allografts in mice. V. Synergy 
between donor tissue extract, procarbazine hydrochloride, and antilymphocyte serum in 
creating long-lasting unresponsiveness mediated by suppressor T cells. Transplantation 
1979;27, 120. 
16. Kulkarni, S.S., Kulkarni, A.D., Gallagher, M.D., and Trentin, J.J. Prolongation of cardiac 
allograft survival by pretreatment of recipient mice with donor blood or spleen cells plus 
cyclophosphamide. Celllmmunol. 1979; 47, 192. 
17. Kelley, S.E., and Corry, R.J. Prolongation of mouse heart allograft survival by prior 
administration of nonspecific blood. Transplant. Proc. 1981; 13,517. 
18. Kilshaw, P.J., Brent, L., and Pinto, M. Suppressor T cells in mice made unresponsive to 
skin allografts. Nature 1975; 255,489. 
19. Bianchi, A.T.J., Bril, H., and Benner, R. Alloantigen-specific suppressor T cells can also 
suppress the in vivo immune response to unrelated alloantigens. Nature 1983; 301,614. 
20. Bianchi, A.T.J., Hussaarts-Odijk, L.M., and Benner, R. Antigenspecific suppressor T cells 
suppress in vivo the cellular immune response to unrelated 'bystander' antigens. Transplant 
Proc.1983;15, 760. 
21. Bril, H., and Benner, R. Specific suppression of anti-host immune reactivity in graft-versus-
host reaction. Adv. Exp. Med. Bioi. 1 982; 149,577. 
22. Bianchi, A.T.J., Hussaarts-Odijk, L.M., and Benner, R. Nonspecific suppression of anti-
graft immunity by antigenspecific T suppressor cells. Adv. Exp. Med. Bioi. 1982; 149, 
651. 
23. Liew, F.Y. Regulation of delayed type hypersensitivity. VII. The role of 1-J subregion 
gene products in the inhibition of delayed type hypersensitivity to major histocompa-
tibility antigen specific suppressor T cells. Eur. J. lmmunol. 1981; 11, 883. 
24. Bianchi, A.T.J., van der Kwast, Th.W., and Benner, R. Allo-1-J-antigens in suppression 
of DTH to H-2 subregion antigens. lmmunol. Today. 1982; 3, 123. 
25. Koch, G., Lok. B.D., van Oudenaren, A., and Benner, R. The capacity and mechanism of 
bone marrow antibody formation by thymus-independent antigens. J. lmmunol. 1 982; 
128, 1497. 
117 
26. Miller, J.F.A.P. Studies on mouse leukaemia. The role of the thymus in leukaemogenesis 
by cell-free leukaemic filtrates. Br. J. Cancer 1960; 14, 93. 
27. Jooste, S.V., Lance, E.M., Levey, R.H., Medawar, P.B., Ruszkiewicz, M., Sharman, R., 
and Taub, R.M. Notes on the preparation and assay of anti-lymphocyte serum for use in 
mice. Immunology 1968; 15,697. 
28. Vander Kwast, Th.H., and Benner, R. T1 and T2 lymphocytes in primary and secondary 
delayed type hypersensitivity of mice. L Contribution in the response to sheep red blood 
cells and to allogeneic spleen cells. Cell. lmmunol. 1978; 39, 194. 
29. North, R.J., Mackaness, G.B., and Elliot, R.W. The histogenesis of immunologically 
committed lymphocytes. Cell. /mmunol. 1971; 3, 680. 
30. Vander Kwast, Th.H., Olthof, J.G., and Benner, R. Primary and secondary delayed type 
hypersensitivity to minor histocompatibility antigens in the mouse. Cell. lmmunol. 1979; 
43, 94. 
31. Sy, M.S., Miiler, S.D., Moorhead, J.W., and Claman, H.N. Active suppression of 1 fluoro 
2,4·dinitrobenzene immune T cells. Requirement of an auxiliary T cell induced by 
antigen.J. Exp. Med. 1979; 149,1197. 
32. Dietz, M.H., Sy, M.S., Benacerraf, 8., Nisonoff, A., Greene, M.l., and Germain, R.N. 
Antigen- and receptor-driven regulatory mechanisms. VII. H-2 restricted anti-idiotypic 
suppressor factor from efferent suppressor T cells. J. Exp. Med. 1981; 153, 450. 
33. Ramshaw, LA., Bretscher, P.A., and Parish, C.R. Regulation of the immune response. 
I. Suppression of delayed type hypersensitivity by T cells from mice expressing humoral 
immunity. Eur. J. /mmunol. 1976; 6, 674. 
34. Kaufmann, S.H.E., Ahmed, J.S., and Hahn, H. Transferable suppression and intrinsic 
unresponsiveness in delayed type hypersensitivity in sheep red blood cells of mice: two 
distinct mechanisms? lmmunobiology 1980; 157,331. 
35. Liew, F.Y. Regulation of delayed type hypersensitivity. VI. Antigen-specific suppressor 
T cells and suppressor factor for delayed type hypersensitivity to histocompatibility 
antigens. Transplantation 1982; 33, 69. 
36. Claman, H.N. Hypothesis T-ce!l tolerance- one signal? Cell. /mmunol. 1978; 48, 201. 
37. Ptak, W., Rozycka, D., Askenase, P.W., and Gershon, R.K. Role of antigen-presenting cells 
in the development and persistence of contact sensitivity. J. Exp. Med. 1980; 151,362. 
38. Lagrange, P.H., and Mackaness, G.B. Site of action of serum factors that block delayed-
type hypersensitivity in mice. J. Exp. Med. 1978; 148, 235. 
39. Sy, M.S., Miller, S.D., Kowach, H.B., and Claman, H.N. A splenic requirement for the 
generation of suppressor T cells. J. lmmunol. 1977; 119, 2095. 
40. Asherson, G.L., Zembala, M., Mayhew, B.,and Goldstein, A. Adult thymectomy prevention 
of the appearance of suppressor T cells which depress contact sensitivity to picrylchloride 
and reversal of adult thymectomy effect by thymus extract. Eur. J. lmmunol. 1976; 6, 
699. 
118 
41. Cantor, H., and Boyse, E.A. Functional subclasses ofT lymphocytes bearing different Ly 
antigens. I. The generation of functionally distinct T cell subclasses is differentiative 
process independent of antigen. J. Exp. Med. 1 975; 141, 1376. 
42. Feldmann, M., Beverley, P.C.L., Woody, J., and McKenzie, l.F.C. T-T interactions in the 
induction of suppressor and helper T cells; analysis of membrane phenotype of precursor 
and amplifier cells. J. Exp. Med. 1977; 145,793. 
43. Cantor, H., and Asofsky, R. Synergy among lymphoid cells mediatingthegraft-versus-host 
response. !I. Synergy in graft-versus-host reactions produced by BALB/c lymphoid cells 
of differing anatomic origin. J. Exp. Med. 1 970; 131, 235. 
44. Scotlay, R. Adult thymectomy does not alter the proportion ofT cells of the Lyt 123 
subclass. Nature 1 982; 300, 529. 
45. Thompson, C. H., Potter, T.A., McKenzie, I.F.C., and Parish, C.R. The surface phenotype 
of a suppressor cell of delayed type hypersensitivity in the mouse. Immunology 1980; 
40, 87. 
46. Cantor, H., and Gershon, R.K. Immunological circuits: cellular composition. Fed. Proc. 
1979; 38, 2058. 
47. McKenzie, I.F.C., and Potter, T.A. Murine lymphocyte surface antigens. Adv. lmmunol. 
1979; 27, 179. 
119 

CHAPTER I X 
SUPPRESSION OF ANTIGRAFT IMMUNITY BY PREIMMUNIZATION 
Ill. CHARACTERIZATION OF SUPPRESSOR T CELLS INVOLVED IN 
SUPPRESSION OF THE EFFERENT PHASE OF DELAYED TYPE 
HYPERSENSITIVITY AGAINST ALLOANTIGENS 
A.T.J. BIANCHI, L.M. HUSSAARTS-ODIJK, E.A.J. WOLTERS 
and R. BENNER 
Department of Cell Biology and Genetics, Erasmus University, Rotterdam, and 
Department of Immunology, Central Veterinary Institute, Lelystad;The Netherlands 
Submitted for publication 
121 
ABSTRACT 
Suppressor T {Ts) cells that can suppress delayed type hypersensitivity (DTH) against histo· 
compatibility {H) antigens can be isolated from spleen and lymph nodes a few days after intra-
venous (iv) immunization of mice with irradiated allogeneic spleen cells. In the present paper 
we investigated the suppression of the efferent phase of DTH in order to characterize the Ts 
cells involved, and to compare them with the afferent phase Ts cells that have been characterized 
·In a previous paper of this series. The DTH against third party alloantigens, which were not 
used for the iv suppressive immunization, could be suppressed by presenting the third party 
alloantigens together with the original alloantigens in the challenge inoculum for eliciting the 
DTH reaction. Thus, the ultimate suppressive effect by the Ts cells, which are active during 
the efferent phase of DTH, is nonspecific. This nonspecific suppression of DTH to alloantigens 
has previously been found for the afferent phase Ts cells as well. The essential population of 
'efferent phase' Ts cells appeared to be Lyt 1+2+, just like the Ts cells involved in suppression 
of the afferent phase of DTH against alloantigens. We did not find any evidence for a H-2 or 
lgh restricted activation and function of the Ts cells active during both limbs of the DTH 
response to H antigens. In view of these similarities between afferent phase and efferent phase 
Ts cells we conclude that there are no arguments as yet to suppose that there is more than one 
type ofT cells involved in the suppression of the afferent and efferent limb of DTH against H 
antigens. 
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INTRODUCTION 
The in vivo cellular immune response by delayed type hypersensitivity (DTH) 
reactive T cells is regulated by a complex system of ao. amplifier (1 ), helper (2, 
3) and suppressor T (Ts) cells (4-6). The previous studies of this series of papers 
deal with the regulation of DTH reactivity of mice against histocmpatibility (H) 
antigens (7, 8). 
Subcutaneous (sc) immunization of mice with allogeneic spleen cells induces a 
state of host-vs-graft DTH reactivity to both major and minor H antigens (9, 10). 
The induction of DTH reactivity can be prevented by iv preimmunization of the 
responder mice with similar irradiated allogeneic spleen cells (7, 11). The iv 
route of preimmunization is obligatory for the induction of suppression, since 
sc preimmunization hardly reduces the DTH response (7). In contrary, at 
intervals longer than one month between primary and secondary sc immunization, 
especially in the case that the immunizing inoculum consists of minor H antigens 
only, secondary type responses can occur (9, 12). 
lv induced suppression is a dose dependent and long-lasting phenomenon (7). 
However, transfer of the suppressive effect with spleen and lymph node cells 
from suppressed mice is only effective during the first few days after iv injection 
of allogeneic irradiated spleen cells (8). The Ts cells involved were found to be 
Lyt-1+2+ (8). This systemic transfer of Ts cells to syngeneic recipients mainly 
affects the afferent phase of the host-vs-graft DTH response (8). The iv induced 
Ts cells are also capable of suppressing the antihost immune reactivity during 
acute and delayed graft-vs-host reactions (13). Precursors of the Ts cells belong 
to the pool of recirculating T lymphocytes, are insensitive to adult thymectomy 
and can be depleted by anti-thymocyte serum treatment in vivo. 
Specificity studies have shown that the activation of Ts cells by alloantigens 
is antigen specific (7). However, their ultimate suppressive effect was found to 
be nonspecific (14, 15). These specificity studies have shown that afferent phase 
of che DTH against alloantigens is extremely susceptible to the regulatory 
activity of Ts cells. A similar conclusion has been drawn by several other 
investigators, who studied suppression of the induction and expression of contact 
sensitivity (CS) and DTH against haptens (4-6, 16, 17). 
In contrast to our previous studies, most of the latter studies are focussed on 
the genetic and cellular requirements and the antigen specificity of the expression 
of the suppressive effect during the efferent phase of CS and DTH to haptens 
(4-6, 17). In this report we have studied the requirements for suppression of the 
efferent phase of DTH against alloantigens, the characterization of the cells 
involved in this type of suppression and the genetic requirements for the systemic 
transfer of the suppression by the Ts cells involved. 
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MATERIALS AND METHODS 
Mice 
Female BALB/c (H-2d, lgha) and (C57BL/Rij x C8A/Rij)F 1 (H-2b/q) mice 
were purchased from the Laboratory Animals Centre of the Erasmus University, 
Rotterdam, The Netherlands. Female D8A/2 (H-2d), C3H/Tif (H-2k) and 
C578L/6J (H-2b) mice were purchased from Bomholtgard, Ry, Denmark. 
Female BALB.B (H-2b), 8ALB.K (H-2k), (BALB/c x 8ALB.K)F 1 (H-2d/k), 
B10.BR (H-2k), 810.02 (H-2d), B10.G (H-2Q), B10.ScSn (H-2b), (810.02 x 
B10.ScSn)F 1 (H-2d/b) and DBA/1 (H-2q) were puchased from OLAC Ltd., 
Bicester, U.K. Female C.B-20 (H-2d, lghb) were obtained from the lnstitut 
fur Biologisch-Medizinische Forschung A.G., Flillinsdorf, Switzerland. Female 
(BALB/c x C3H/Tif)F 1 (H-2d/k) mice were bred at our own department. 
Preparation of Cell suspensions 
Mice were killed by exposition to carbondioxide vapour. Spleens or lymph 
nodes were removed, placed in balanced salt solution (BSS) and squeezed 
through a nylon gauze filter to provide a single cell suspension. Nucelated cells 
were counted with a Coulter counter model BZI (Coulter Electronics, Harpenden, 
U.K.). The viability of the cell suspensions obtained was determined in the 
trypan blue exclusion test and was found to be at least 90o/. 
Immunization 
Suppression was induced by iv immunization with 5 x 107 allogeneic spleen 
cells. Within 3 hours before iv injection the cells had been irradiated in vitro 
with 20 Gy, generated in a Philips Muller MG 300 X-ray machine as described 
in detail previously (18). DTH was induced by sc immunization in the inguinal 
area with 1 x 1 o7 non irradiated allogeneic spleen cells. 
Systemic transfer of DTH reactivity 
For systemic transfer of DTH, T cells were activated under graft-vs-host (GvH) 
conditions (19) by iv injection of 2 x 107 nucleated spleen cells into lethally 
irradiated allogeneic recipients within 4 hours after irradiation. Peak numbers of 
DTH reactive T cells occurred in the spleen and lymph nodes of the recipient 
mice at 4 to 6 days after irradiation (19). This could be demonstrated by trans-
ferring the spleen and lymph node cells to secondary recipients which were 
syngeneic to the original spleen cells donors. The secondary recipient mice were 
challenged for induction of a DTH response within 1 hour after transfer. 
Systemic transfer of suppression 
The state of suppression was transferred to recipient mice by iv injection of 
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spleen and lymph node cells from mice which had been iv suppressed 4 days 
previously. A few hours after transfer, the recipients were sc immunized for 
induction of DTH reactivity. Another 6 days later the recipients were challenged 
for induction of a DTH response. 
Assay for immune lymphocyte transfer reactivity 
The immune lymphocyte transfer (I L T) reactivity of lymph node cells from 
immunized donors, directed against H antigens of a particular recipient strain, 
was determined by sc injection of 5 x 106 of these lymph node cells into the 
dorsum of the right hind foot of mice of the relevant recipient strain. In the 
left hind foot the recipients received a sc injection of 5 x 106 lymph node cells 
from nonimmune mice, syngeneic with the immunized donor mice. The response 
induced by the latter injection is called a normal lymphocyte transfer (N L T) 
reaction. For I L T and N L T the cells were injected in a volume of 50 MI. The 
specific I L T reactivity was calculated as I L T-N L T and was expressed in 10·3 em. 
Selective elimination of Thy-1.2, Lyt-1.1 and Lyt-2 positive cells 
Monoclonal lgM anti-Thy-1.2 antibodies (clone F7D5) were purchased from 
OLAC Ltd., Bicester, U.K. Monoclonal lgG2a anti-Lyt-1.1 (clone 7-20.6/3) was 
purchased from Cedar Lane Laboratories Ltd., Hornby, Ontario, Canada. Mono-
clonal lgM anti-Lyt-2 was obtained by in vitro culture of an lgM anti-Lyt-2 
producing hybridoma, which was kindly provided by Dr. F.W. Fitch, Department 
of Pathology, University of Chicago, U.S.A. The procedure for the selective 
depletion of the lymphocyte subsets has been described in detail previously (8). 
Assay for DTH 
DTH reactions were determined by measuring the difference in thickness of 
the hind feet 24 hours after sc injection of a challenge dose of 2 x 107 of the 
appropriate allogeneic spleen cells into the dorsum of the right hind foot. As a 
control for background DTH reactivity, naive syngeneic mice were used which 
only received the challenge dose. The specific DTH response was calculated as 
the relative increase in foot thickness of the immune mice minus the relative 
increase in foot thickness of the control mice. The swelling of the control mice 
ranged between 15 and 25%. 
RESULTS 
Effect of iv induced suppressor cells on the efferent phase of DTH 
We have previously shown that Ts cells induced by iv immunization with 
irradiated allogeneic spleen cells suppress the afferent limb of the DTH response 
(8). The effect of iv induced suppressor cells on the efferent phase of DTH 
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Fig. 1. Transfer of DTH effector T cells to iv suppressed recipient mice. DTH reactive T cells 
specific for (C57BL x CBA)F 1 alloantigens were generated by iv injection of 2 x 107 BALB/c 
spleen cells into lethally irradiated (C57BL x CBA)F 1 mice. Five days later spleen and lymph 
node cells of these rec"1pients were iv transferred to a group of naive BALB/c recipient mice 
and to a group of BALB/c recipient mice which had been iv suppressed with 5 x 107 irradiated 
(C57BL x CBA)F 1 spleen cells 4 days earlier. A control group of BALB/c recipient mice, 
which were only suppressed, was included. One hr after transfer of the DTH effector T cells, 
all groups of BALB/c recipient mice were challenged with (C57Bl x CBA)F 1 spleen cells. 
According to the same schedule, naive 810.ScSn recipient mice and 810. ScSn recipient mice 
which had been iv suppressed with irradiated 5 x 107 DBA/2 spleen cells, were iv infused with 
81 O.ScSn DTH effector T celts activated against DBA/2 atloantigens. A control group of 
suppressed B10.ScSn mice was included. One hr after transfer of the DTH effector T cells all 
groups of B10.ScSn recipient mice were challenged for anti-DBA/2 DTH. In both experiments 
DTH responses were measured 24 hr after challenge. Each column respresents the mean 
response ± SE (n = 6). The percentage specific suppression is shown in parentheses. In both 
experiments significant suppression of OTH reactivity (p < 0.01) was found in a! I groups of 
m·1ce wh'1ch were suppressed by iv pre·1mmun'1zation with irradiated allogeneic cells. 
against alloantigens has not been studied yet. Therefore the effect of these 
suppressor cells upon activated DTH effector T cells was investigated by iv 
infusion of such DTH effector T cells in previously iv immunized ('suppressed') 
mice. To this end, DTH effector T cells were generated in a GvH reaction. 
DTH reactive T cells of BALB/c origin, activated under GvH conditions against 
(C57BL x CBA) F 1 alloantigens, were transferred to syngeneic BALB/c secondary 
recipients. The secondary recipient mice had been iv preimmunized with 5 x 107 
irradiated (C57BL x CBA)F1 spleen cells 4 days earlier. Control groups of 
BALB/c mice either received anti-F1 activated syngeneic lymphoid cells only or 
were iv preimmunized with 5 x 107 irradiated F1 spleen cells only. The DTH 
reactivity of all groups of mice was evaluated by challenge with F1 spleen cells 
immediately after transfer of the DTH effector T cells. The data from these 
experimen_ts, depicted in Fig. 1, show that transfer of DTH reactivity was only 
succesful in naive secondary recipients and not in recipient mice which had been 
126 
iv preimmunized before. Similar data were obtained with B10.ScSn recipient 
mice which had been iv preimmunized with 5 x 107 irradiated DBA/2 spleen 
cells and were injected with syngeneic anti-DBA/2 reactive DTH effector T cells 
(Fig. 1 ). 
Surface markers of iv induced suppressor cells 
The surface markers of the suppressor cells that can suppress the efferent 
phase of DTH were determined in the immune lymphocyte transfer I I L T-N L T) 
assay. Therefore, suppressor cells were induced in C3H mice by iv injection of 
5 x 107 irradiated (C57BL x CBA)F 1 spleen cells. Four days later, spleen cells 
were used as a source of suppressor cells. Another group of C3H mice was sc 
immunized with 1 x 107 F 1 spleen cells. Five days later the draining lymph 
nodes of these mice were used as source of DTH effector T cells. Subsequently, 
5 x 106 immune lymph node cells were transferred together with either 1 x 107 
naive spleen cells or 1 x 107 'suppressed' spleen cells into the dorsum of a hind 
SUPPRESSOR CELLS' I EFFECTOR CELLS21 
1, 107 SPL ICI 
I, 107 sn I~ Thy-1.1 + Cl (10'-•1 
1, !07 SPL io Lyt-1.1 +C) 117101 
1 • 107 SPl- Ia Lyt-2 + Ci 125%1 
10 20 30 40 50 
Fig. 2. Surface markers of iv induced suppressor cells active during the efferent phase of DTH. 
1. C3H suppressor cells were induced by iv immunization of C3H mice with 5 x 107 irradiated 
(C57BL x CBA)F 1 spleen cells. Four days later the suppressed ce!lswere treated with the 
indicated monoclonal antibodies and/or complement, After treatment, 1 x 107 of these 
cells were transferred into the dorsum of the right foot of (C57BL x CBA)F 1 recipient 
mice. 
2, C3H DTH effector T cells were induced by sc immunization with 1 x 107 {C57BL x 
CBA)F 1 spleen cells, Five days later the draining lymph nodes were dissected and a cell 
suspension was made. Subsequently, 5 x 106 of these cells were transferred into the 
dorsum of the right hind foot of (C57BL x CBA)F 1 recipient mice. Suppressor and DTH 
effector cells were stimultaneously transferred. As a control, a similar number of un-
activated lymphoid cells was injected into the dorsum of the left hind foot. 
3, DTH in the {C57BL x CBA)F 1 recipient mice was measured as the difference in thickness 
(in 10·3 em) between the right and left hind foot± SE (n = 6) 24 hr after local transfer. 
The percentage specific suppression is shown in parentheses. Only the group of mice which 
received suppressor cells that were treated with complement only, showed a significant 
suppression of DTH, 
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foot of naive F1 recipient mice, which were syngeneic with the spleen cells 
used for iv and sc immunization. Fig. 2, lines 1 and 2, show that the I LT responsa 
by the C3H DTH effector T cells was suppressed by the addition of C3H spleen 
cells from suppressed mice. Depletion of Thy-1.2 positive, Lyt-1 positive or 
Lyt-2 positive cells from the inoculum of DBA/2 suppressor cells, by using the 
appropriate monoclonal antibodies and complement, showed that the suppression 
of the efferent phase of the DTH response is dependent on Ts cells expressing 
Thy-1.2 and Lyt-1 as well as Lyt·2 surface antigens (Fig. 2, lines 3-5). 
Suppression of DTH to third party bystander alloantigens during the efferent 
phase of DTH 
We have shown earlier that iv induced Ts cells are antigen specific with regard 
to their antigen recognition (7). However, after restimulation of these Ts cells by 
the specific antigen(s), the DTH response to simultaneously administered third 
party alloantigens becomes suppressed as well (14, 15). The data presented 
above show that iv preimmunization also induces Ts cells which can suppress 
the efferent phase of DTH. 
In the experiments described below, we investigated whether the simultaneous 
presentation of the specific and third party alloantigens during the efferent 
phase of DTH (in the challenge) only can also prevent the DTH response to the 
third party alloantigens. Therefore, B10.ScSn (H-2b) mice were iv injected with 
irradiated H-2 compatible, but non·H-2 incompatible BALB.B (H-2b) spleen cells. 
Seven days later these mice were sc immunized with H-2 incompatible 810.D2 
IH-2d) spleen cells. Another 6 days later the mice were challenged with either 
H-2 and non-H-2 incompatible BAL8/c {H-2d) spleen cells or a mixture of 
8ALB.8 and 810.02 spleen cells. 
A similar experiment was done with D8A/2 (H-2d) responder mice, which 
were iv suppressed with non-H-2 incompatible 810.02 (H-2d) spleen cells, while 
DTH reactivity was induced with H-2 incompatible DBA/1 (H-2q) spleen cells. 
Subsequently, DTH responses were elicited by challenge with either H·2 and 
non-H-2 incompatible B10.G (H-2q) spleen cells or a mixture of 810.02 and 
D BA/1 spleen cells. 
It appeared in both combinations that the simultaneous presentation of the 
specific alloantigens used for iv preimmunization and the third party alloantigens 
in the challenge dose only, was suficient for the suppression of the DTH response 
to the third party alloantigens. Suppression was also found when the specific 
and the third party alloantigens were presented on separate cells (Fig. 3, expts. 
A and B). Similar data were obtained in a combination of mouse strains with a 
810 background that were H-2 incompatible with the 810.BR responder mice 
(Fig. 3, expt. C). 
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Fig, 3. Suppression of DTH to third party bystander alloantigens during the efferent phase of 
OTH. Responder mice were iv injected with 5 x 107 irradiated allogeneic spleen cells (the 
'specific a\\oantigens') or syngeneic cells, and sc immunized with 1 x _107 a\\ogeneic spleen 
cells (the 'third party alloantigens') 7 days later. Challenge for DTH was performed on day 6 
after sc immunization. Each column represents the mean response ± SE (n "" 6). In all 
experiments significant suppression of DTH (p < 0.01) against the third party bystander 
antigens was found when the specific and third party alloantigens were presented together 
in the challenge only (line 1 ). Significant suppression (p < 0.01) was also found when both 
types of alloantigens were presented on separate cells in a mixture (line 3). The columns of 
line 2 and 4 represent the positive controls. The percentage specific suppression and the 
H-2 haplotypes are shown in parentheses. 
Transfer of non-H-2 specific Ts cells, which are induced by iv injection of H-2 
and non-H-2 incompatible spleen cells 
It has been shown in other studies (16) that iv injected hapten-modified H-2 
incompatible lymphoid cells induce Ts cells that exert their suppressive effect 
only after transfer to the mouse strain from which the hapten-modified allogeneic 
cells were derived, and not after transfer to recipients which are syngeneic with 
the donors of the Ts cells. We investigated whether non-H-2 specific Ts cells 
induced by iv injection of H-2 and non-H-2 incompatible spleen cells are able to 
transfer their suppressive effect to recipients syngeneic with the donors of the Ts 
cells. Therefore, groups of BALB/c (H-2d) responder mice were iv injected with 
either irradiated non-H-2 incompatible 810.02 (H-2d) spleen cells, irradiated 
non-H-2 and H-2 incompatible B10.ScSn (H-2b) spleen cells, or irradiated 
syngeneic BALB/c spleen cells. Four days after the iv immunization, spleen and 
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Fig. 4. (A). Suppression of DTH against non-H-2 alloantigens induced by iv injection of H-2 
and non-H-2 incompatible spleen cells. Responder mice were iv injected with 5 x 107 irradiated 
H-2 compatible, but non-H-2 incompatible spleen cells, H-2 and non-H-2 incompatible spleen 
cells or syngeneic spleen cells. Seven days after iv preimmunization all groups of mice were 
sc immunized with 1 x 107 non-H-2 incompatible spleen cells. Challenge for non-H-2 specific 
DTH was done on day 6 after sc immunization. 
(B.) Transfer of suppression by non-H-2 specific suppressor T cells induced by iv injection 
of H-2 and non-H-2 incompatible spleen cells. Donor mice were iv injected with 5 x 107 
irradiated H-2 compatible, but non-H-2 incompatible spleen cells or H-2 and non-H-2 
incompatible spleen cells. Four days after iv immunization, the spleen and lymph node cells 
from these mice were iv transferred to syngeneic recipient mice. Another group of recipient 
mice received spleen and lymph node cells from nonsuppressed donors (positive control}. A 
few hours after transfer, all mice were sc immunized with 1 x 107 allogeneic spleen cells. 
Challenge for DTH was performed on day 6 after sc immunization. Each column represents 
the mean response ± SE (n = 6): The percentage specific suppression and the H-2 hap!otypes 
are shown in parentheses. Significant suppression of DTH reactivity (p < 0.01) was found in 
all groups of responder mice which were suppressed by iv preimmunization with irradiated 
allogeneic spleen cells or received lymphoid cells from iv suppressed donor mice. 
lymph node cells from some mice of these three groups were transferred to 
syngeneic recipeint mice. Immediately after this transfer, the recipient 8ALB/c 
mice were sc immunized with H-2 compatible and non-H-2 incompatible 810.02 
spleen cells and tested six days later for anti-810.02 OTH. The other mice of the 
three goups were sc immunized with 810.02 spleen cells and six days later 
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tested for anti-B10.D2 DTH. It appeared that iv injection of H-2 and non-H-2 
incompatible spleen cells was as effective as H-2 compatible spleen cells for 
induction of non-H-2 specific suppression. Futhermore, spleen and lymph node 
cells from the iv immunized donor mice did not revea! any difference in the 
capacity to transfer the suppressive effect to syngeneic or H-2 incompatible 
recipients (Fig. 4). 
Similar data were found in C57BL/6J (H-2b) responder mice iv injected 
with irradiated H-2 compatible BALB.B (H-2b) and H-2 incompatible BALB/c 
(H-2d) spleen cells (Fig. 4). 
Lack of H-2 restriction in the suppression of the afferent phase of DTH by iv 
induced Ts cells 
We investigated whether Ts cells that are induced by non-H-2 alloantigens 
recognize these antigens and suppress the induction of DTH effector T cells 
during the afferent phase of the DTH response in a H-2 restricted fashion. There-
fore, BALB/c (H-2d) donor mice were iv suppressed with irradiated H-2 
compatible but non-H-2 incompatible 810.02 (H-2d) spleen cells, while BALB.K 
(H-2k) mice were iv suppressed with irradiated H-2 compatible B 10. BR ( H-2k) 
spleen cells. Four days later, spleen and lymph node cells from the suppressed 
BALB/c and BALB.K mice were transferred to naive BALB/c recipient mice. 
As a control, spleen and lymph node cells from non-suppressed BALB/c and 
BALB.K mice were transferred to separate groups of naive BALB/c recipients. 
Immediately after transfer, all recipients were sc immunized with H~2 
compatible, but non-H-2 incompatible B10.D2 spleen cells. Six days later all 
mice were challenged with similar B10.D2 spleen cells. Suppression of the 
subsequent DTH response was found in the recipients of syngeneic BALB/c 
suppressor cells as well as in the recipients of H-2 incompatible BALB.K 
suppressor cells (Fig. 5 A). 
Similar data were obtained with regard to the suppression of DTH against 
B10.D2 (H-2d) coded non-H-2 alloantigens in BALB/c (H-2d) responder mice 
infused with non-H-2 specific BALB/c (H-2d) or BALB.B (H-2b) suppressor cells 
(Fig. 5 B). Since systemic transfer of Ts cells mainly affects the afferent phase 
of DTH (8). these results strongly suggest that there is no special need for H-2 
restricted recognition of the non-H-2 alloantigens by the Ts cells or for a H-2 
restricted interaction between the Ts cells and the DTH reactive T cells during 
the induction of the DTH reactivity. 
Lack of H-2 restriction in the suppression of the efferent phase of DTH by 
activated Ts cells 
The requirement for H-2 compatibility between activated Ts cells and DTH 
effector T cells for suppression of the efferent phase of DTH was investigated. 
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Fig. 5. Lack of H-2 restriction in the suppression of the afferent phase of DTH by Ts cells. 
BALB/c (H-2d), BALB.K (H-2k) and BALB.B (H-2b) donor mice were iv injected with 5 x 
107 irradiated 810.02 (H-2d), B10.BR (H-2k) and B10.ScSn (H-2b) spleen cells, respectively. 
Four days after iv immunization, spleen and lymph node cells from these mice were 
iv transferred to BALB/c responder mice. As positive controls, other groups of BALB/c 
responder mice received naive BALB/c, BALB.K or BALB.B spleen and lymph node cells. One 
hour after transfer, all mice were sc immunized with 1 x 107 non-H-2 incompatible 810.02 
spleen cells and tested for DTH antoher six days later. Each column represents the mean 
response ± SE (n = 6). The percentage specific suppression and the H-2 haplotypes are shown 
in parentheses. Significant suppression of DTH reactivity (p < 0.01) was found in all groups 
of responder mice which received spleen and lymph node cells from iv suppressed BALB/c, 
BALB.K and BALB.B donor mice. 
Therefore, B10.BR (H-2k) mice were ivsuppressed with irradiated H-2 compatible 
but non-H-2 incompatible BALB.K (H-2k) spleen cells, while 810.02 (H-2d) 
mice were iv suppressed with irradiated H-2 compatible but non-H-2 incompatible 
BALB/c (H-2d) spleen cells. Suppressor cells from both groups of mice were 
tested for suppression of the efferent limb of the OTH response in the I L T-N L T 
assay. Therefore, the suppressor cells were transferred into the dorsum of a hind 
foot of (BALB/c x C3H)F 1 (H-2d/kl mice in combination with 810.02 OTH 
effector T cells against the BALB/c coded non-H-2 alloantigens. As a positive 
control another group of F1 mice received 810.02 OTH effector T cells only. 
The data presented in Fig. 6 A show that H-2 compatibility between the Ts cells 
and the OTH effector T cells was not needed for suppression of the efferent 
phase of OTH. 
Subsequently we investigated whether recognition of the non-H-2 alloantigens 
by the Ts cells during the suppression of the efferent phase of OTH is subject to 
H-2 restriction. Therefore, Ts cells were induced by iv injection of B10.ScSn 
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(H-2b) mice with irradiated H-2 compatible but non-H-2 incompatible BALB.B 
(H-2b) spleen cells. In parallel, DTH effector T cells were induced by sc 
immunization of ( B 1 O.ScSn x B 1 0.02) F 1 (H-2b/d) mice with non-H-2 
incompatible BALB/c (H-2d) spleen cells. Thereafter, (B 1 O.ScSn x B 1 0.02) F 1 
DTH effector T cells against BALB/c non-H-2 alloantigens were transferred 
alone or in combination with B10.ScSn anti-BALB.B Ts cells into the dorsum 
of a hind food of BALB/c mice. This experiment (Fig. 6 B) gid not reveal any 
need for restricted recognition of the non-H-2 alloantigens by activated Ts cells 
for suppression of the efferent phase of DTH. 
Lack of lgh restriction in the suppression of the afferent and efferent phase of 
DTH by Ts cells 
Finally we investigated whether the Ts cells that are induced by non-H-2 aile-
antigens suppress the induction and expression of DTH effector T cells in an lgh 
restricted fashion. 
For the afferent phase, BALB/c (lgha) and C.B-20 (lghb) donor mice were iv 
suppressed with irradiated H-2 compatible but non-H-2 incompatible DBA/2 
spleen cells. Four days later spleen cells from suppressed BALB/c and C.B-20 
mice were transferred to naive BALB/c recipient mice. As a control, spleen and 
lymph node cells from nonsuppressed BALB/c and C.B-20 mice were transferred 
to separate groups of BALB/c recipients. Immediately after transfer all recipients 
were sc immunized with DBA/2 spleen cells. Six days later all mice were 
challenged with similar DBA/2 spleen cells. The results show that Ts cells from 
BALB.K and C.B-20 mice were equally effective in suppressing the afferent 
phase of DTH (Fig. 7 A). Therefore, the afferent phase Ts cells for non-H-2 
alloantigens are not lgh restricted. 
For the efferent phase, BALB/c (lgha) and C.B-20 (lghb) mice were iv 
suppressed for DBA/2 non-H-2 alloantigens. The Ts cells from these BALB/c 
and C.B-20 mice were tested in the I L T-N L T assay for suppression of the 
efferent phase of DTH. Therefore, these suppressor T cells and BALB/c anti-
DBA/2 DTH effector T cells were sc injected in the dorsum of a hind foot of 
DBA/2 mice. The data presented in Fig. 7 B show that Ts cells from BALB/c 
and C.B-20 mice were equally effective in suppressing the efferent phase of 
DTH. Therefore, lgh compatibility between Ts and DTH effector T cells is not 
needed for suppression of the efferent phase of DTH to non-H-2 alloantigens. 
DISCUSSION 
The experiments described here establish that iv injection of mice with 
irradiated allogeneic spleen cells induces Ts cells which affect the efferent limb 
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Fig. 6. (A). Lack of H-2 restriction in the interaction between Ts cells and DTH effector T 
cells in the efferent phase of DTH. 
1. Ts cells were induced by iv immunization of 810.BR (H-2k) mice with 5 x 107 BALB.K 
(H·2k) spleen cells. Four days later, 1 x 107 spleen cells from these mice were transferred 
into the dorsum of the right hind foot of (BAL8/c x C3H)F1 (H·2d/k) recipient mice. 
2. Ts cells were induced by iv immunization of 810.02 (H·2d) mice with 5 x 107 irradiated 
BALB/c (H·2d) spleen cells. Four days later, 1 x 107 spleen cells from these mice were 
transferred into the dorsum of the right hind foot of {BALB/c x C3H)F 1 (H·2d/k) recipient 
mice. 
3. 810.02 (H-2d) DTH effector T cells were induced by sc immunization with 1 x 107 
BALB/c (H·2d) spleen cells. Five days later, 5 x 106 cells from the draining lymph nodes 
were transferred into the instep of the right hind foot of (BALB/c x C3H)F 1 {H·2d/k) 
recipient mice. 
(8.) Lack of H-2 restriction in the interaction between Ts cells and antigen in the efferent 
phase of DTH. 
4. Ts cells were induced by iv immunization of B10.ScSn {H-2b) mice with 5 x 107 irradiated 
BALB.B (H-2b) spleen cells. Four days later 1 x 107 spleen cells from these mice were 
transferred into the dorsum of the right hind foot of BALB/c (H-2d) recipient mice. 
5. {B10.ScSn x B10.02}F 1 (H-2b/d) DTH effector T cells were induced by sc immunization 
with 1 x 107 BALB/c (H-2d} spleen cells. Five days later, 5 x 106 cells from the draining 
lymph nodes were transferred into the dorsum of the right hind foot of BALB/c (H-2d} 
recipient mice. 
6. Ts cells and DTH effector T cells were transferred simultaneously. As a control, the left 
hind foot of the recipient mice was injected with a similar number of naive lymphoid cells 
from the appropriate donor strains. 
DTH responses in the (BALB/c x C3H)F 1 and BALB/c recipient mice were measured 24 hr 
after local transfer and are expressed in 10·3 em ± SE {n = 6). The percentage specific 
suppression is shown in parentheses. All groups of recipient mice which received Ts cells 
and DTH effector T cells showed a significant suppression of DTH (p < 0.01). 
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('challenge phase') of DTH to alloantigens. We have shown previously by 
studying the proliferative activity in the draining lymph nodes of mice after sc 
immunization with allogeneic spleen cells (7, 8) that iv preimmunization also 
induces Ts cells which suppress the afferent limb of DTH against alloantigens. 
In contrast to Miller eta!. (17, 20) who were able to transfer suppression of 
the efferent limb of CS against 2,4-dinitro-1-fluorobenzene (DNFB) by iv 
injection of activated Ts cells, we could not transfer efferent phase suppression 
intravenously, at least not with lymphoid cells isolated from donor mice 4 to 7 
days after the iv suppressive injection. 
Dietz eta/_ (21) demonstrated that Ts cells, which were isolated 7 days after 
iv induction of azobenzenearsonate (ABA) specific suppression, could only 
suppress the DTH response of the recipients when administered at the time of 
immunization. Transfer one or more days after immunization was ineffective. 
They showed that the afferent phase Ts cells induced second order Ts cells that 
suppressed the efferent phase. 
In our experiments, the iv suppressed mice themselves displayed efferent 
phase suppression of DTH against alloantigens on day 6 after the secondary sc 
immunization, when the mice were challenged for DTH. Therefore we investigated 
whether lymphoid cells from iv suppressed and subsequently sc immunized mice 
were more potent in systemic transfer of efferent phase suppression. However, 
also under these conditions no suppressive effect could be demonstrated in mice 
which received these cells a few hours before challenge (data not shown). On the 
other hand, the experiments involving transfer of DTH effector T cells to iv 
suppressed recipients (Fig. 1) or cotransfer of DTH effector T cells and lymphoid 
cells from iv suppressed mice in an I L T-N L T assay (Fig. 2) show that iv injection 
of irradiated allogeneic spleen cells does induce Ts cells active during the efferent 
phase of DTH against alloantigens. These efferent phase Ts cells appeared to be 
Lyt-1+2+ (Fig. 2). 
The occurence of 'bystander' suppression of DTH against third party aile-
antigens (Fig. 3) also demonstrates that iv immunization with irradiated 
allogeneic spleen cells induces 'efferent phase' Ts cells. Thus afferent phase Ts 
cells (8) as well as efferent phase Ts cells that can regulate DTH against alia-
antigens occur in spleen and lymph nodes 4 to 7 days after the iv suppressive 
injection. 
The inability to transfer efferent phase suppression by iv injection of Ts cells 
in the period just before challenge may depend on an inefficient or inappropriate 
migration of the systemically transferred Ts cells to the hind foot, where the 
activity of DTH effector T cells has to be suppressed. 
Although we know from previous experiments (7) that activation of alia-
antigen induced Ts cells is antigen specific, suppression of the efferent phase 
of DTH to third party bystander alloantigens (Fig. 3) shows that, after activation 
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Fig. 7. {A.} Lack of lgh restriction in the suppression of the afferent phase of DTH by Ts cells. 
BALB/c {lgha) and CB-20 (lghb} donor mice were iv injected with 5 x 107 irradiated DBA/2 
spleen cells. Four days after iv immunization spleen cells from these mice were iv transferred 
to BALB/c responder mice. As positive controls, other groups of BALB/c responder mice 
received naive BALB/c or C.B-20 spleen and lymph node cells. One hour after transfer, all 
mice were sc immunized with 1 x 107 non-H-2 incompatible DBA/2 spleen cells and tested 
for DTH another six days later. Each column represents the mean response ± SE {n "" 6). 
The percentage specific suppression and the lgh allotype are shown in parentheses. Significant 
suppression of DTH reactivity (p < 0.01) was found in all groups of responder mice which 
received spleen and lymph node cells from iv suppressed BALB/c or C.B-20 donor mice. 
(B.) Lack of lgh restriction in the interaction between Ts cells and antigen in the efferent 
phase of DTH. 
1. Ts cells were induced by iv immunization of C.B-20 (lghb) mice with 5 x 107 DBA/2 
spleen cells. Four days later, 1 x 107 spleen cells from these mice were transferred into the 
dorsum of the right hind foot of DBA/2 recipient mice. 
2. Ts cells were induced by iv immunization of BALB/c (lgha) mice with 5 x 107 DBA/2 
spleen cells. Four days later, 1 x 107 spleen cells from these mice were transferred into the 
dorsum of the right hind foot of DBA/2 recipient mice. 
3. BALB/c (lgha) DTH effector T cells were induced by sc immunization with 1 x 107 DBA/2 
spleen cells. Five days later, 5 x 106 cells from the draining lymph nodes were transferred 
into the dorsum of the right hind foot of DBA/2 recipient mice. 
4, Ts cells and DTH effector T cells were transferred simultaneously. As a control, the left 
hind foot of the recipient mice was injected with a similar number of naive lymphoid 
cells from the appropriate donor strains. DTH responses in the DBA/2 recipient mice were 
measured 24 hr after local transfer and are expressed in 10-3 em± SE (n == 6). The 
percentage specific suppression is shown in parentheses. All grOUiJS of recipient mice which 
received Ts cells and DTH effectorT cells showed significant suppression of DTH (p < 0.01 ). 
of the Ts cells with the specific alloantigens, the ultimate suppressive effect by 
the efferent phase Ts cells is nonspecific. Suppression of DTH to third party 
bystander alloantigens even occured when the specific and third party antigens 
occurred on separate cells, suggesf1ng that associative recognif1on of the alia-
antigens involved is not required for the Ts cells in order to display their non-
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specific suppressive effect. Similar data on nonspecific bystander suppression of 
DTH against third party antigens in vivo have been described by ourselves for the 
afferent limb of DTH to alloantigens (14, 15), by Zembala eta!. for suppression 
of the efferent limb of DTH against picrylchloride and oxazolone (22) and by 
Ramshaw et a!. for DTH to protein antigens (23). Other studies dealing with 
suppression of CS and DTH to haptenized cells indicate that the suppressive 
effect of afferent (5, 16) and efferent phase (5, 17, 24, 25) Ts cells is antigen 
specific. However, these reports do not describe experiments which are 
appropriate to demonstrate nonspecific bystander suppressive effects. 
Restriction requirements have been described in several Ts cell systems: for 
the activation of Ts cells (17), for the interaction of Ts cells and responder T 
cells in MLR (26, 27), for the interaction between different types of Ts cells and 
Ts cell factors in a suppressor cell cascade (5, 21, 25, 28, 29) and for the 
recognition of antigen by Ts cells (6, 30). The results depicted in Fig. 4 show 
that non-H-2 specific Ts cells can be induced by iv preimmunization with spleen 
cells that are H-2 as well as non-H-2 incompatible with the responder. No restriction 
requirements were found for these Ts cells in order to transfer suppression of the 
afferent phase of DTH to naive recipients. These results are at variance with 
those of Miller et a!. (16, 17). They showed that hapten speicific Ts cells, 
induced by H-2 compatible haptenized cells, act during the efferent phase of 
the DTH response only and could be transferred to H-2 compatible as well as to 
H-2 incompatible recipient mice, while Ts cells induced with H-2 incompatible 
haptenized cells were afferent phase Ts cells and could only be transferred to 
recipients with the same H-2 haplotype as the donors of the haptenized 
allogeneic cells. The lack of H-2 restriction requirements for the efferent phase 
Ts cells found by Miller, et a/. (17) is compatible with our data concerning 
suppression of the efferent phase of DTH against alloantigens by Ts cells (Fig. 6). 
Furthermore, our data show that systemic transfer of afferent phase Ts cells is 
not lgh restricted (Fig. 7 A). This is compatible with the afferent phase Ts1 
cells acting in hapten specific Ts cells cascades (5, 2, 8). The Ts2 and Ts3 from 
these Ts cell cascades and their suppressor factors TsF2 and TsF3 have shown to 
be H-2 (1-J) and lgh restricted in the suppression of the efferent phase of DTH 
(5, 21, 31). Our data do not show any H-2 (Fig. 6) or lgh (Fig. 7 B) restriction 
requirement for Ts cells during suppression of the efferent phase of DTH against 
alloantigens. 
To summarize, the data presented do not reveal any difference between the 
Ts cells active during the afferent (8) and efferent limb of DTH against alia-
antigens. Thus, despite of all well documented examples of different subsets 
of hapten specific Ts cells for suppression of the afferent and efferent phase of 
DTH and CS to haptens, there is no reason as yet to suppose that the afferent and 
efferent limb of DTH to alloantigens is regulated by different subsets of Ts cells. 
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Delayed-type hypersensitivity (DTH} to both major histocompatibility 
complex (H-2} and non-H-2-coded antigens can be induced by subcutaneous 
immunization with allogeneic lymphoid cells in the mouse. While subcutaneous 
immunization with allogeneic cells preferentially induces DTH reactivity, 
intravenous immunization, especially with irradiated allogeneic cells, induces a 
state of suppression. Suppression is manifest both in direct host-versus-graft 
(HvG} (1} assays and under graft-versus-host (GvH} conditions (2}, where spleen 
cells of suppressed mice are used to reconstitute irradiated allogeneic hosts. The 
suppression is mediated by T cells (2, 3}. We have now studied the specificity of 
the suppressive effect by subcutaneous immunization of 'suppressed' mice with a 
combination of alloantigens comprising the antigen(s) used to induce the 
suppressor T cells as well as unrelated alloantigens. We report here that reaction 
against the third party alloantigens was effectively suppressed, provided these 
antigens were presented in combination with the antigen(s) that had induced the 
suppressor T cells. Both sets of alloantigens do not need to be physically 
associated. 
Mice, suppressed to H-2 histocompatibility antigens, do not display a DTH 
response against these antigens, but respond normally against third party antigens 
(Table 1, groups A and E). The suppression is H-2 subregion-specific: mice, 
suppressed for either H-21 or H-2D antigens, display normal DTH reactivity after 
subcutaneous immunization with other H-2 subregion antigens (Table 1, groups 
B and C). Table 1, group D, shows that suppression of the HvG reactivity to H-2 
subregions is haplotype-specific. We have also observed that intravenous injection 
of cells incompatible for minor histocompatibility antigens could not suppress 
DTH reactivity to subcutaneously administered H-2 alloantigens and vice versa. 
Thus suppressor T cells require restimulation with the original immunizing 
antigen: they are strictly antigen-specific as far as their activation is concerned. 
In GvH reactions H-21 and Mls antigens activate DTH-reactive T cells (4). This 
activity is assayed in secondary recipients, after passive transfer of lymphoid 
cells from animals undergoing the GvH reaction (5, 6). The suppression found in 
HvG reactions is also found in GvH reactions (Table 1, group E). 
The specificity of the suppressive effect was studied by subcutaneous immuni-
zation of 'suppressed' mice with a combination of alloantigens comprising the 
antigen(s) used to induce the suppressor T cells as well as unrelated alloantigens. 
Reaction against the third party alloantigens was effectively suppressed, provided 
these antigens were presented in combination with the antigen(s) that had 
induced the suppressor T cells. This holds also for GvH reactions (Table 2). The 
phenomenon was observed for complete H-2 differences (groups A and C) as 
well as for H-2 subregion differences (groups B and D). Intravenous preim-
munization with an alloantigen suppressed the DTH response to a challenge by 
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Table 1 Specificity of antigen recognition by suppressor T cells 
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Suppressor T cells were induced by intravenous (i.v.) pre·tmmunizatlon of groups of six 
mice with 5 x 10 7 X-irradiated {2,000 rad) allogeneic spleen cells. HvG reactivity was stimulated 
7 days later by subcutaneous (s.c.) injection of 1 x 107 allogeneic spleen cells, distributed over 
the inguinal area. Six days later the mice were tested for DTH reactivity by injection of 2 x 
107 of the same allogeneic spleen cells into the dorsum of the right hind foot. Footswe!rtng 
was measured 24 h after challenge. Untreated control mice received only the challenge dose. 
The swelling in these control mice varied between 12 and 20%. DTH responses are expressed 
as % specific increase in foot thickness, and corrected for nonspecific swelling in the control 
mice. The histograms represent the arithmetic mean± s.e. The H-2 haplotype (group A), the 
H-2 subregion differences {group Band C), and the haplotype of the H-20 locus (group D) are 
shown in parentheses. GvH reactions were elicited by i.v. injection of 1 x 107 spleen cells 
('responder cells') into X-irradiated (700 rad) allogeneic recipient mice. Five days after 
reconstitution the total cell yield of spleen, inguinal, axillary and mesenteric lymph nodes of a 
recipient mouse was injected i.v. into an untreated secondary recipient syngeneic with the 
spleen cell donor. DTH reactivity was measured as in HvG reactions. The H-2 haplotype of 
the mice and cells used (group E) are shown in parentheses. The origin of the H-2 subregions 
(K, 1-A, 1-J, 1-E, D): A.SW s sss s, A.TH s sss d, A.TL s kkk d, BALB,B b bbb b, BALB/c d ddd 
d, BALB,K k kkk k, B10.BR k kkk k, B10.A k kkk d, B10,AKM k kkk q, B10.A(2R) q kkk b, 
B10.AQR q kkk d, B10,T(6R) q qqq d. 
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Table 2 Specificity of the suppressive effect mediated by suppressor T cells 
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The experimental details are the same as in Table 1. The H-2 haplotypes (groups A and C), 
or the H-2 subregion differences (groups B and D) are shown in parentheses. BALB/c x. KF1 
means Fl hybrid of BALB/c x BALB.K, B10.A x T(6R)F1 means F1 hybrid of B10.A x 
B10.T(6R). The origin of the H-2 subregions of the A.AL strain is k kkk d. The other strains 
are described in the legend to Table 1. 
completely different alloantigens, as long as the preimmunizing antigen was also 
present in the inducing inoculum (Table 2, groups A-C). The same result was 
obtained after suppression with non·H·2 alloantigens, subsequent immunization 
with a mixture of the same non-H-2 alloantigens plus unrelated 'bystander' H-2 
antigens, and eventual testing for DTH reactivity against the H-2 antigens only 
(Table 3, groups A and B). These experiments clearly show that the 'bystander' 
antigens and the antigens used to induce the suppressor T cells do not have to be 
presented by the same cells. 
Nonspecific suppressive effects have been demonstrated previously in vivo 
(7, 8) and in vitro (9-13). Contact sensitizing agents (14, 15) as well as hapten-
derivatized syngeneic (16, 17) and allogeneic (18) cells readily induce suppressor 
T cell activity. The generation of this activity is dependent on complex 
interactions of three sets of suppressor T cells in a regulatory circuit under 
control of lgH and H-2 genes (19, 20). Fresno eta/. (11-13) have isolated an 
antigen-specific suppressor factor from continuously growing suppressor T cell 
clones. This factor was found to be a protein which, after interaction with 
antigen, breaks down into two peptides of 45,000 and 24,000 molecular weight. 
The former subunit suppresses both antigen-specific and other Lyt 1 + T cells. 
Intravenous preimmunization with X·irradiated allogeneic cells also induces 
suppressor T cell activity. The type of the suppressor T cell activated depends on 
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Table 3 Recognition of specific and 'bystander' antigens on separate cells 
r~sp slrc•n 'Y pr~>mm~n,znl•on s< •mmun•znl•on C~OIIPnge •1. spec1f1< •n<rens• foot 1~.c>n•» 
810 0:1 (H·:Id) 6Al9/< 8ALBB(H ,,, BIOS<Sn (K~21>) =-
810 01 810 02 BALB 8 (H ·21>1 810 ScSn (K·2b) 
610 02 8AL6/c 8AL8/c. 610 ScSn (H-21>) 810ScSn (H-1b) =-BID 01 610 02 BALB{c-BIOScSn (H-11>) BIOScSn (H-21>) 
DBA/1 IH-ldl BID Dl 810 G ( H -1'<.) DBA/I (H-1'<.) 
=-" 
DBA /1 OBA/2 610 G I H -2'<.1 OBA/1 (H-1'<.) 
DBA /1 810 02 BID 02 • DBA/I IH -1'<.1 DBA/1 IH·2q_l =--
OBA/1 OBA/2 810 D1. OBA/1 (H· 2'<.1 DBA/I (H-2q_) 
10 10 30 1.0 50 60 
Suppressor T cells against minor histocompatibility antigens were induced as described in 
the legend to Table 1, which also gives the details of the assays. The H-2 haplotype differences 
are shown in parentheses. 
the dose of antigen and on treatment of the mice with cyclophosphamide (21). 
Liew (7), using high antigen doses and cyclophosphamide to induce suppressor T 
cell activity, has shown that suppression of DTH to H-2 subregion products can 
be induced if, and only if, the H-2 incompatibility includes the 1-J subregion. 
The suppressor T cells are then antigen-specific, recognize the allo-1-J molecules 
and suppress also the DTH response to other H-2 subregion gene products if 
these are presented on the same cells as the allo-1-J determinants (7). The 
suppressor T cells activated by our protocol (which differs from Liew's by using 
a lower dose of antigen and no cyclophosphamide) do not need to recognize 
allo-1-J determinants (Table 1) and will nonspecifically suppress the response to 
'bystander' antigens, irrespective of whether the specific and 'bystander' antigens 
are physically associated. 
Various mechanisms have been proposed to date for the beneficial effect of 
blood transfusion on kidney transplant survival (22, 23). The data of Fresno et 
a/. ( 11-13), combined with our finding of nonspecific suppression of the in vivo 
immune response to 'bystander' alloantigens, even if they are not physically 
associated with the specific antigens, may well explain the blood transfusion 
effect. Sharing histocompatibility antigens by the transfused blood cells and the 
transplanted kidney and/or the passenger blood cells might reactivate antigen-
specific suppressor T cells after transplantation, and that might supress the 
anti-graft reactions in a nonspecific way. 
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SUMMARY 
Delayed type hypersensitivity {DTH) against alloantigens can be induced by sc immuniza-
tion with allogeneic cells. The induction of DTH can be suppressed by iv preimmunization of 
the mice with similar allogeneic spleen cells, provided the cells are irradiated before injection. 
This supression is mediated by T cells. The suppressor activity can be induced not only by 
H-2 and non-H-2 coded antigens, but also by H-2 subregion coded antigens. Suppression 
induced by K, l or D subregion coded antigens is specific for that particular subregion as well 
as for its haplotype. 1-J coded alloantigens were found to be not necessary for the induction 
of antigenspecific suppressor T cells. After restimulation of suppressor T cells by the 'specific' 
a!loanf1gens, the DTH to s·lmultaneously administered third party alloantigens becomes 
suppressed as well. This nonspecific suppression of DTH to third party 'bystander' alloantigens 
also occurs when the 'specific' and the third party antigens are presented on separate cells, 
provided that both cell types are administered together at the same site. The simultaneous 
presentation of both sets of alloantigens during the induction phase of DTH only is sufficient 
to prevent the normal development of DTH to the third party antigens. 
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INTRODUCTION 
Suppression of cellular immunity in mice by intravenous (iv) preimmunization 
is a well-known phenomenon. Most studies deal with suppression of contact 
sensitivity (1-3) or delayed type hypersensitivity (DTH) to haptens (4, 5) after iv 
preimmunization with hapten-modified syngeneic (1-5) or allogeneic lymphoid 
cells (2). Some of them have shown that the development of suppressor activity 
depends upon complex interactions of three sets of suppressor T cells in a 
regulatory circuit under control of lgH and H-2 genes (3, 6). 
Studies concerning suppression of cellular immunity against alloantigens are 
less numerous. Suppression of DTH to alloantigens (7-10) and suppression of 
skin (11, 12) and heart allograft rejection (13) can be induced by ivpreim-
munization with different types of donor cells. Most investigators have reported 
that, in addition to iv preimmunization with donor antigen, pretreatment with 
antilymphocyte serum (12, 14) or cyclophosphamide (7, 8, 13) is necessary to 
obtain the suppressive effect. Our own studies have shown that the use of 
immunosuppressive drugs or antisera is superfluous in order to induce suppression 
of DTH to alloantigens by iv preimmunization (9, 10). Furthermore, in our 
hands, the antigen dose needed for optimal suppression is rather small as 
compared with the other studies (7, 8). This iv induced suppression persists for a 
long period (9) and can be transferred by T lymphocytes only (10). We have 
shown by in vivo [3H]TdR-incorporation studies that the iv induced suppressor 
T cells suppress the induction of DTH by subcutaneously administered H-2 and 
non-H-2 alloantigens (9). The activation ofT cells responsible for suppression of 
DTH to H-2 alloantigens was found to be specific for the H-2 haplotype of the 
cells used for iv preimmunization. Furthermore, iv injection of cells incompatible 
for non-H-2 alloantigens could not suppress DTH to H-2 alloantigens or vice 
versa (9). 
Our previous studies, however, did not deal with the ability of H-2 subregion 
coded antigens to induce suppressor T cells by iv preimmunization. This is of 
particular interest, since it has been reported that 1-J alloantigens are required in 
order to induce the suppressive activity (7). The present paper pays attention to 
this particular aspect and, in addition, shows that the suppressive effect mediated 
by the antigen-sp13cific suppressor T cells in vivo is nonspecific. 
MATERIALS AND METHODS 
Mice 
A.SW (H-2s), BALB/c (H-2d), B10.A (H-2a), and C3H/HeJ (H-2k) mice were 
purchased from the Laboratory Animals Centre of the Erasmus University, 
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Rotterdam. DBA/2 mice were purchased from the Radiobiological Institute TNO, 
Rijswijk, The Netherlands. A.TL {H-2tl), A.TH {H-2t2), BALB.B {H-2b), BALB.K 
{H-2k), {BALB/c x BALB.K)F1 {H-2d/k), B10.ScSn {H-2b), 810.02 {H-2d), 
B10.BR {H-2k), B10.G {H-2q), {B10.ScSn x B10.D2)F1 {H-2b/d), B10.AQR 
{H-2YI), B10.T{6R) {H-2Y2), B10.AKM {H-2m), B10.A{2R) {H-2h2), and DBA/1 
{H-2q) mice were purchased from OLAC Ltd., Bicester, United Kingdom. 
{810.T{6R) x 810.A)F1 {H-2y2/a), and 810.MBR {H-2bq11 were bred at our 
own department. The age of the responder mice varied between 10 and 24 
weeks. Only female mice were used. 
Preparation of cell suspensions 
Mice were killed by carbon dioxide. Spleens were removed, placed in balanced 
salt solution {BSS) and squeezed through a nylon gauze filter to provide a single· 
cell suspension. Nucleated cells were counted with a Coulter counter model B. 
The viability of the cell suspensions obtained was at least 90o/~ 
Immunization 
Suppression was induced by iv preimmunization with 5 x 107 allogeneic 
spleen cells. Within 3 hours before iv injection the cells had been irradiated in 
vitro with 20 Gy, generated in a Philips Muller MG 300 X-ray machine as described 
in detail previously {15). DTH was induced by sc immunization with 1 x 107 
non irradiated allogeneic spleen cells. When mixtures of spleen cells derived from 
two different mouse strains were used for sc immunization, the cells were 
treated with mitomycin C. The interval between iv induction of suppression and 
sc immunization for DTH was 7 days. Six days after the sc immunization the 
mice were tested for DTH reactivity by injection of a challenge dose into the 
dorsum of the right hind foot. 
Mitomycin C treatment 
Treatment of spleen cells with mitomycin C {Kyowa Hakko Kogyo Co. Ltd., 
Tokyo, Japan) was carried out as described by Blomgren and Svedmyr {16). A 
number of, 2 to 10 x 1 oB, spleen cells was incubated for 30 min at 37°C in 40 ml 
BSS containing 25pg mitomycin C per mi. After treatment with mitomycin C, 
the cells were washed with BSS three times. 
Assay forD TH 
DTH reactions were determined by measuring the difference in thickness of 
the hind feet 24 hr after sc injection of a challenge dose of 2 x 107 of the 
appropriate allogeneic spleen cells into the dorsum of the right hind foot. As a 
control for background DTH reactivity, naive syngeneic mice were used which 
152 
only received the challenge dose. The specific DTH response was calculated as 
the relative increase in foot thickness of the immune mice minus the relative 
increase in foot thickness of the control mice. The swelling of the control mice 
ranged between 15 and 25o/~ 
RESULTS 
Induction of suppressor T cells by H-2 subregion-coded al/oantigens and their 
specificity 
To investigate whether H-2 subregion-coded antigens can induce a state of 
suppression by iv immunization, and to study the specificity of the suppressor T 
cells {10) involved, we employed several combinations of H-2K, H-21 and H-2D 
incompatible mouse strains. For H-2K, B10.AOR mice were iv injected with 
either 5 x 107 irradiated H-2K incompatible B10.A spleen cells, H-21 
incompatible B10.T{6R) spleen cells, or syngeneic B10.AOR spleen cells. Seven 
days later the mice were sc immunized with 1 x 107 B 1 O.A or B 1 O.T{6 R) spleen 
cells and challenged with similar spleen cells another six days later. It appeared 
that the iv preimmunization of B10.AOR mice with H-2K incompatible spleen 
cells did suppress the anti H-2K DTH reactivity, but not the anti H-21 DTH 
reactivity {Fig. 1, exp. A and B). Similarly, iv preimmunization with H-21 or H-2D 
incompatible spleen cells led to a H-21 of H-2D subregion specific suppression of 
the DTH reactivity, respectively {Fig. 1, exp. B-D). 
Subsequently we investigated whether the iv induced suppression to H-2 
subregion coded antigens is specific for the haplotype of the cells used for 
immunization. Thus, B 10.8 R {H-2Dk) mice were iv injected with either irradiated 
H-2D incompatible B10.AKM {H-2Dq) spleen cells, B10.A{2R) {H-2Db) spleen 
cells, or syngeneic B10.BR spleen cells. Seven days later the mice were sc 
immunized with B10.AKM or B10.A(2R) spleen cells and challenged with 
similar cells another six days later. It appeared that the suppression of the DTH 
reactivity to H-2D subregion coded alloantigens was haplotype specific {Fig. 1, 
exp. E). The same result was obtained with a combination of B10.A {H-2Kk). 
B 1 O.MB R {H-2Kb). and B1 O.AOR {H-2Kq) mice, which have different haplotypes 
for the H-2K subregion {Fig. 1, exp. F). 
The specificity of the suppressive effect by antigenspecific suppressor T cells 
Previous studies {9, 10) and those above show that suppressor T cells, induced 
by iv preimmunization with alloantigens, are antigenspecific. This conclusion 
brings us to the question concerning the specificity of the suppressive effect 
mediated by these suppressor T cells. What happens when 'suppressed' mice are 
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EXP. RE5P. STRAIN I. V. PREIMMUNIZATION S.C. IMMUNIZATION %SPECIFIC INCREASE FOOT THICKNESS 
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Fig. 1. Induction and specificity of suppressor T cells regulating DTH to H-2 subregion coded 
ant"1gens. Responder mice were iv injected with 5 x 107 irradiated allogene·lc or syngeneic 
spleen cells and sc immunized with 1 x 107 allogeneic spleen cells 7 days later. Challenge for 
DTH was performed on day 6 after sc immunization. Each column respresents the mean 
response ± SE (n,6). In all experiments significant suppression of DTH reactivity (p < 0.01) 
was only found in mice iv and sc immunized with the same H-2 subregion coded antigens. The 
H-2 subregion differences (exp. A-D), the haplotype of the H-20 locus (exp. E) and the 
haplotype onhe H-2K locus {exp. F) are shown in parentheses. 
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sc immunized with third party alloantigens in combination with the alloantigens 
that had been used for induction of the antigenspecific suppressor T cells? 
This was investigated in mouse strain combinations that were either fully H-2 
incompatible, only H-2 subregion incompatible, non-H-2 incompatible, or H-2 
and non-H-2 incompatible. Thus, BALB.B (H-2b) mice were iv injected with 
irradiated H-2 incompatible BALB/c (H-2d) or syngeneic BALB.B spleen cells. 
Seven days later these mice were sc immunized with H-2 incompatible BALB.K 
(H-2k) or (BALB/c x BALB.K)F1 (H-2d/k1 spleen cells and challenged with 
similar spleen cells another six days later. A similar experiment was done with 
B 10.8 R (H-2k) responder mice, which were iv suppressed with H-2 incompatible 
B10.ScSn (H-2b) spleen cells, while DTH reactivity was induced and elicited 
with B10.D2 (H-2d) or (B10.ScSn x B10.D2)FI (H-2b/d) spleen cells. It appeared 
that lv preimmunization with alloantigens indeed suppressed the DTH response 
to the third party alloantigens, but only when these third party antigens were 
presented together with the alloantigens that previously had induced the 
suppressor T cells (Fig. 2, exp. A and B). 
The same data was obtained in combinations of mouse strains that were H-2K 
and/or H-21 incompatible and in combinations that were H-2 and/or non-H-2 
incompatible. Thus, iv preimmunization with H-2K and H-21 coded alloantigens 
could suppress the anti H-21 and anti H-2K DTH response, respectively, when 
the subregion coded alloantigen used for iv preimmunization was also present in 
the induction and challenge-phase of DTH (Fig. 2, exp. C and D). Similarly, 
suppressor T cells induced by either H-2 or non-H-2 coded alloantigens also 
suppressed the anti non-H-2 and anti H-2 DTH response, respectively, provided 
the antigens used for iv suppression were also present in the inoculum used in 
the induction and challenge-phase of DTH (Fig. 2, exp. E-L). 
These results show that alloantigen-specific suppressor T cells effectively 
suppress the reaction against third party alloantigens, provided these antigens are 
presented as 'bystanders' to the antigen(s) that had induced the suppressor T 
cells. 
Effect of the mode of presentation of the specific and 'bystander' antigens 
In the previous section it was shown that the ultimate suppressive effect by 
the antigen-specific suppressor T cells is nonspecific. However, it is unclear from 
these experiments whether the simultaneous presentation of the 'specific' and 
the 'bystander' antigens is required in the induction as well as the challenge-phase 
or that combined presentation in the induction phase is sufficient. Furthermore, 
the above experiments do not reveal whether or not associative recognition of 
the specific and 'bystander' antigens is involved. Therefore, subsequent 
experiments were devoted to these questions. Thus, BALB.B (H-2b) responder 
mice were iv injected with irradiated H-2 incompatible BALB/c (H-2d) or 
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Fig. 2. Specificity of the suppressive effect upon DTH to al!oantigens by alloantigen-specific 
suppressor T cells. Responder mice were iv injected with 5 x 107 irradiated allogeneic or 
syngeneic spleen cells and sc immunized with 1 x 107 allogeneic spleen cells 7 days later. 
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Challenge for DTH was performed on day 6 after sc immunization. Each column respresents 
the mean response ± SE {n=6). In all experiments significant suppression of DTH reactivity 
(p < 0.01) against third party antigens was found, when the third party antigens were presented 
as 'bystander' antigens in combination with the antigens used for the iv induction of antigen 
specific suppressor T cells, the 'specific' antigens. The suppressed combinations are shown in 
the first line of each experiment. The nonsuppressed DTH response against the combination 
of 'specific' and third party antigens is shown in the second line. The other histograms of 
each experiment represent a positive control and a specificity control. The H-2 haplotypes are 
shown in parentheses. 
syngeneic BALB.B spleen cells. Seven days later the mice were sc immunized 
with H-2 incompatible (BALB/c x BALB.K)FI (H-zdlk) spleen cells or a mixture 
of BALB/c (H-2d) and BALB.K (H-2k) spleen cells. Another six days later all 
mice were challenged with BALB.K spleen cells (Fig. 3, exp. A). Similar 
experiments were done in combinations incompatible for the whole H-2 complex 
(Fig. 3, exp. B), or H-2K and H-21 (Fig. 3, exp. C and D), or H-2 and non-H-2 
alloantigens (Fig. 3, exp. E and F). The results from all these experiments 
show that simultaneous presentation of the alloantigens used for iv preim-
munization and the 'bystander' alloantigens, during the induction of DTH only, 
is sufficient to suppress the DTH reactivity to the 'bystander' alloantigens. 
Suppression was also found when the 'specific' and third party 'bystander' 
alloantigens were presented on separate cells, provided that the mix of both cell 
types was administered to the same site (Fig. 3). However, when the specific and 
third party 'bystander' alloantigens were administered to separate sites during 
the sc immunization, no suppression of DTH reactivity against the third party 
alloantigens was found (fig. 4, exp. A-C). 
Suppression by partially overlapping sets of non-H-2 alloantigens 
Finally we investigated whether the overlap between the non-H-2 coded alia-
antigens of two H-2 compatible, non-H-2 incompatible donor strains can be 
sufficient to activate enough iv induced antigen-specific suppressor T cells to 
suppress the DTH reactivity against the incompatible non-H-2 alloantigens. Thus, 
BALB/c (H-2d) mice were iv injected with irradiated allogeneic B10.D2 (H-2d) 
spleen cells, DBA/2 (H-2d) spleen cells, or syngeneic BALB/c (H-2d) spleen cells. 
Seven days later all mice were sc immunized with B10.D2 spleen cells. Another 
six days later they were tested for DTH by challenge with similar spleen cells 
(Fig. 5, exp. A). Similar experiments were done in three other combinations 
(Fig. 5, exp. B-D). The results of these experiments show that a partial overlap 
between the sets of non-H-2 alloantigens of the two donor strains used for iv and 
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Fig. 3. Effect of the mode of presentation of 'specific' and third party 'bystander' alloantigens 
upon the suppression of OTH to alloantigens. Responder mice were iv injected with 5 x 107 
irradiated allogeneic or syngeneic spleen cells and sc immunized with 1 x 107 allogeneic spleen 
cells 7 days later. Challenge for OTH was performed on day 6 after sc immunization, Each 
column represents the mean response ± SE (n=6). In all the experiments significant suppression 
of DTH reactivity (p < 0.01) against third party 'bystander' antigens was found, when the 
'specific' and third party 'bystander' antigens were presented only during the sc induction of 
the DTH reactivity (line 1). Significant suppression (p < 0.01) was also found when both 
types of antigens were presented on separate cells, but simultaneously administered in a mix 
at the same site (line 3). The histograms on lines 2 and 4 represent the positive controls. 
The H·2 haplotypes are shown in parentheses. 
sc immunization, respectively, is sufficient to obtain suppression of the same 
magnitude <!S in the case of using the same allogeneic donor strain for iv and sc 
immunization. 
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810.01 BIO.Ol BALBI< IBIO.ScSn 810.ScSn 
Fig. 4. Effect of administration of the 'specific' and the third party alloantigens to separate 
sites upon the induction of DTH against the third party alloantigens. Responder mice were iv 
injected with 5 x 107 irradiated allogeneic of syngeneic spleen cells. Seven days later all mice 
were sc immunized in the brachial area with 1 x 107 spleen cells presenting the 'specific' 
al!oantigens. Simultaneously, they were sc immunized in the inguinal area with 1 x 107 spleen 
cells presenting the third party al!oantigens. Challenge for DTH was performed on day 6 after 
sc immunization. Each column represents the mean response ± SE (n"'6). In all experiments 
no significant difference was found in DTH reactivity between the responder mice, which 
were iv preimmunized with irradiated allogeneic (the 'specific' antigens) or with irradiated 
syngeneic cells. The H-2 haplotypes are shown in parentheses. 
DISCUSSION 
The data presented in this paper demonstrate that suppression of DTH to alia-
antigens can be induced not only by H-2 and non-H-2 coded antigens, but also 
by the H-2 subregion coded antigens K, I and D (Fig_ 1 ). The suppression for a 
particular H-2 subregion is specific for that subregion as well as for its haplotype 
(Fig. 1 ). To express their suppressive effect, the suppressor T cells involved must 
be restimulated with the original antigen. Quite similar results have been obtained 
by others in the suppression of mixed lymphocyte reactions (MLR) (17, 18). 
They showed that suppression of MLR can be mediated by K, I or D specific 
suppressor T cells (18, 19). 
Our results do not confirm the observation of Liew (7) that suppression of 
DTH to H-2 subregion coded antigens only occurs if an 1-J incompatibility is 
included. The requirement of an I·J allogeneic effect has also been described in 
suppression of contact sensitivity when suboptimal conditions are choosen for 
suppression, while under optimal conditions no I·J allogeneic effect was found 
to be needed (20). The biochemical nature of the 1-J antigens, however, is still 
uncertain. Studies in which monoclonal antibodies were used have shown that 
1-J is probably heterogeneous (21). Moreover, molecular and genetic studies 
159 
EXP. RESP.STRAIN I.V.PREIMMUNIZATION S.C. IMMUNIZATION t SPECIFIC INCREASE FOOT THICKNESS 
BAL8/c 810.02 810.02 ~ 
A BALB/c DBA/2 810.02 0-< 
BALB/c BALB/c 810.02 
BALB/c OBA/2 OBA/1 c:::=:J---< 
8ALB/c 810.01 OBA/2 ~ 
BALB/c BALB/c 08A/1 
OBA/2 810.02 810.01 
c OBA/2 8ALB/c 810.02 
OBA/2 08A/2 810.02 
BALB.K C3H/HeJ CJH/HeJ [}-< 
' 
BALB.K BlO.BR C3H/HeJ c:::::J-< 
BALB.K BALB.K CJH/HeJ 
, 
" " "" '" 
Fig. 5. Supression of DTH to non·H-2 alloantigens by partially overlapping sets of non-H-2 
alloantigens. Responder mice were iv injected with 5 x 107 irradiated allogeneic or syngeneic 
spleen cells and sc immunized with 1 x 107 allogeneic spleen cells 7 days later. Challenge for 
DTH was performed on day 6 after sc immunization. Each column represents the mean 
response± SE (n,6). In all experiments significant suppression of DTH reactivity (p < 0.01) 
was found after iv preimmunization with non-H-2 coded alloantigens, independent of whether 
the non-H-2 alloantigens used for iv suppression, for the sc induction of DTH reactivity, 
and for the challenge were derived from the same strain (line 1) or from different H-2 compatible 
mouse strains (!ine 2). Line 3 represents the positive control. 
could not demonstrate the existence of an 1-J locus between 1-A and 1-E (22). 
In contrast to our experimental set up, Liew (7) made use of cyclophosphamide 
(CY) treated responder mice. Earlier investigations dealing with su~pression of 
DTH to heterologous eryhrocytes have shown that the Lyt phenotype of the 
suppressor T cell that can transfer suppression depends on whether or not the 
responding mice are treated with CY. When CY was used, the suppressor T cells 
appeared to be Lyt-1+2- (23). while in the absence of CY Lyt-1·2+ suppressor T 
cells were found (24). Transfer experiments with suppressor T cells induced 
according to our protocol have shown that the suppression can be abolished by 
treatment with anti Lyt-1 as well as with anti Lyt-2 and complement (unpublished 
data). We are presently investigating whether the suppression in our system is 
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determined by one type of suppressor T cells or by several subsets of pheno-
typically different suppressor T cells. Taken together the above observations 
suggest that in the experiments described by Liew (7) and us different suppressor T 
cell systems or different parts of a more complicated suppressor T cell circuit 
are involved. 
The most important aspect of the present studies is the finding that after 
restimulation of suppressor T cells by the 'specific' antigens, the induction of the 
in vivo immune response to simultaneously administered third party antigens is 
also significantly suppressed. In some experiments a residual response was found 
(Fig. 2). This response, however, was always less than half the value of the 
response against the third party and the 'specific' antigens together. The residual 
response cannot be explained by supposing that it represents the response 
against the third party antigens, since the DTH response against the third party 
antigens only was of the same magnitude as the DTH response against the third 
party antigens and the 'specific' antigens together (Fig. 2). 
Most studies concerning the specificity of suppression of contact sensitivity 
(CS) and DTH reactivity against haptens deal with suppression during the 
effector phase of the response (3-5, 25, 26). By in vivo proliferation studies (9) 
and adoptive transfer experiments (unpublished data) we have shown that 
suppressor T cells induced by iv preimmunization with alloantigens suppress the 
induction as well as the expression phase of the DTH reaction. The present study 
shows that the simultaneous presentation of the 'specific' and third party 
antigens during the sc induction of DTH only is sufficient for suppression of the 
response to the latter. 
In MLR it has been shown that antigen·specific suppressor T cells induced by 
H-2 subregion or non-H-2 coded antigens could suppress the response to third 
party alloantigens when the suppressor T cells were reactivated by the 'specific' 
antigens (27, 28). Similar results have been obtained in experiments on the 
suppression of in vitro antibody formation (29, 30). Nonspecific suppression of 
the in vivo immune response against 'bystander' antigens by antigen-specific 
suppressor T cells has been described for the effector phase of CS to picrylchloride 
and oxazolone (25. 26) and for DTH to protein antigens (31, 32) and H-2 
subregion coded antigens (7). In the latter studies it was shown that suppression 
of DTH against the 'bystander' antigens only occurs when the 'specific' and 
'bystander' antigens are physically associated. 
In the suppression of CS to 4-hydroxy-3-nitrophenol no suppression of CS to 
'bystander' antigens has been found, even not in animals that had been primed as 
well as challenged with both the 'specific' and 'bystander' antigens (33). However, 
this lack of nonspecific suppression might be due to the separate administration 
of both antigens. The experiments presented in this paper reveal that suppression 
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of DTH to third party alloantigens also occurs when the 'specific' and the 
'bystander' antigens are present on separate cells, provided that both cell types 
are administered together at the same site (Fig. 3). When both cell types were 
injected at separate sites (e.g., the 'specific' antigens in the brachial area and the 
third party antigens in the inguinal area), no suppression of DTH to the third 
party antigens was found (Fig. 4). This suggests that the mediators accounting 
for the nonspecific suppressive effects are only effective in the close proximity 
of the site of production. 
The nonspecific suppression of DTH to 'bystander' alloantigens by specifically 
reactivated suppressor T cells and the observation that the 'specific' and 
'bystander' antigens do not need to be physically associated explain why allogeneic 
cells from different H-2 compatible mouse strains can induce suppression of 
DTH against each other (Fig. 5). As there is always an overlap between the 
non·H·2 alloantigens of two given H·2 compatible mouse strains (34), the shared 
antigens are able to reactivate a part of the iv induced antigen-specific suppressor T 
cells. The nonspecific suppressive effect mediated by these activated suppressor T 
cells apparently is sufficient to suppress the DTH reactivity against the non·shared 
antigens as well. 
The nonspecific T cell dependent suppression of DTH against third party allo· 
antigens can be explained by the recent data of Fresno eta!. (35·37). They have 
isolated an antigen-specific suppressor factor from continuously growing T celt 
clones. This factor is a protein which, after interaction with the specific antigen, 
breaks down in two peptides of 45,000 and 24,000 MW. The former subunit 
suppresses antigenspecific and other lyt·1 + T cells. The data of Fresno eta!., 
combined with the present data about nonspecific suppression of the in vivo 
immune response to 'bystander' alloantigens, even if they are not physically 
associated, may well explain the beneficial blood transfusion effect upon kidney 
transplant survival (38). Sharing histocompatiblity antigens by the transfused 
blood cells and the transplanted kidney and/or the passenger blood cells might 
reactivate antigen·specific suppressor T cells after transplantation, which might 
suppress the anti·graft reactions in a nonspecific way. 
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CHAPTER XII 
GENERAL DISCUSSION 
Several T cell subpopulations have been described with different functions 
within the immune system, for instance helper T cells (Th), amplifier T cells 
(Ta), DTH reactive T cells (Tdth), cytotoxic T cells (Tc) and suppressor T cells 
{Ts). The Lyt cell surface markers make it possible to discriminate between 
some of these subpopulations. 
Th cells and most of the Tdth cells are Lyt-1+2-, whereas Tc and Ts cells are 
Lyt-1-2+ or Lyt-1+2+ (1). Recently a monoclonal antibody against the murine 
T4 cell surface marker has been described (2). The T4 marker discriminates 
better forTh cells and Tdth cells than the Lyt 1 marker. 
The relationship between Th cells and T cells that mediate DTH has been 
studied by several investigators {3-5). They were not able to prove that B cell 
help and DTH reactivity can be mediated by one and the same T cell. Using 
Lyt-1 +2- cloned Th cells we were able to demonstrate that Th cells can mediate 
DTH responses (chapter Ill). The clones used for these studies have been shown 
to release several biologically active mediators, the induction of which is strictly 
antigen-specific and H-21A restricted (6). Weiss and Dennert (7), also demonstrated 
that uncloned and cloned alloantigen specific Lyt-1+2- T cell lines are able to 
elicit antigen specific DTH responses. Lin and Askonas (8) showed that an 
Lyt-1-2+ influenza A specific cytotoxic T cell clone was also able to elicit DTH 
responses after combination with the specific antigen. This is not amazing 
since some studies have shown that Lyt-1-2+ T cells may also mediate DTH 
{9). 
The question is whether Th cells are more effective in eliciting DTH responses 
than Tc cells. When we compare the reactivity in DTH of the cloned Th cells 
used in our experiments with the reactivity of the cloned T cell line used by 
Weiss and Dennert {7) or with the reactivity of the Tc cells used by Lin and 
Askonas (8), it appears that Th cells are much more effective. Further research 
is needed to reveal whether this difference is due to the different culture condi~ 
tions, or reflects an intrinsic difference between both T cell subpopulations. 
Priming of mice with SRBC or minor H-antigens not only induces DTH 
reactive effector T cells but also long-lived memory T cells (1 0). These memory 
T cells are insensitive to treatment with antimitotic drugs and have to be 
reactivated before secondary type DTH responses can be elicited (10). Studies 
by others ( 11, 12) investigating as to whether long-lived memory cells recirculate 
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or mainly belong to a resident population suggest that memory T cells can have 
either nature dependent on the type of cellular immune response studied. 
We investigated by means of thoracic duct cannulation whether the memory T 
cells involved in secondary DTH against SRBC and minor H-antigens recirculate 
(chapter IV). It was shown that thoracic duct lymphocytes (TDL) from mice 
which were immunized with SRBC or minor H-antigens several weeks previously, 
could adoptively transfer the ability of secondary DTH to these antigens. By 
passing such immune TDL through intermediate recipients we demonstrated that 
these SRBC or minor H-antigen specific memory T cells recirculate from blood 
to lymph. Thus, these memory T cells have the same characteristics as memory 
cells involved in secondary humoral immune responses (13-15). 
While secondary DTH to SRBC and minor H-antigens can be readily induced, 
secondary DTH to fully H-2 incompatible allogeneic cells does not occur (chapter 
V, and ref. 1 0). Even adoptive transfer of TDL from mice immunized with H-2 
incompatible spleen cells to irradiated recipients did not reveal a memory effect 
(chapter IV). This is in contrast with the results of Hall et at. (12). They have 
shown that in rats a dramatic and specific increase of allograft reactivity can be 
demonstrated after immunization with MHC coded antigens, prov'1ded an adop· 
tive transfer system is used. 
Subsequently we investigated whether class I and class II alloantigens separately 
are similarly incapable of eliciting secondary DTH (chapter VI. It appeared that 
class I alloantigens, just like SRBC and minor H antigens, are able to induce 
secondary type DTH, whereas class II alloantigens and combinations of class II 
and class I alloantigens do not induce secondary type DTH responsiveness. This 
lack of secondary DTH against a set of H-antigens that includes class II alia-
antigens cannot be explained by the suppressive effect of enhancing antibodies 
(16) or by the lack of appropriate restriction molecules (chapter VI). The 
experiments show that priming with class II alloantigens has a dominant effect, 
which prevents secondary DTH reactivity to class I alloantigens. The final proof 
for the existence of a dominant suppressive mechanism can be obtained in 
transfer experiments. Therefore one should investigate whether cells or factors 
isolated from mice which are primed, or primed and boosted, with a set of 
alloantigens that include class II alloantigens, can suppress a secondary type 
anti-class I DTH response in mice that received multiple immunization with 
class I alloantigens only. 
It is generally accepted that recognition of SRBC (chapter Ill) and minor H· 
antigens (17, 18) by DTH effector T cells is restricted by H-2 coded molecules. 
However, there is no general agreement about theexistenceofrestricted recognition 
of H-2 coded alloantigens (17, 18). Smith and Miller (18) and Weiss and Dennert 
(7) have shown that in vivo activated H-2 specific DTH effector T cells and lA 
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specific T cell lines can express DTH reactivity after transfer to H-2 incompatible 
naive recipients. They concluded that H-2 specific DTH effector T cells are un-
restricted. We have shown, on the other hand, that the anti-class I DTH response 
is restricted by class II molecules, whereas the anti-class II DTH response is 
restricted by class I molecules (chapter VI). Moreover, to our opinion the results 
of Smith and Miller and Weiss and Dennert do not exclude that their responses 
were actually H-2 restricted. To explain this we hypothesized the following 
(fig. 1 ). During the induction of DTH effector T cells to H-2 subregion coded 
alloantigens, these antigens are recognized by the reactive T cells in the context 
of the other H-2 molecules on the surface of the same allogeneic cells or, after 
processing by antigen-presenting cells (APC) in the context of the H-2 molecules 
of the APC. When the alloantigens are presented on cells from which the other 
H-2 molecules are syngeneic with the responder mouse, only synrestricted DTH 
effector T cells will be induced. On the other hand, when the particular H-2 
alloantigens are presented on an allogeneic H-2 background, the DTH effector 
T cells induced by direct interaction with the allogeneic cells will be allores-
tricted, while the DTH effector T cells induced after alloantigen processing 
and presentation by APC will be synrestricted. 
Van der Kwast (17) has shown in studies concerning H-2 restricted recogni-
tion of minor H-antigens in DTH, that macrophage processing of H-antigens is 
only important during induction of DTH and not during the expression phase. 
Therefore DTH effector T cells should recognize H-2 alloantigens on an allo-
geneic H-2 background only when the specific H-2 alloantigens are presented in 
Fig. 1. Mode! for syngeneically 
and allogeneically H-2 restricted 
recognition of H-2 subregion 
coded alloantigens. 
DTH 
Reactive 
Cell 
DTH 
"Syn" restricted 
Reactive "AIIo" restricted 
Cell 
DTH 
Reactive "Syn" restricted 
Cell 
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combination with the allogeneic H~2 restriction molecules during the activation 
of the DTH reactive T cells. 
The studies which are discussed above (chapters IV- VI) show that the sc 
route is an adequate way to induce DTH against H-antigens. The effect of iv 
administration of different doses of allogeneic spleen cells has also been investi-
gated. It appeared that iv immunization with allogeneic spleen cells can induce a 
state of DTH reactivity as well as a state of suppression (chapter VIII). The state 
of suppression due to the iv immunization becomes manifest after secondary sc 
immunization only and is not due to a shift in the moment of peak responsiveness 
(chapter VII). Two sc injections of the same antigen, on the other hand, do 
not lead to a lower DTH response than a single sc immunization. On the 
contrary, we have shown in situations where minor H~ or class I coded H-
antigens are used for primary and secondary sc immunization, that accelerated 
DTH responses evolve {chapter V). Thus the iv route of preimmunization seems 
to be obligatory for the induction of suppression of DTH against H-antigens. 
It was found that this state of suppression depends on antigen-specific Ts cells 
(chapters VII and VIII). From studies of DTH against heterologous erythrocytes 
(20, 21) and haptens (22- 24), it is known that iv administration of high doses 
of such antigens also induce a state of dominant suppression which depends on 
Ts cells. 
Suppression of DTH against H-antigens can be induced by iv injection of 
irradiated allogeneic spleen cells as well as by iv injection of non-irradiated 
allogeneic spleen cells. To avoid allogeneic effects and persistence of the injected 
allogeneic cells, we used irradiated allogeneic cells for the induction of suppression, 
usually. 
The suppressive effect appeared to be long-lasting (chapter VII). Transfer of 
the suppressed state with T cells from iv immunized donor mice to naive 
recipients was, on the other hand, only effective during the first few days after 
the iv suppressive injection (chapter VIII). The systemic transfer of Ts cells 
mainly affected the afferent limb (induction) of DTH (chapter VIII). Transfer of 
suppression of the efferent phase of DTH could be demonstrated only when the 
Ts cells were mixed with DTH effector T cells in vitro and the subsequent DTH 
response was quantitated in the immune lymphocyte transfer assay (chapter IX). 
The precursors of the Ts cells belong to the pool of recirculating T lympho-
cytes, which are insensitive to ATx and can be depleted by ATS treatment in 
vivo (chapter V Ill). In contrast to other examples of DTH suppressor systems 
(25, 26), the presence of the spleen was not needed for induction of the antigen-
specific Ts cells (chapter VIII). 
Analyses of the Lyt-1 and Lyt-2 markers on the cell surface of the Ts cells, 
showed that for suppression of the afferent as well as the efferent phase of 
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DTH to alloantigens Lyt-1 +2+ Ts cells are essential. Other authors described 
hapten specific Ts cells which affect either the afferent (27) or the efferent limb 
(22, 28) of DTH. Furthermore, cascades of different Ts cell subsets have been 
described, which affect both limbs of the DTH response (29). The Ts subsets 
which are involved in suppressor cell cascades could be distinguished from each 
other by different Lyt phenotypes and by different H-2 and lgh restriction 
requirements (29, 30). Our experiments could not demonstrate any need for 
restricted recognition of antigen and DTH reactive T cells by the afferent and 
efferent phase Ts cells (chapter IX). Thus until now there are no arguments 
to suppose that there is more than one type of Ts cell essential for both limbs of 
the DTH response against H-antigens. 
The alloantigen specific Ts cells can be induced not only by H-2 and non H-2 
coded alloantigens but also by H-2 subregion coded alloantigens (chapters 
VII, X & XI). Our studies do not confirm the observation of Liew (31) that 
suppression of DTH against H-2 subregion antigens only occurs when an 1-J 
incompatibility is involved. An important aspect of our studies is the finding 
that after restimulation of the Ts cells by the specific antigens, the induction 
of the in vivo immune response to simultaneously administered third-party 
alloantigens is also significantly suppressed (chapters IX- XI). This suppressive 
effect on DTH to third party alloantigens is called 'bystander suppression', 
Simultaneous presentation of the specific- and the third party-alloantigens either 
during the sc induction of DTH or during the challenge to elicit the DTH 
reaction, is sufficient for bystander suppression. This reinforces the conclusion 
from our transfer experiments (chapters V Ill & IX) that the iv induced Ts cells 
can affect either limb of the alloantigen specific DTH response. 
Bystander suppression also occurs when the specific and the third party-
alloantigens occur on separate cells, provided that both cell types are 
administered together at the same site (chapters IX- XI). A summary of our 
data on suppression of DTH to specific and third party·alloantigens is given in 
table 1. 
The next step in future research of alloantigen specific suppression should be 
the study of the nature of the putative suppressor factor(s). We have shown 
already that the ultimate suppressive effect by the Lyt-1 +2+ Ts cells is non-
specific (chapters IX- XI). From other studies (32, 33) it is known that most 
antigen specific Ts cells release antigen specific suppressor factors. These factors 
have to interact with the specific antigen (32) or with the specific antigen and 
another T cell (33) before a nonspecific suppressor factor is released. Most of the 
studies which describe the nature and working mechanism of supPressor factors 
are dealing with well-defined antigens like haptens (24, 29, 30, 33). In our 
studies (chapters VIII & IX) we are dealing with several different alloantigens. 
These alloantigens may have different requirements for the optimal induction of 
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Table 1. Suppression of specific- and thirdparty a/loantigens. • 
i.v. preimmunuzation s.c. immunization challenge for DTH 
A A A 
A B 8 
A AB AB 
A AB B 
A A+B B 
A A/B 8 
A B AB 
A 8 A+B 
*Summary of data presented in chapters IX- XI. 
suppression of 
DTH response 
yes 
no 
yes 
yes 
yes 
no 
yes 
yes 
A and B indicate groups of non-overlapping alloantigens; A represents the 'specific alloantigens' 
and B the 'third party alloantigens'; AS indicates that both sets of alloantigens are expressed 
together on the same allogeneic cells; A+B indicates that the alloantigens A and 8 are presented 
together in a mixture of cells expressing either A orB; A/8 indicates that the alloantigens A 
and Bare presented simultaneously at separate s"1tes. 
the appropriate Ts cells. Isolation and screening of suppressor factors with a 
defined antigen specificity is more difficult when a large number of different 
alloantigens is involved. The use of strain combinations with smaller and more 
defined alloantigenic differences may facilitate the study of the suppressor 
factors involved in suppression of DTH to alloantigens. This indicates the use of 
recombinant mouse strains (chapter X - XI) or the C57BL/6 mutant strains 
(34). The C57BL/6 mutants have small mutations in the H-2 K or I region, 
which result in biochemically and serologically well-defined structural alterations 
in the K or I molecules. Preliminary experiments have shown that DTH responses 
and suppression of DTH can be achieved in combinations of C57B L/6 mice and 
C578L/6 mutant mice with a mutation in the K or I region. 
The data of nonspecific suppressor factors (32, 33) in combination with our 
own data of bystander suppression of DTH to H-antigens may offer an explana-
tion for the above described (viz. 1.5) beneficial blood transfusion effect upon 
kidney transplant survival (35). 
The blood transfusion donor and the kidney donor have both a unique pattern 
of compatible and incompatible H-antigens with the kidney transplant patient. 
In an outbred population, like the human population, there will be always an 
overlap between the H-antigens of the donor of the transfused blood and the 
kidney donor (fig. 2). After kidney transplantation, these shared alloantigens 
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might reactivate specific Ts cells, which are induced by the blood transfusion. 
Subsequently, these reactivated Ts cells might suppress the kidney graft 
rejection in a nonspecific way. 
TRANSPLANT 
RECIPIENT 
BLOOD 
DONOR 
KIDNEY 
DONOR 
Fig. 2. Illustration of the putative overlap between the H-antigens of the transplant recipient, 
the blood-donor and the kidney-donor. A-F refer to different H-antigens. An overlap between 
the H-antigens of the blood-donor and the kidney-donor might cause the beneficial effect of 
blood transfusion on kidney transplant rejection (viz. 1.5). 
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SUMMARY 
Cellular immunity in vivo was studied in mice by means of the delayed type 
hypersensitivity (DTH) assay with emphasis on the response to histocompatibility 
(H) antigens. The first part of the experimental work of this thesis (chapters Ill 
- VI) deals with the cellular and genetic requirements for induction and expression 
of DTH, while the second part (chapters VII- XI) deals with the requirements 
for suppression of DTH. 
In most instances, T cells mediating DTH responses share the Lyt phenotype 
and H*2 restriction requirements with helper T cells. This raises the question 
as to whether helper activity and DTH can be mediated by the same activated T 
cells. In chapter Ill this was investigated by making use of clones of SR BC 
specific Th cells. DTH responses could be elicited after local transfer of 
cloned Th cells together with the specific antigen in the dorsum of a hind foot of 
syngeneic recipient mice. The C57B L/6J-derived cloned Th cells mediated DTH 
responses only in mice which were H-2 K and 1-A compatible with C57BL/6J 
mice. With the available mouse strains we could not distinguish for K or i-A 
restriction. Transfer of cloned Th cells to T cell deficient syngeneic nu/nu 
mice showed that host T cells were not essential for the DTH response. As few as 
1000 cloned Th cells injected together with the specific antigen were able to 
elicit a specific DTH response. In comparison with in vivo activated lymph 
node cells, the cloned Th cells were far more effective on a per cell basis. Thus, 
helper activity and DTH can be mediated by the same T cells. 
Secondary type DTH responses can be induced against SRBC and minor H-
antigens. We investigated whether memory T cells involved in secondary DTH 
against SRBC and minor H-antigens recirculate. This was done by thoracic duct 
cannulation (chapter IV). It was found that thoracic duct lymphocytes (TDL) 
from mice which had been immunized with the specific antigens several weeks 
previously could adoptively transfer the capacity of secondary DTH to the 
specific antigens. By passing these immune TD L through an intermediate recipient 
it was demonstrated that the memory T cells involved recirculate from blood to 
lymph. 
Priming and booster immunization with fully H-2 incompatible cells did not 
induce secondary type DTH. We investigated whether class I and class II alia-
antigens separately are also incapable of eliciting secondary DTH (chapter 
V). It appeared that class I coded alloantigens (H-2 K and D), just like SRBC 
and minor H-antigens, could induce secondary type DTH, whereas class II 
coded alloantigens (H-21) and combinations of class II and class I alloantigens 
failed to induce secondary type DTH. From these experiments we concluded 
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that priming with class II alloantigens has a dominant effect which prevents 
secondary DTH to class I alloantigens. 
The question as to whether the elicitation of DTH reactivity against class 
I or class II coded alloantigens is restricted by other H-2 molecules, has been 
investigated in chapter VI. These experiments provided evidence that DTH 
reactive T cells which are activated against class I alloantigens, need to recognize 
these antigens in the context of syngeneic class II molecules to elicit a DTH 
response, while T lymphocytes activated against class II alloantigens need to 
recognize these antigens in the context of syngeneic class I molecules. Thus, with 
regard to the requirement of MHC restriction, DTH against class I alloantigens 
and class II alloantigens does not differ essentially from DTH against minor H-
antigens and conventional antigens like heterologous erythrocytes. 
In chapters IV - VI it is shown that subcutaneous (sci immunization is 
appropriate for inducing DTH against H-antigens. Subcutaneous preimmuni-
zation does even induce a state of secondary type DTH reactivity when minor H-
antigens or class I coded alloantigens are administered. Intravenous (iv) preimmuni-
zation, on the other hand, induces a state of suppression which becomes mani-
fest after a subsequent secondary sc immunization for the induction of a DTH 
response (chapter VII). 
The iv route was found to be obligatory for the suppressive effect and the 
extent of suppression appeared to depend on the dose of iv injected irradiated 
allogeneic spleen cells (chapter VII). It has been shown that the intravenous 
injection of H-antigens induces Ts cells by which the suppressive effect could be 
transferred to naive recipient mice (chapters V Ill & I X). 
Although the iv induced suppressive effect persisted in the suppressed mice 
for at least 70 days, systemic transfer of Ts cells was effective during the first 
few days after their induction only. The systemic transfer mainly affected the 
afferent limb of DTH. Efferent phase Ts cells could be demonstrated only by 
cotransfer of lymphoid cells from iv suppressed mice and DTH effector T cells in 
the immune lymphocyte transfer assay (chapters VIII & IX). 
For suppression of the afferent as well as the efferent phase of alloantigen 
specific DTH Lyt-1+2+ Ts cells appeared to be essential. We did not find evidence 
for a H-2 or lgh restricted activation and function of the Ts cells active in both 
limbs of alloantigen specific DTH. Therefore we concluded that there are no 
arguments as yet to suppose that there is more than one type of Ts cells involved 
in the suppression of the afferent and efferent limb of DTH against H-antigens 
(chapters VIII & IX). 
Specificity studies showed that the activation of the Ts cells by alloantigens 
is antigen-specific (chapters VII, X & XI I. However, after restimulation ofthe Ts 
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cells by the specific antigens, the induction of the in vivo immune response to 
simultaneously administered third-party alloantigens was also significantly 
suppressed. This nonspecific suppression of DTH to third party 'bystander' alia-
antigens also occurred when the specific and the third-party alloantigens were 
presented on separate cells, provided that both cell types were administered 
together at the same site. Simultaneous. presentation of both sets of alloantigens 
either during the sc induction of DTH or in the challenge to elicit the DTH 
reaction, was also sufficient for bystander suppression (chapters IX- XI). 
For a detailed insight into the nature of the bystander suppressive effect, 
future research should be focussed on the isolation and characterization of the 
suppressor factor(s) which are released after stimulation of Ts cells with the 
specific antigen. 
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SAMENVATTING 
Cellula ire immuniteit in vivo werd bestudeerd bij de muis met behulp van de 
vertraagd type overgevoeligheidsreaktie ( DTH I, waarbij de nadruk lag op het 
onderzoek naar de reaktie tegen transplantatie of histocompatibiliteits (H) 
antigenen. 
Het eerste deel van het onderzoek, dat in dit proefschrift is beschreven (hoofd-
stuk Ill - VII, heeft betrekking op de cellulaire en genetische voorwaarden voor 
het optreden van een DTH reaktie, terwijl het tweede gedeelte (hoofdstuk VII -
XI) betrekking heeft op de voorwaarden voor het onderdrukken van een DTH 
reaktie. 
Meestal hebben de T lymphocyten die een DTH reaktie veroorzaken het 
zelfde Lyt fenotype en dezelfde voorwaarden voor H-2 restrictie als helper T 
(Th) eel len. Dit roept de vraag op ofT cellen die in staat zijn om helper activiteit 
te geven ook in staat zijn tot een DTH reaktie. In hoofdstuk Ill werd dit nader 
bestudeerd, waarbij gebruik gemaakt is van klonen van Th cellen die specifiek 
waren voor het antigeen SRBC. 
DTH reakties konden worden opgeroepen door lokale injektie van geklo-
neerde Th cellen, samen met het specifieke antigeen, in een achterpoot van 
syngene recipient muizen. De van C57BL/6J muizen afkomstige gekloneerde Th 
cell en gaven aileen DTH reakties in muizen die H-2 Ken 1-A compatibel waren met 
C57BL/6J muizen. Met de geteste muizenstammen kon geen onderscheid worden 
gemaakt tussen K of 1-A restrictie. Transfer van gekloneerde Th cell en naar T eel 
deficiente nu/nu muizen toonde aan dat T cell en van de gastheer niet noodzakelijk 
waren voor de reaktie. Reeds 1000 gekloneerde Th cell en, welke sa men met het 
specifieke antigeen werden ingespoten, waren voldoende om een DTH reaktie op 
te roepen. Beoordeeld op het effekt per eel, bleken gekloneerde Th cell en veel 
effektiever dan in vivo geaktiveerde lymfkliercellen. De konklusie uit deze 
experimenten is, dat dezelfde T cellen die in staat zijn om helper aktiviteit te 
geven ook een DTH reaktie kunnen opwekken. 
Sekundair type DTH reakties kunnen worden geinduceerd tegen SRBC en 
minor H-antigenen. Wij onderzochten of memory T cell en, die betrokken zijn bij 
de sekundaire DTH reaktie tegen SRBC of minor H-antigenen, recirculeren. Dit 
werd onderzocht met behulp van ductus thoracicus cannulatie (hoofdstuk IV). 
Gevonden werd dat ductus thoracicus lymfocyten (TD L), afkomstig van muizen 
die enige weken eerder waren geimmuniseerd, in staat waren om het vermogen 
tot sekundaire DTH reaktiviteit voor het specifieke antigeen over te dragen aan 
naiVe muizen. Door deze immune TDL iv toe te dienen aan een intermediaire 
recipient en vervolgens te isoleren uit de ductus thoracicus, kon worden aange~ 
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toond, dat de betrokken T memory eel len recirculeren van bloed naar lymfe. 
Primaire en sekundaire immunisatie met eel len die volledig H~2 incompatibel 
zijn, induceert geen sekundair type DTH reaktie. We onderzochten of klasse I of 
klasse II alloantigenen afzonderlijk oak het vermogen missen om een sekunw 
daire DTH reaktie op te wekken (hoofdstuk V). Het bleek dat klasse I gecodeer-
de alloantigenen (H-2 K en D), net a is SRBC en minor-H antigenen, een sekun-
dair type DTH reaktie konden induceren. Klasse II gecodeerde alloantigenen 
(H-21) of combinaties van klasse II en klasse I alloantigenen waren hiertoe niet 
in staat. Uit deze experimenten konkludeerden wij dat primaire immunisatie 
met klasse II alloantigenen een dominant effekt heeft, dat er voor zorgt dat 
sekundair type DTH reakties tegen gelijktijdig aangeboden klasse I alloantigenen 
worden voorkomen. 
De vraag of een DTH reaktie gericht tegen klasse I of klasse II alloantigenen 
wordt bepaald door andere H-2 moleculen, is onderzocht in hoofdstuk VI. Op 
grond van deze experimenten werden aanwijzingen verkregen dat DTH reaktieve 
T cellen, welke geaktiveerd zijn tegen klasse I alloantigenen, deze antigenen 
moeten herkennen in de kontekst van syngene klasse II moleculen. T lymfocyten 
die tegen klasse II alloantigenen zijn geaktiveerd, daarentegen, moeten deze 
antigenen herkennen in de kontekst van syngene klasse I moleculen. Wat betreft 
het optreden van MHC restrictie verschilt DTH tegen klasse I en klasse II allo-
antigenen dus niet wezenlijk van DTH tegen minor H~antigenen en conventionele 
antigenen, zoals heterologe erythrocyten. 
Uit hoofdstuk IV - VI blijkt dat subcutane (sc) immunisatie een geschikte 
manier is om DTH tegen H-antigenen te induceren. Subcutane preimmunisatie 
met minor~H antigenen of klasse 1 alloantigenen induceert zelfs een staat van 
'memory' voor sekundaire DTH reaktiviteit. lntraveneuze (iv) preimmunisatie, 
daarentegen, induceert een staat van suppressie welke tot uiting komt bij een 
daarop volgende sc immunisatie voor de induktie van DTH (hooldstuk VII). 
Voor het verkrijgen van het suppressief elfekt bleek iv immunisatie een vereiste 
en de mate van suppressie bleek afhankelijk van de dosis iv geinjekteerde, be-
straalde miltcellen (hoofdstuk VII). Door de intraveneuze injektie van H-anti-
genen werden Ts cellen geinduceerd, waarmee het suppressief kon worden over~ 
gedragen naar naive muizen (hoofdstuk VIII & IX). 
Hoewel in gesupprimeerde muizen het iv geinduceerde suppressieve effekt 
aanhield gedurende een periode van minstens 70 dagen, bleek iv toediening 
van Ts cellen slechts effektief gedurende de eerste paar dagen na induktie van 
suppressie. lv toediening van Ts cell en beinvloedde voornamelijk de induktie van 
een staat van DTH. Het v66rkomen van Ts cell en die de expressie van DTH on-
derdrukken, kon aileen worden aangetoond door gelijktijdige iv toediening van 
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lymphoide cellen van gesupprimeerde muizen en DTH effektor T cellen in de 
'immune lymphocyte transfer assay' (hoofdstuk V Ill & I X). Voor suppressie van 
zowel de afferente als de efferente fase van de alloantigeen specifieke DTH 
bleken Lyt-1+2+ Ts cellen essentieel. Wij vonden geen aanwijzing voor een H-2 
of lgh 'restricted' activatie en functie van Ts cellen welke aktief zijn gedurende 
beide fasen van de alloantigeen specifieke DTH. Op grand van deze resultaten 
konkludeerden wij dat er geen argumenten zijn om te veronderstel!en dat er 
meer dan een type Ts eel betrokken is bij de afferente en efferente lase van DTH 
tegen H-antigenen. 
Specificiteitsstudies toonden aan dat de aktivatie van de Ts cell en door allo-
antigenen antigeenspecifiek is (hoofdstuk VII, X & XI). Echter, na restimula-
tie van de Ts cellen door de specifieke antigenen, werd de induktie van DTH 
tegen gelijktijdig aangeboden 'third party' alloantigenen ook onderdrukt. Deze 
niet-specifieke suppressie van DTH tegen 'third party bystander' alloantigenen, 
trad ook op wanneer de specifieke en de 'third party' alloantigenen werden 
aangeboden op afzonderlijke cellen. Een voorwaarde daarbij was dat beide cel-
typen gezamenlijk werden aangeboden op dezelfde plaats, De gezamenlijke 
aanbieding van beide sets aHoantigenen, aileen gedurende de sc induktie van 
DTH reaktiviteit of aileen gedurende de 'challenge' om een DTH reaktie op te 
roepen, was oak voldoende om de DTH tegen 'bystander' alloantigenen te 
onderdrukken. 
Voor een beter inzicht in de aard van het suppressief effekt op DTH tegen 
'bystander' antigenen zou toekomstig onderzoek zich moeten richten op de 
isolatie en de karakterisering van suppressorfaktor(en), we ike worden vrijgemaakt 
na stimulatie van Ts cell en met het specifieke antigeen. 
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